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Rearrangement and Cascade Reactions:  New Synthetic Methods and the Total 
Synthesis of Diazonamide A 
 
 
 David Lee Waller, Ph.D. 
University of Pittsburgh, 2008
 
 This dissertation describes the development of several cascade reactions and their application 
to the synthesis of structurally and/or biologically relevant molecules.  We successfully developed a 
three-step, one-pot carboalumination-Claisen rearrangement-addition reaction, which provides 
complex allylic alcohols from simple starting materials.  While attempting to extend this 
methodology to nitrogen-containing substrates, a tandem hydrozirconation-iminium ion addition 
reaction was developed that allows simple access to functionalized isoindolinones.  An oxidative 
rearrangement of enol ethers to spiroketals was developed, contributing an unusual approach to these 
highly sought after functionalities.  Finally, an approach to the complex natural product diazonamide 
A was investigated with the intention of applying the Chan rearrangement.  Eventually, the 
complexities of total synthesis forbid the use of the Chan rearrangement, and an alternative pathway 
was developed that led to the application of a cascade acyl chloride-oxazoline ring scission to install 
critical components of diazonamide. 
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1. WATER ACCELERATED CASCADE REACTIONS 
1.1 INTRODUCTION 
1.1.1 Carboalumination of Alkynes 
Some of the earliest accounts of the carbometallation of alkynes appeared around 1970 and 
included metals such as Mg,1 Rh,2 and Cu.3  An preliminary report detailing carboalumination 
appeared in 1960,4 demonstrating the reaction of acetylene with triethylaluminum at 60 °C.  Of all of 
these carbometallations, the method which proved most general was carbocupration,5 until the 
catalytic carboalumination was published.  The zirconium-catalyzed carboalumination of alkynes 
(Scheme 1-1) was discovered by Negishi and co-workers in 1978.6   
 
R
AlMe3
cat. Cp2ZrCl2 AlMe2
R
1-1  
Scheme 1-1.  Zirconium-catalyzed carboalumination. 
The carboalumination of alkynes is one of the most versatile methods for the preparation of 
olefins with defined geometry.  Terminal alkynes give excellent regioselectivity, often greater than 
95:5 in favor of terminal metallation.  Internal symmetrical alkynes also give excellent 
stereoselectivity.7 The mechanism of carbometallation was initially thought to involve 
carbozirconation by MeZrCp2Cl, followed by transmetallation to Al (Scheme 1-2).8   
 
 1 
AlMe3 + Cp2ZrCl2
R
R
ZrCp2
Me2Al
Cl
ZrCp2Me
Cl
Cl AlMe2Cl
δ+ δ−
Al
Me2
Cl
ZrCp2
Cl
R
transmetallation
AlMe2
R
+ Cp2ZrCl2
Me
1-2
1-3
1-4
1-1  
Scheme 1-2.  Initially proposed mechanism of zirconium-catalyzed carboalumination. 
  
Subsequent mechanistic investigations weakened support for the 
carbozirconation/transmetallation mechanism.  A mixture of Me2AlCl-Cp2ZrCl2 was also found to 
be a good methylating agent, although no Cl-Me exchange could be observed by NMR. The 
formation of MeCp2ZrCl would be necessary for the mechanism in Scheme 1-2 to be valid.  NMR 
data clearly indicated the reversible Cl-Me exchange between Zr and Al in mixtures of AlMe3-
Cp2ZrCl2.    These data led to a revision of the proposed mechanism of carboalumination to a Zr-
assisted direct Al-C bond addition to the alkyne (Scheme 1-3). 
 
 2 
AlMe3 + Cp2ZrCl2
R
R
Me Al
Me2Al
Cl
ZrCp2Me
Cl
Cl ZrCp2Me
δ+ δ−
Zr
Cp2
Cl
AlMe
Cl
R
AlMe2
R
+ Cp2ZrCl2
Me Cl
1-2
1-5 1-6
1-1  
Scheme 1-3.  Revised and generally accepted mechanism of carboalumination. 
    
Furthermore, when a 1:1 mixture of AlEt3 and Cl(Me)ZrCp2 was treated with 1-heptyne, only 
1-7 and 1-8 were isolated in a combined 93% yield, with only trace amounts of the product derived 
from methylalumination formed (Scheme 1-4). 
 
C5H11
1) Et3Al
Cp2ZrCl(Me)
2) H3O+
nC5H11
Et
nC5H11
Et
+
93% (70:30)
1-7 1-8
 
Scheme 1-4.  Attempted crossover experiment demonstrating that Cp2ZrCl(Me) is not the active 
methylating agent in zirconium-catalyzed carboalumination. 
    
A solvent effect is also observed in the zirconium-catalyzed carboalumination of alkynes.  
The relative rate of the reaction decreases on going from 1,2-dichloroethane to chlorobenzene to 
benzene, following the general trend of the dielectric constants of the solvents (ε = 10.4, 5.6, and 2.3, 
 3 
respectively).  This observation is in agreement with the existence of the highly polarized 
intermediate 1-5. 
A complementary method that furnishes the products of a net anti-carbometallation has been 
reported recently.9  Homopropargyl alcohols as well as their one carbon homologues undergo 
standard zirconium-catalyzed carboalumination, but when heated, the products of an anti-
carbometallation were isolated.  Negishi has proposed a thermal isomerization through bis-alane 
intermediate 1-10.  Methyl transfer to aluminum and reformation of the olefin generates metallacycle 
1-12, the masked product of anti-carboalumination of the alkyne (Scheme 1-5).  Good yields and 
excellent anti/syn selectivities are observed (>98:2).  It is interesting that this isomerization is 
thermally induced.  Without heating, only syn-carbometallation products are isolated.   
 
Me AlMe2
O
Al
Me AlMe2
Me
Me
H
O
Al
Me AlMe3
H
CH3
O
Al
Me H
CH3
OAlMe2
1-9 1-10
1-11 1-12  
Scheme 1-5.  Mechanism of thermal isomerization resulting in anti-carboalumination. 
  
Vinyl alanes resulting from carboaluminations of alkynes can be transformed in a variety of 
ways, making them versatile intermediates.  The Al of the resulting vinyl alane can be readily 
exchanged with H(D),6 I,10 Hg,11 B,12 Zr,12 trapped with epoxides,13 chloroformates,13 and imines14 
 4 
or coupled to vinyl15 or aryl halides.16 Carboalumination has found recent utility in the synthesis of 
the carotenoids17 and the insect juvenile hormones I and II.18  
In 1993, Wipf and Lim reported dramatic rate enhancing effects of water on 
carboaluminations.13 Standard Negishi carboalumination of 1-octyne proceeds in 3 hours at room 
temperature to yield a 95:5 mixture of regioisomers following aqueous acidic workup (Scheme 1-6).  
Addition of stoichiometric amounts of water allows for the same carboalumination to proceed at -70 
°C within minutes.  Yields and selectivities are identical to those reported by Negishi.3   
 
nC6H13
1) AlMe3
Cp2ZrCl2
2) H3O+
nC6H13
Me
nC6H13
Me
+
95:5
23 oC
nC6H13
1) AlMe3
Cp2ZrCl2
2) H3O+
nC6H13
Me
nC6H13
Me
+
95:5
-70 oC
H2O
3-24 h
10 min
1-13 1-14
1-13 1-14
 
Scheme 1-6.  The Negishi carboalumination and the water-accelerated carboalumination discovered 
by Wipf and Lim. 
  
The vinyl alane intermediates obtained from the water-accelerated carboalumination can be 
manipulated in the same fashion as standard carbometallation intermediates.  The structure of the 
active carboaluminating reagent, however, remains elusive.  The origin of the rapid rate acceleration 
also remains in doubt.  Wipf proposed the oxo-bridged dimer 1-15 (Scheme 1-7) as the catalytically 
active species, although its existence at temperatures above 0 °C was questionable at the time of 
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publication. More recent results from the Wipf group19,20 indicate that temperature is not a factor in 
the rate enhancement.  
 
R
Cp2Zr
O
Al
R
R
1-15  
Scheme 1-7.  Proposed oxo-bridged intermediate responsible for water related rate enhancement of 
carboalumination. 
1.1.2 The Nature of Water/Alane Mixtures 
The composition of mixtures of alkylalalanes and water is the subject of considerable 
research.21  This effort is largely funded by the polymer industry because these mixtures are known 
to efficiently co-promote olefin polymerization in the presence of group 4 metallocenes.22  
Methylaluminoxane (MAO) is, by far, the most popular and effective polymerization co-catalyst.  
MAO has been known to promote the polymerization of monomers since the early 1960s.23  MAO is 
generated by the controlled hydrolysis of AlMe3, forming the Al-O-Al linkage with the extrusion of 
CH4 gas. This relates it to the accelerated carboalumination conditions developed by Wipf and Lim.  
Although the structure and reactivity of MAO is highly dependent on the method of preparation,24 
MAO most likely approximates the nature of the mixtures formed when water-accelerated 
carboalumination conditions are generated in the laboratory.  Despite its widespread use, little is 
known about its structure or physical properties.  MAO is, however, known to be an equilibrating 
mixture of oligomers with an average molecular weight of 1100.25 Substantial efforts have been 
made to acquire information about the structure of MAO and related systems with 27Al NMR, mass 
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spectrometry, and computational methods.26,27 These efforts have generated some concrete findings, 
but are plagued by inconsistencies associated with the handling of MAO.  The reaction of water and 
alkyl alanes (Scheme 1-8) has been followed by NMR and reported to be dependant on temperature, 
with full consumption of the water protons occurring around 0 °C.28   
 
AlMe3 H2O+ (MeAlO)n + CH4
 
Scheme 1-8.  The reaction of AlMe3 with water. 
  
It should be noted that these NMR experiments were performed in diethyl ether, and the 
reaction was followed by observing the proton resonances of the alkyl groups on aluminum.  It is 
generally accepted that MAO is always contaminated with free AlMe3 (if it is removed, the MAO 
oligomer will release more AlMe3) and contains a constant Me/Al ratio of 1.529.  Multinuclear NMR 
investigations have shown that four-coordinate aluminum centers predominate in MAO, although 
some three-coordinate centers do exist.30 All of the oxygen atoms in MAO are believed to be three-
coordinate.24 About 15-20% of the methyl groups of MAO are believed to be bridging between Al 
atoms in a rapidly exchanging fashion31 and these methyl groups participate in reactions which 
activate metallocenes for catalytic olefin polymerization.   
The Lewis acidity of the reagent has been proposed to be very similar to that of AlMe3.24,32 
This acidity has been attributed to either free AlMe3 or open sites on oligomeric aluminoxanes.  The 
actual structures which most commonly are postulated for MAO are shown in Scheme 1-9.  Cyclic 
6-membered fused rings (1-16) of varying length and 4-membered rings33 (1-17) were observed by 
X-ray diffraction.  More recently, Sinn and co-workers34 have proposed structures representing the 
tetramer of 1-18, which is based on the tert-butyl monomer 1-19 which has been observed by X-ray 
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diffraction.  Thus, the structure of MAO can be drawn as a collection of rapidly equilibrating 
oligomers which contain acidic sites that participate in chemical reactions.  
 
O
Al
O
Al
O
Al
O
Al
O
AlO
Al
O
Al
Al
O
Al
Al
Al
OAlO
AlOAl
O Al
O
Al O
Al
OAlO
AlOAl
O Al
O
Al O
Al
tBu
tBu
But
But
tBu
tBu
1-16 1-17
1-18 1-19  
Scheme 1-9.  Proposed structures of aluminoxanes. 
1.1.3 The Claisen Rearrangement 
The Claisen rearrangement of allyl vinyl ethers (1-20→1-21, Scheme 1-10) was discovered 
in 1912.35 Since this initial report, it has become one of the most utilized methods for introducing 
molecular complexity.36   
 
1
2
4
5
6
3
O O
1
2
4
5
6
3
1-20 1-21  
Scheme 1-10.  The Claisen rearrangement and the numbering of the allylic vinyl ether system. 
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The Claisen rearrangement is a concerted, non-synchronous37 pericyclic reaction that shows 
a strong preference for a chair-like transition state.  Calculations have estimated the stability of the 
chair transition state (1-23) over the boat transition state (1-22) of allyl vinyl ether to be 6.6 
Kcal/mol (Scheme 1-11).38 The preference for the chair-like transition state can, however, be 
overridden by conformational constraints.   
 
O
O
1-22 1-23  
Scheme 1-11.  The possible boat (1-22) and chair (1-23) conformations of the Claisen 
rearrangement. 
  
In most cases, the electronic structure of the transition state is thought to range from a 
number of limiting electronic distributions (1-25, 1-26) which can be derived from the traditional 
aromatic transition state (1-24)(Scheme 1-12). However, the electronic structure of the transition 
state continues to be debated since it is highly dependant on substitution.39   
 
O O O
1-24 1-25 1-26  
Scheme 1-12.  Proposed transition states of the Claisen rearrangement. 
  
The Claisen rearrangement benefits thermodynamically from the scission of a C-O σ-bond 
and two C-C π-bonds and the formation of a new C-O π-bond, a new C-C σ-bond and a new C-C π-
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bond.  This benefit of roughly 20 kcal/mol is derived mainly from the conversion of the C-C π-bond 
into a C-O π-bond.  
The synthetic utility of the Claisen rearrangement has been well documented over the 105 
years since its discovery.  Advances have been made steadily over the years, including the study of 
the metal-promoted rearrangement.  Protic as well as Lewis acids were found to effectively promote 
the Claisen rearrangement and other closely related [3,3] sigmatropic rearrangements.  Aluminum 
has proven to be a most effective and widely used metal for the promotion of the Claisen 
rearrangement.40 In a recent example, Wipf and co-workers reported an accelerated aromatic Claisen 
rearrangement using water-activated alanes (Scheme 1-13).40(b) 
 
O OH
1) AlMe3 (4 eq)
H2O (1 eq)
2) H3O+
94%1-27 1-28  
Scheme 1-13.  The aromatic Claisen rearrangement promoted by water-activated alane. 
  
Recently, transition metals have found increased use for the catalysis of the Claisen 
rearrangement, including highly diastereoselective and enantioselective variants.41 A testament to 
the utility of the Claisen rearrangement and its variants is its continued use in tandem methodology 
and in the synthesis of complex natural products.   For example, Wipf and co-workers reported a 
tandem aromatic Claisen rearrangement/catalytic asymmetric carboalumination (Scheme 1-14) 
utilizing water-activated alane and Erker’s catalyst.42   
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O HO
OH
Zr
Cl
Cl
1.  Me3Al, H2O, CH2Cl2
2.  Air
5 mol%
75%, 75% ee
1-27 1-29
 
Scheme 1-14.  Tandem Claisen rearrangement/carboalumination in the presence of Erker's catalyst. 
  
Ganesan and co-workers recently completed the total synthesis of okaramine J using an aza-
Claisen rearrangement (Scheme 1-15).43 An advanced intermediate in a total synthesis of the 
complex natural product azadirachtin was accessed using a microwave-assisted Claisen 
rearrangement.44 
 
Azadirachtin
N
H
N
NH
NH
O
O
H
HO
H
Okaramine J
MeO2C O
OO
CO2Me
OHAcO
OH
O
O
O
OH
H
O
H
 
Scheme 1-15.  Structures of okaramine J and azadirachtin. 
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1.2 RESULTS AND DISCUSSION 
1.2.1 Proof-of-Concept Studies 
Based on results of the Wipf group on water-accelerated processes, a cascade involving a 
water-accelerated carboalumination and an aliphatic Claisen rearrangement was envisioned.  Since 
the aliphatic Claisen rearrangement gives rise to an aldehyde, vinyl addition should follow 
rearrangement, thereby comprising a cascade reaction (Scheme 1-16).  This proposed sequence will 
form three new C-C bonds by converting an achiral allyl vinyl ether into an allylic alcohol 
containing three contiguous stereocenters. 
 
R2
R3
OH
R1
R2 O R3
R1
Al
Me
MeAlMe3, H2O
Cp2ZrCl2
O
H
R3
R2
* **
R1
Zirconium-Catalyzed, Water-
Accelerated Carboalumination
Aluminum-Promoted
Claisen Rearrangement
Vinyl Alane Addition
R1
Al
Me
Me
 
Scheme 1-16.  Proposed three-step cascade reaction to form allylic alcohols. 
  
The initial proof-of-concept reaction was performed with cinnamyl vinyl ether (1-30). 
Treatment of the carboalumination product of 1-hexyne with 1-30 in CH2Cl2 at -78 °C gave a 42% 
yield of 1-31a and 1-31b as a 1:1 mixture of diastereomers (Scheme 1-17).  The desired product was 
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accompanied by substantial amounts of 1-32, which was characterized by 1H NMR and mass 
spectroscopy.   
 
C4H9
OPh2)
1) AlMe3 (5 eq)
H2O (2.5 eq)
Cp2ZrCl2 (10 mol%)
42% (1:1)
Ph OH
+
1-30
1-32
Ph OH
C4H9
1-31a
Ph OH
C4H9
+
1-31b
~30%  
Scheme 1-17.  Proof-of-concept experiment. 
1.2.2 Optimization Studies  
Optimization of the cascade reaction was performed with cinnamyl vinyl ether (1-30) and 1-
hexyne.  The initial goal was to increase the yield of 1-31 by suppressing the formation of 1-32, 
derived from methyl addition to the aldehyde (Table 1-1).  It was postulated that the large excess of 
AlMe3 (5 eq) present in the reaction mixture was responsible for the methyl addition to the aldehyde.  
Reduction of the equivalents of both AlMe3 and H2O to 2.2 and 1.1, respectively (Entry 1), 
suppressed the undesired methyl addition to nearly undetectable levels.  Further reduction to 2 
equivalents of AlMe3 and 1 equivalents H2O (Entry 2) furnished the desired product in 60% yield 
with no evidence of the methyl transfer by-product; however some hydrolysis of the starting vinyl 
ether was indicated by TLC analysis. 
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Table 1-1.  Cascade carboalumination/Claisen rearrangement optimization. 
Entry AlMe3 (eq) H2O (eq) Yieldc
1
2
3
4
6
7
5
2.2 1.1
2.05 1.0
1.5 0.75
1.0 0.5
2.5 1.25
2.2 2.25
2.25 0.56
Solvent
8
9
2 1
2.25 1.2
ClCH2CH2Cl
Toluene
CH2Cl2
CH2Cl2
CH2Cl2
CH2Cl2
CH2Cl2
CH2Cl2
CH2Cl2
56
60
0
0
60
25
61
60
48
C4H9
OPh
Ph OH
C4H9
2)
1) Conditionsa
1-30
1-31a/b
a Carboalumination performed at 0 oC in the presence of 10 mol % 
Cp2ZrCl2. b 1-30 added at -78 oC and allowed to warm to ambient
temperature.  c dr = 1:1.
b
 
  
Reduction of the amount of AlMe3 to levels below 2 equivalents resulted in no reaction or 
only a trace of conversion (Entries 3 and 4).  Raising the amount of AlMe3 to 2.5 equivalents and 
H2O to 1.25 equivalents had little effect on the yield (Entry 5).   
 With the conditions optimized for vinyl ether 1-30, the amount of water added to the reaction 
was further investigated.  Equimolar amounts of AlMe3 and H2O gave a very slow reaction and 
lowered the yield substantially (Entry 6).  Interestingly, good yields were obtained with 
substoichiometric amounts of H2O (Entry 7); however, this was unique to simple unfunctionalized 
allyl vinyl ethers.  The optimum stoichiometry was 2 equivalents of AlMe3 and 1 equivalent of H2O, 
with a yield of approximately 60%.  No change in the rate of the reaction in CH2Cl2 was observed 
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with the exception of a large amount of water, which slowed the reaction.  The reaction proved to be 
somewhat sensitive to solvent.  Conducting the entire reaction in dichloroethane showed no benefit 
over dichloromethane (Entry 8).  When toluene was used as a solvent, the rearrangement/addition 
step was very slow and gave a yield of only 50% (Entry 9).  Therefore, dichloromethane was chosen 
as the solvent of choice for this transformation.  To extend the method to a synthetically useful state, 
the scope of the cascade was examined and the results are discussed below. 
1.2.3 Synthesis and Cascade Reaction of Carboxyl-Substituted Vinyl Ethers 
The first group of substrates tested with the optimized conditions contained a carboxyl group.  
Acid 1-34 was prepared in 95% yield by treating the sodium salt of cinnamyl alcohol with betaine 1-
33, according to the method of Büchi (Scheme 1-18).45   
 
N
O
O+
_
1) NaH, THF
2)Ph OH Ph O
O
OH
TMSCHN2
20% MeOH/benzene Ph O
O
OMePh O
O
OH
Ph O
O
OH Ph O
O
N
Me2NH(HCl)
EDCI, DMAP, Et3N
95%
1-33
99%
1-34
1-34 1-35
1-34 1-3648%  
Scheme 1-18.  Preparation of carboxyl group containing substrates. 
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Treatment of 1-34 with TMSCHN2 in methanolic benzene46 furnished methyl ester 1-35 in 
quantitative yield.  Acid 1-34 was also coupled with dimethyl amine using standard coupling 
methods to give the corresponding dimethyl amide 1-36 in a modest 48% yield (Scheme 1-18).   
These substrates were submitted to the cascade reaction, with the results summarized in 
Table 1-2.  Acid 1-34 was incompatible with the reaction conditions, resulting in immediate 
decomposition with no recovery of any starting material (Table 1-2, Entry 1).   
 
Table 1-2.  Summary of results of the cascade reaction with carboxyl group-containing substrates. 
1
2
3
Entry Substrate
10 (5:1)
37
0
Yield (%) (dr)bConditions Products (major:minor)a
1-34
1-35
1-36
i
ii
iii
Ph
N
OH
Ph
O
Ph
N
OH
Ph
O
1-38 1-39
Decomposition
Reaction Conditions: (i) 5 eq AlMe3, 2.5 eq H2O, 10 mol % Cp2ZrCl2, 2 eq hexyne
(ii) 2.5 eq AlMe3, 1.25 eq H2O, 10 mol % Cp2ZrCl2, 2 eq hexyne (iii) 10 eq AlMe3, 4 
eq H2O, 10 mol % Cp2ZrCl2, 2 eq hexyne. a Shown as major (left):minor (right). b
Determined by integration of the 1H NMR spectrum of the product mixture.
MeO
O
C4H9
1-37
 
When ester 1-35 was submitted to the reaction, only dienoate 1-37 (37%) and cinnamyl 
alcohol (47%) were isolated (Table 1-2, Entry 2).  Dienoate 1-37 is the result of vinyl alane addition 
into the α,β-unsaturated ester with subsequent elimination of cinnamyl alkoxide (Scheme 1-19).  
This result demonstrated the incompatibility of good Michael acceptors with the water-activated 
vinyl alanes. 
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 Ph O OMe
O
C4H9Al
Me
Me
Ph
O O
OMe
2)
1)        AlMe3, H2O 
      Cp2ZrCl2 (10 mol%)
δ-
δ+
C4H9
Ph OH
MeO
O
C4H9
+
1-35
1-37  
Scheme 1-19.  Proposed fragmentation mechanism of ester 1-35 during the cascade reaction. 
 
Amide 1-36 was submitted to the cascade reaction and required 10 and 4 equivalents of 
AlMe3 and H2O, respectively, for any reaction to occur.  The reaction proceeded in very low yield 
(10%) but with a diastereoselectivity of 5:1 (Table 1-2, Entry 3).  This lack of reactivity could be due 
to the highly aggregated AlMe3/H2O mixtures that coordinate to the amide oxygen and thus block 
the reactive Lewis acidic sites of aluminum. 
1.2.4 Synthesis and Cascade Reactions of Alkoxy Propenols 
The next class of substrates tested were derived from allylic alcohols.  Ester 1-35 was 
reduced with DIBAL-H to give a low yield of the desired allyl alcohol 1-40 (31%) and cinnamyl 
alcohol, resulting from 1,4-reduction and subsequent expulsion of alkoxide ion.  A wide variety of 
reducing agents were screened but DIBAL-H proved to be the most effective (Scheme 1-20).  
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DIBAL-H
Ph O OHPh O
O
OMe
Ph O OMe
1) NaH, THF
CH2Cl2
-78 oC
Ph O OTIPS
TIPSCl
Imidazole, DMAP
CH2Cl2
1-35
1-40
1-40
1-40
1-41
1-42
29%
2) CH3I
97%
93%  
Scheme 1-20.  Preparation of alkoxy propenol derivatives. 
  
The allylic alcohol 1-40 was treated with NaH followed by CH3I to provide methyl ether 1-
41 in 97% yield.  1-40 was also silylated with TIPSCl in the presence of imidazole and DMAP to 
furnish silyl alcohol 1-42 in 93% yield (Scheme 1-20).       
Allylic alcohol 1-40 was submitted to the standard cascade reaction conditions, i.e. 4 
equivalents of AlMe3 and 2 equivalents of H2O.  The reaction proceeded to completion within 10 
min and led to rearrangement products 1-43 and 1-44 in 30% yield and 10:1 diastereoselectivity 
(Table 1-3, Entry 1).  The configuration of the major diastereomer (1-43) was determined to be all 
syn by x-ray analysis of a derivative (vide infra).  The low yield can be attributed to multiple 
background reactions taking place, as indicated by TLC and GC analysis.  Two identifiable side-
reactions were the hydrolysis of the starting vinyl ether and methyl addition to the intermediate 
aldehyde.  
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Table 1-3.  Summary of results of cascade reactions of alkoxy propenol derivatives. 
 
1
2
3 60 (10:1)
12 (8:1)
30 (10:1)1-40
1-41
1-42
i
ii
iii
Ph OH
C4H9
OTIPS
Ph OH
C4H9
OTIPS
1-47 1-48
Ph OH
C4H9
OH
Ph OH
C4H9
OH
1-43 1-44
Entry Substrate Yield (%) (dr)bConditions Products (major:minor)a
Ph OH
Ph
Ph OH
Ph
1-45 1-46
Ph Ph
Reaction Conditions: (i) 4 eq AlMe3, 2 eq H2O, 10 mol % Cp2ZrCl2, 2 eq hexyne (ii)
2.1 eq AlMe3, 1 eq H2O, 10 mol % Cp2ZrCl2, 2 eq phenylacetylene (iii) 2.1 eq AlMe3, 
1 eq H2O, 10 mol % Cp2ZrCl2, 2 eq hexyne. a Shown as major (left):minor (right). b
Determined by integration of the 1H NMR spectrum of the product mixture.  
 Methyl ether 1-41 failed to undergo the desired process, instead giving only decomposition 
products, and 1-45 and 1-46 were isolated in 12% combined yield (Table 1-3, Entry 2).  These 
compounds are derived from the process shown in Scheme 1-21.  Coordination and elimination of 
the methoxy group generated the oxocarbenium ion 1-49.  Readdition of the vinyl alane in a 
conjugate fashion into 1-49 generated intermediate 1-50 which underwent the cascade Claisen 
rearrangement-vinyl alane addition. 
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Ph
Al
Me
Me
O OMePh O OMe
[3,3] Sigmatropic Rearrangement
then Vinyl Addition
O Ph
Al OMeMe
Me
2)
1)        AlMe3, H2O 
      Cp2ZrCl2 (10 mol%)
δ -
Ph
O PPh h
1-41
Ph
Ph
OH
Ph
1-45/1-46
1-50
1-49
 
Scheme 1-21.  Fragmentation pathway leading to 1-45/1-46. 
 
Although an interesting process, cleavage of this type renders ether moieties with sterically 
accessible oxygen atoms incompatible with the Lewis acidic water-activated alane.  The bulky TIPS 
ether 1-42 did not suffer from this problem.  Allyl vinyl ether 1-42 underwent the cascade reaction in 
good yield (60%) and in high diastereoselectivity (10:1) to provide the monoprotected alcohols 1-47 
and 1-48 (Table 1-3, Entry 3). To assign the stereochemistry of 1-47, it was desilylated with TBAF 
to furnish the corresponding diol which had spectral data identical to 1-43, confirming its 
stereochemistry as all syn (Scheme 1-22). 
 
Ph
OTIPS
OH
C4H9
Ph
OH
OH
C4H9
TBAF
THF
74%
1-47 1-43  
Scheme 1-22.  Deprotection of 1-47. 
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1.2.5 Synthesis and Cascade Reactions of Alkylated Vinyl Ethers 
Allylic vinyl ethers which bear alkyl substitution at the 1 and/or 2 position are difficult to 
prepare.  However, isopropenyl ether 1-51 was prepared via Hg(II)-catalyzed alcohol exchange with 
2-methoxypropene,47 in 45% yield (Scheme 1-23). 
 
Ph OH
Hg(OAc)2
O
Ph O
45%
1-51
 
Scheme 1-23.  Preparation of 1-51. 
  
One of the most mild and selective methods for the formation of allylic vinyl ethers is the 
alkene isomerization method of Frauenrath.48  This method uses Ni-centered catalysts, usually 
NiCl2(dppb), which must be activated with Li(Et)3BH.  Generally, stereoselectivities are 95:5 or 
greater and there is a good regioselectivity for terminal olefins.  Bis-allyl ether 1-52 was constructed 
by alkylation of the sodium salt of cinnamyl alcohol in 97% yield (Scheme 1-24).  Treatment of bis-
allyl ether 1-52 and catalytic NiCl2(dppb) in THF with catalytic Li(Et)3BH generated the Ni-H 
containing catalyst necessary to effect terminal olefin isomerization.  Vinyl ether 1-53 was isolated 
in 50% yield in a 94:6 ratio in favor of the (Z)-isomer. 
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Ph OH
NiCl2(dppb) (10 mol %) Ph O
I
1) NaH, THF
2) Ph O
LiEt3BH (10 mol %)
97%
1-52
1-5350% (87% BRSM)
94:6 (Z:E)  
Scheme 1-24.  Preparation of 1-53 via alkene isomerization. 
  
A recent addition to the literature on the preparation of allylic vinyl ethers by Buchwald and 
co-workers demonstrated the copper-mediated coupling of vinyl iodides and bromides with 
alcohols.49  The process is catalytic and the olefin geometry is retained throughout the process.  The 
conversion does require the presence of commercially available phenanthroline 1-55.  Yields are 
variable, but the reaction scales very well.  This chemistry was used for the synthesis of butyl-
substituted vinyl ether 1-56.  Vinyl iodide 1-5450 was coupled to cinnamyl alcohol in the presence of 
CuI, CsCO3, and 1-55. After heating the mixture for 24 hours, a low 17% yield of vinyl ether 1-56 
was obtained as a pure geometric (E,E)-isomer (Scheme 1-25). 
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Ph OH
CuI (10 mol %)
Ph O
C4H9
I 1-55 (20 mol %)
Cs2CO3
Toluene, 80 oC
+
C4H9
N N
1-54
1-56
1-55
17%
 
Scheme 1-25.  Preparation of 1-56 via Cu-catalyzed coupling. 
  
With the alkyl substituted vinyl ethers in hand, 1-51 was submitted to the standard 
conditions, affording tertiary alcohols 1-57 and 1-58 in 75% yield but in poor diastereoselectivity of 
3:2 (Table 1-4, Entry 1).  Vinyl ether 1-53 underwent the cascade rearrangement/addition in 65% 
yield and with a 10:1 diastereoselectivity, partially derived from the mixture of olefins that went into 
the reaction, therefore this is indicative of a highly diastereoselective process (Table 1-4, Entry 2).  
Butyl-substituted vinyl ether 1-56 also underwent the cascade rearrangement/addition in 90% yield 
and good diastereoselectivity, although a third diastereomer was present according to 1H NMR 
analysis.   (Table 1-4, Entry 3). 
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Table 1-4.  Summary of results of the cascade reaction of alkylated allyl vinyl ethers. 
1c
2
3d 90 (10:1:0.8)
65 (10:1)
75 (3:2)1-51
1-53
1-56
i
ii
iii
Ph
C4H9
OH
C4H9
Ph
C4H9
OH
C4H9
1-61 1-62
Ph OH
C4H9
Ph OH
C4H9
1-57 1-58
Entry Substrate Yield (%) (dr)bConditions Products (major:minor)a
Ph OH
Ph
Ph OH
Ph
1-59 1-60
Reaction Conditions: (i) 2.1 eq AlMe3, 1 eq H2O, 10 mol % Cp2ZrCl2, 2 eq hexyne
(ii) 2.1 eq AlMe3, 1 eq H2O, 10 mol % Cp2ZrCl2, 2 eq phenylacetylene (iii) 2.1 eq
AlMe3, 1 eq H2O, 10 mol % Cp2ZrCl2, 2 eq hexyne. a Shown as major (left):minor
(right).  b Determined by integration of the 1H NMR spectrum of the product mixture.  
c Major and minor diastereomers are unassigned. d Minor diastereomers are
unassigned as indicated.  
1.2.6 Synthesis and Cascade Reactions of Phenethyl-Substituted Vinyl Ethers 
All of the examples presented thus far demonstrate the cascade reaction on substrates based 
on the cinnamyl alcohol moiety.  A series of substrates based on allylic alcohol 1-64 was synthesized 
to demonstrate the chemistry with alkyl substitution at the 6-position of the allylic vinyl ether 
system.  Allylic alcohol 1-64 was synthesized according to a literature protocol (Scheme 1-26).51  
Horner-Wadsworth-Emmons olefination of hydrocinnamaldehyde furnished enoate 1-63 in 72% 
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yield as a single geometric isomer (E).  Reduction of 1-63 with DIBAL proceeded in quantitative 
yield to give the desired (E,E)-allylic alcohol 1-64.  
 
Ph OH
Ph
O
H Ph OEt
O
P
O
OEt
O
(EtO)2
NaH, THF
DIBAL-H
CH2Cl2
1-63
1-64
72%
100%  
Scheme 1-26.  Preparation of allylic alcohol 1-64. 
  
Using previous methods, a series of analogous substrates were synthesized.  Alcohol 1-64 
underwent Hg(II)-catalyzed alcohol exchange with ethyl vinyl ether in a moderate 47% yield to give 
vinyl ether 1-65 (Scheme 1-27).  Allylic alcohol 1-64 was coupled to betaine to furnish the unstable 
acid 1-66.  This acid was immediately coupled with dimethyl amine (EDCI, DMAP) to yield the 
dimethyl amide 1-67 in 36% overall yield.  
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Ph OH
Hg(OAc)2
O
Ph O
Ph OH
N
O
O+
_
1) NaH, THF
2) Ph O
O
OH
Me2NH(HCl)
EDCI, DMAP, Et3N Ph O
O
N
1-64 1-65
1-64 1-66
1-67
47%
36% for two steps  
Scheme 1-27.  Preparation of hydrocinnamate derivatives 1-65 and 1-67. 
  
To access allylic alcohol 1-69, 1-64 was condensed with ethyl propiolate in the presence of 
Et3N to give an 81% yield of the (E,E)-ester 1-68 (Scheme 1-28, geometry assigned based on J = 
12.5 Hz for α-hydrogen).  Ester 1-68 was directly subjected to DIBAL reduction, from which only 
the (E)-allylic alcohol 1-69 was isolated in 45% yield, along with alcohol 1-64, derived from 1,4-
reduction and elimination of alkoxide. 
 
O
OEt
Et3N, CH2Cl2
Ph OH
Ph O
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Scheme 1-28.  Preparation of allylic alcohol 1-69. 
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Vinyl ether 1-65 underwent the cascade reaction in 78% yield to furnish a 3:2 mixture of 
separable diastereomers, 1-70 and 1-71 (Table 1-5, Entry 1).  Allylic alcohol 1-69 provided diols 1-
72 and 1-73 in 17% yield as a 10:0.8:0.5 mixture of diastereomers (Table 1-5, Entry 2).  The lower 
yield can be attributed to the significant number of side-products formed in this reaction.  Once 
again, amide 67 failed to undergo the desired reaction until the equivalents of AlMe3 and H2O were 
raised to 10 and 4, respectively, furnishing amide alcohols 1-74 and 1-75 in 34% yield as a 10:4:1 
mixture of diastereomers (Table 1-5, Entry 3).  These examples demonstrate that alkyl-substituted 
allyl vinyl ethers undergo the cascade reaction as effectively as the aryl-substituted derivatives. 
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Table 1-5.  Summary of results of the cascade reaction of phenethyl-substituted vinyl ethers. 
 
1c
2d
3d 34 (10:4:1)
17 (10:0.8:0.5)
78 (5:3)1-65
1-69
1-67
i
ii
iii
OH
C4H9
N
OH
C4H9
N
1-74 1-75
OH
Ph
OH
Ph
1-70 1-71
Entry Substrate Yield (%) (dr)bConditions Products (major:minor)a
OH
Ph
OH
OH
Ph
OH
1-72 1-73
Ph
Ph
Ph
Ph
Ph
Ph
O O
Reaction Conditions: (i) 2.1 eq AlMe3, 1 eq H2O, 10 mol% Cp2ZrCl2, 2 eq
phenylacetylene  (ii) 4 eq AlMe3, 2 eq H2O, 10 mol% Cp2ZrCl2, 2 eq phenylacetylene 
(iii) 10 eq AlMe3, 4 eq H2O, 10 mol% Cp2ZrCl2, 2 eq hexyne. a Shown as major
(left):minor (right). b Determined by integration of the 1H NMR spectrum of the
product mixture. c Major and minor diastereomers are unassigned. d Minor
diastereomers are unassigned as indicated.  
1.2.7 Stereochemistry of the Cascade Process 
In order to assign the relative configuration of the major diastereomers, diol 1-76, the product 
of the cascade reaction of 1-40 with phenylacetylene, was derivatized to its mono-p-bromobenzoyl 
ester 1-77, and shown by x-ray diffraction to be all syn (Scheme 1-29).  In addition to mono-
benzoate 1-77, a 75% yield of the bis-benzoate was also obtained, but the latter was not 
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diastereomerically pure and therefore unsuitable for analysis.  Additionally, amide 1-38 (see Table 1-
2) was assigned as the all syn diastereomer by X-ray diffraction.   
 
Ph
OH
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Ph
Br
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Br
1-76
1-77
Ph O OH
AlMe3 (4 eq)
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10 mol% Cp2ZrCl2
Ph Ph
OH
OH
Ph
1-40
1-7623%
dr 95:5
18%
dr 1:0
+ Bis-ester (75%)
Ph
N
OH
Ph
O
(X-ray)
(X-ray)
1-38
 
Scheme 1-29.  X-ray analysis of ester 1-77 and 1-38 confirm the syn,syn-configuration for the 
major diastereomers. 
The all syn configuration of the major diastereomer formed in the cascade process can be 
explained by a chair-like transition state for the accelerated Claisen rearrangement (Scheme 1-
30).36a,52,53  The resulting aldehyde (or ketone) is then subjected to a highly selective Felkin-Anh 
addition54 of the vinyl alane, directed by the α-stereocenter.  After aldehyde 1-78 is formed, addition 
takes place with the most bulky substituent orthogonal to the carbonyl π-bond.  This conformation 
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follows the Felkin-Anh model and allows the nucleophile to assume a Bürgi-Dunitz trajectory for 
attack onto the carbonyl group,55 resulting in the observed syn stereochemistry (1-79). 
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Scheme 1-30.  Proposed mechanism for cascade reaction. 
  
In the addition of alkylaluminum reagents to aldehydes, a 6-membered transition state is 
generally preferred over a 4-membered transition state when more than one equivalent of AlR3 is 
employed.56  In the present case, chelation control in the addition can be ruled out since substrates 1-
40 and 1-42 gave identical diastereomers (vide supra).  The stereodirecting effect of the newly 
formed aldehyde α-stereocenter, in combination with the steric demand of the oligomeric alane 
nucleophile,57 leads to a high overall induction in the carbonyl addition step.  Further support for the 
significance of steric effects is provided by the poor diastereoselectivity of substrates that lack an α-
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stereocenter. Poor diastereoselectivity is also observed if the intermediate is a ketone, such as 1-51, 
which is known to exhibit diminished, substituent dependent complexation to aluminum Lewis acids 
compared to aldehydes.58 
It is possible that the intermediate aldehyde 1-78 might epimerize under the reaction 
conditions, leading to decreased product diastereomeric ratio; therefore, it was attempted to isolate 
this intermediate and compare it to the product of a thermal Claisen rearrangement with a substrate 
of known configuration.  Allyl vinyl ether 1-53, when subjected to microwave heating,59 underwent 
a [3,3] sigmatropic rearrangement in 10 min to yield aldehyde 1-80 in 60% yield as a 10:1 mixture of 
diastereomers (Scheme 1-31).60 Conversely, attempts to quench a cascade carboalumination-Claisen 
rearrangement-vinyl alane addition reaction before the allyl vinyl ether was consumed resulted only 
in recovered starting material and final cascade reaction products.  Presumably, nucleophilic addition 
to the intermediate aldehyde was too rapid for preparative isolation.  However, the addition of alkyl 
alanes to carbonyl groups is slower than vinyl transfer, and when the reaction with an alkyl 
aluminoxane was quenched prematurely, aldehyde 1-80 was isolated in 55% yield.  A 9:1 
diastereoselectivity was observed in this reaction, and the configuration of 1-80 was identical to the 
aldehyde obtained by thermal rearrangement, thus indicating that α-epimerization during the cascade 
reaction was unlikely. 
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H
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H
Ph
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Scheme 1-31.  Control reactions for test of stereochemical integrity of the aldehyde intermediate. 
  
Since the addition of water to mixtures of alane and zirconocene leads to a significant rate 
increase in the alkyne carboalumination,13 the potential accelerating effect of water in the aldehyde 
addition was probed.  Treatment of aldehyde 1-80 at -78 °C with vinyl alane 1-81, prepared via 
Negishi carboalumination61 in the absence of water, led in less than 1 min to addition product 1-59 
as a modest 3:1 mixture of diastereomers (Scheme 1-32).  In the presence of stoichiometric 
quantities of water, the vinyl alane also rapidly added to this aldehyde, but in 8:1 diastereocontrol.  
These results indicate that, while no measurable rate enhancement in the already fast 1,2-addition is 
gained at -78 °C from the addition of water, the larger aluminoxane cluster acting as a bulky 
nucleophile in the 1,2-addition or a tighter transition state leads indeed to improved facial selectivity 
in the carbonyl addition step. 
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Scheme 1-32.  Control experiments establish the beneficial effect of water on the 
diastereoselectivity of the addition process. 
 
1.2.8 Conversion of 1,6-Diene to Cyclopentene 
As a practical demonstration of the synthetic potential of this new cascade reaction, a 
10:1:0.8 mixture of the 1,6-dienes 1-61 and 1-62 was converted to cyclopentenol 1-83 in the 
presence of ruthenium catalyst 1-8262 (Scheme 1-33).  These substituted cyclopentenes have found 
use in the preparation of carbocyclic nucleosides, some of which are potent antiviral agents lacking 
the labile anomeric linkage that increases susceptibility to degradative enzymes such as 
phosphorylases.63,64   
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Scheme 1-33.  Preparation of cyclopentenes by ring closing metathesis. 
 
1.2.9 [1,3] vs [3,3] Rearrangement.   
The [1,3] sigmatropic rearrangement of allyl vinyl ethers can compete with the [3,3] 
sigmatropic shift36a especially in the presence of strong Lewis acids and with substrates that favor 
allyl cation intermediates.65  While reaction products in the cascade process derived from [1,3] 
rearrangement have not been observed, this process is feasible under the typical reaction conditions. 
To attempt to observe the [1,3] rearrangement, cyclopropylmethyl vinyl ether 1-85 was prepared in 
high yield from alcohol 1-84 by a Hg(II)-mediated vinyl ether exchange.  Indeed, 1-85 was smoothly 
converted into allylic alcohol 1-88 under the cascade conditions(Scheme 1-34).  The conversion of 
1-85 to 1-88 appears to be the first case of a [1,3] sigmatropic rearrangement of a cyclopropane 
analog of an allyl vinyl ether.66   
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Scheme 1-34.  [1,3] Rearrangement of cyclopropylmethyl vinyl ether 1-85. 
 
1.2.10 Conclusions 
A rapid diastereoselective three-step cascade carboalumination-Claisen rearrangement-
carbonyl addition process leading to 1-6-diene functionalities containing allylic alcohols  with up to 
three contiguous stereocenters has been developed.  The stoichiometric quantities of water that are 
used as an additive increase the rate of the [3,3] sigmatropic rearrangement as well as the 
diastereoselectivity of the carbonyl addition.  The resulting products are readily converted to 
substituted cyclopentenes.  The cascade strategy has also be extended to a sequence involving a [1,3] 
sigmatropic shift. 
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2. AZA-COPE REARRANGEMENTS AND N-ACYL IMINIUM ION CHEMISTRY 
2.1      INTRODUCTION 
2.1.1 Aza-Cope Rearrangements 
The studies on Claisen rearrangements promoted by water-activated alanes described in the 
previous chapter prompted an investigation into whether the same strategy could be used to promote 
other sigmatropic rearrangements.  The aza-Cope rearrangement is a closely related sigmatropic 
process which has been extensively utilized in synthesis.  For example, Overman and co-workers 
have used the aza-Cope rearrangement to form intermediate ketone 2-4 during their synthesis of 
gelsemine (Scheme 2-1).67    
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O
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H
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Scheme 2-1.  Aza-Cope rearrangement to access 2-4 in Overman’s synthesis of gelsemine. 
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The aza-Cope rearrangement is known to be catalyzed by acids and bases.  Krantz and co-
workers have used protic acids as promoters of sigmatropic processes which form allenes.68 As 
shown in Scheme 2-2, when aminal 2-5 was treated with formic acid, iminium ion formation 
followed by sigmatropic rearrangement furnished the allenyl lactam 2-8 after workup. 
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O
•
MeMe Me
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O
•
HCO2H [3,3]
H3O+
2-5 2-6 2-7
2-8
95%  
Scheme 2-2.  Aza-Cope rearrangement to furnish allene 2-8.   
2.2      RESULTS AND DISCUSSION 
2.2.1 Preliminary Investigations 
Although there are examples to the contrary, a common problem with the aza-Cope 
rearrangement is prolonged reaction times.  It was anticipated that water-activated alane could 
dramatically increase the rates of these reactions.  Extending on some models by Krantz,69 an acidic 
cascade would generate an iminium ion from an aminal using water-activated alane (Scheme 2-3).  
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The iminium ion would then undergo an aza-Cope rearrangement and be trapped by addition of a 
methyl group from the alane, generating an allene. 
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•
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Scheme 2-3.  Proposed aza-Cope rearrangement promoted by water-activated alane. 
  
Initial exploration of the water-activated, alane-promoted aza-Cope rearrangement reaction 
began with preparation of methoxylactam 2-11, accessible in three steps from succinimide.  
Mitsunobu alkylation with alcohol 2-9 proceeded in 42% yield to furnish imide 2-10 which was 
readily reduced with NaBH4 (Scheme 2-4).  The crude corresponding hydroxy lactam was subjected 
to acid-catalyzed methanol exchange to provide the model lactam 2-11 in 45% yield.  Lactam 2-11 
was added to a -78 °C solution of AlMe3 (3 eq.) and H2O (1.5 eq.).  After 24 h at room temperature, 
only lactam 2-12  and starting material could be observed by 1H NMR (Scheme 2-4).  All of the 
exploratory reactions towards the aza-Cope rearrangement were studied by 1H NMR analysis of the 
crude reaction mixtures.70      
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Scheme 2-4.  Preparation and reactions of model substrate 2-11. 
  
The formation of 2-12 indicated that the desired ionization was occurring, however addition 
of a methyl group from AlMe3 was quenching the iminium ion needed for sigmatropic 
rearrangement.  The elimination of the methoxy group was extremely slow at room temperature, 
contrary to the reactivity observed with water-activated alane in other reaction manifolds.  The 
studies of Hart and co-workers on iminium ion sigmatropic rearrangements suggested that 
substitution at the nitrogen bearing exo-carbon in pyrrolidones can promote the aza-Cope 
rearrangement.71  Thus, branched methoxy lactam 2-15 was explored. This compound was prepared 
in an analogous fashion to methoxylactam 2-11.  Mitsunobu alkylation of succinimide with 
secondary alcohol 2-13 proceeded sluggishly to provide imide 2-14 in a 32% yield (Scheme 2-5).  
The imide was reduced with sodium borohydride and converted to its corresponding methoxy lactam 
2-15 in 56% yield over two steps as a 1:1 mixture of diastereomers. 
 39 
 NH
O
O
PPh3, DIAD
THF
32%
N
O
O
1) NaBH4, MeOH
2) MeOH, PPTS
56% over two steps
N
O
OMe
HO
dr 1:1
2-14 2-15
2-13
 
Scheme 2-5.  Preparation of alkyl-branched substrate 2-15. 
 
Addition of 2-15 to a mixture of AlMe3 (3 eq.) and H2O (1.5 eq.) provided, after 24 h at room 
temperature, only recovered starting material (Scheme 2-6).  A water-accelerated zirconium-
catalyzed carboalumination was attempted on methoxy lactam 2-15, however after 24 h at room 
temperature, only starting material was recovered.  The lack of reactivity indicated that the 
succinimide scaffold was unsuitable for this chemistry.     
 
N
O
OMe
AlMe3 (3 eq)
H2O (1.5 eq)
CH2Cl2
No Reaction
N
O
OMe
AlMe3 (3 eq)
H2O (1.5 eq)
CH2Cl2
No Reaction
Cp2ZrCl2 (10 mol %)
2-15
2-15
 
Scheme 2-6.  Attempted reactions of alkyl branched substrate 2-15. 
  
Before the rate of the sigmatropic rearrangement vs. methyl addition could be addressed, 
iminium ion formation had to occur.  Therefore, a more ideal substrate would include a more 
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activated leaving group.  An analogous phthalimide derivative seemed promising since the site of 
elimination would now be activated by both the amide nitrogen and the aromatic ring. 
The alkyl branched methoxy lactam 2-18 was selected as the next target substrate.  
Mitsunobu alkylation of phthalimide with secondary alcohol 2-13 provided the alkylated imide 2-16 
in a low 20% yield (Scheme 2-7).  Sodium borohydride reduction of imide 2-16 proceeded in 
moderate yield to provide hydroxy lactam 2-17 as a 1:1 mixture of diastereomers.  Acid mediated 
methanol exchange with hydroxy lactam 2-17 furnished methoxylactam 2-18 in 76% yield.   
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Scheme 2-7.  Preparation of phthalimide substrate 2-18. 
  
Treatment of methoxy lactam 2-18 with AlMe3 (3 eq.) and H2O (1.5 eq.) in CH2Cl2 returned 
only starting material.  Increasing both the stoichiometry between AlMe3 and H2O and the overall 
equivalents did not impart any detectable conversion (Scheme 2-8).   
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2-18  
Scheme 2-8. Attempted reactions of phthalimide substrate 2-18.  
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Again, a water-accelerated zirconium-catalyzed carboalumination was attempted on 
methoxylactam 2-18.  Conditions which employed AlMe3 (3 eq.), H2O (1.5 eq.), and catalytic 
zirconocene dichloride led only to starting material (Scheme 2-9).  This time, an increase in AlMe3 
and H2O (6 and 2 eq., respectively) furnished a low conversion to olefin 2-19.   
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Scheme 2-9.  Attempted carboalumination of 2-18. 
 
In the absence of any evidence of iminium ion formation, a change in the leaving group was 
investigated.  Hydroxy lactam 2-17, an intermediate in the preparation of methoxy lactam 2-18, was 
tested under the standard conditions (3 eq. AlMe3 and 1 eq. H2O).  Unfortunately, only starting 
material was observed by NMR (Scheme 2-10). 
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Scheme 2-10.  Attempted aza-Cope rearrangement of hydroxy lactam 2-17. 
    
The acylation of hydroxy lactam 2-17 was completed to provide a substrate more prone to undergo 
elimination (Scheme 2-11).72 
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Scheme 2-11.  Preparation of 2-20. 
    
Acetoxy lactam 2-20 was added to a solution of AlMe3 (4 eq.) and H2O (1 eq.) (Scheme 2-
12).  After 5 min at room temperature, NMR analysis indicated only alkylated lactam 2-21, derived 
from elimination and addition of a methyl group onto the iminium ion. 
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Scheme 2-12.  Attempted aza-Cope rearrangement of acetoxy lactam 2-20. 
    
The rapid formation of 2-21 in high yield indicated that the desired type of reactivity was 
demonstrated by the substrate.  Unfortunately, no sigmatropic rearrangement had occurred.  The 
same reaction was then studied in the presence of zirconocene dichloride.  Acetoxy lactam 2-20 was 
added to a solution of AlMe3 (3 eq.), H2O (1 eq.), and catalytic zirconocene dichloride (Scheme 2-
13).  Again, after 5 min at room temperature, only lactam 2-21 was formed. 
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Scheme 2-13.  Attempted carboalumination of 2-20. 
  
These results indicated that an elimination process, followed by a sigmatropic rearrangement 
seemed unlikely to occur given the high nucleophilicity of the water-activated alane.  The lifetime of 
the iminium ion would have to be sufficiently long to allow for the sigmatropic rearrangement to 
occur.  Given the rapid addition to the iminium ion at low temperatures, this tandem reaction 
manifold was abandoned.   
2.2.2 Carboalumination Studies on Lactam-based Substrates and Medium Ring      
Formation 
The investigations of the water-activated alane-promoted aza-Cope rearrangement raised 
some intriguing questions about the reactivity of water-activated alane and the scope of water-
accelerated carboalumination.  Previous work has clearly demonstrated that these reagents were 
highly Lewis acidic, yet no elimination/iminium ion formation was observed with substrates known 
to undergo acid-mediated elimination.  Further, the resistance to carboalumination that the lactam-
based substrates demonstrated was quite unusual.  This prompted an investigation into whether 
proximity to Lewis basic functionality affects carboalumination.   
Towards this end, methoxy lactam 2-24, which contained a three-carbon spacer between the 
alkyne and amide functionality, was synthesized (Scheme 2-14).  Mitsunobu alkylation of 
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phthalimide with alkynol 2-22 gave the alkylated imide 2-23 in 81% yield.  Sodium borohydride 
reduction followed by acid-mediated methanol exchange furnished the methoxylactam 2-24 in 91% 
over two steps.   
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Scheme 2-14.  Preparation of 2-24, containing a three carbon spacer between amide and alkyne. 
  
The addition of 2-24 to a solution of AlMe3 (3 eq.) and H2O (1 eq.) returned only starting 
material after 24 h at room temperature.  The addition of 2-24 to a solution of AlMe3 (3 eq.) and H2O 
(1 eq.) and catalytic zirconocene dichloride furnished a mixture of starting material (84%) and 
carboalumination product 2-25 (16%) by NMR analysis (Scheme 2-15).   
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Scheme 2-15.  Reaction of 2-24 under carboalumination conditions. 
  
Since carboalumination was observed at a slow rate, and no elimination occurred, the next 
step was the synthesis of tertiary alcohol 2-26 to investigate its effect on elimination Thus, addition 
of MeMgBr to imide 2-23 proceeded smoothly to furnish 2-26 (Scheme 2-16).   
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Scheme 2-16.  Preparation of 2-26. 
  
When hydroxy lactam 2-26 was added to a solution of AlMe3 (3 eq.), H2O (1 eq.) and 
catalytic zirconocene dichloride, NMR analysis of the reaction mixture after 24 h indicated 
approximately 10% carboalumination (2-27) with only starting material remaining (Scheme 2-17).  
Thus, the tertiary hydroxy group was not any more reactive towards elimination than the secondary 
hydroxyl group. 
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Scheme 2-17.  Attempted carboalumination of tertiary alcohol 2-27. 
  
Subsequently, the alkyne was tethered further away from the central region of the substrate.  
A longer tether might also provide a novel method to form medium or large rings which contain 
olefins of defined geometry by a three step, one pot operation:  carboalumination, elimination and 
vinyl alane addition (Scheme 2-18).  Preliminary investigations into this method began by 
constructing a precursor which would be cyclized to form a 9-membered ring.   
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Scheme 2-18.  Proposed cascade cyclization sequence. 
 
      Alcohol 2-29 was synthesized by the isomerization of the commercially available hept-3-
yne-1-ol with the KAPA reagent73 in 85% yield (Scheme 2-19).  Imide 2-30 was then constructed by 
Mitsunobu alkylation of phthalimide with alkynol 2-29, which proceeded in 82% yield.  This 
material was submitted to standard carboalumination conditions, AlMe3 (3 eq.), H2O (1 eq.) and 
zirconocene dichloride (10 mol%); however, only methyl addition to the imide was observed.  
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Scheme 2-19.  Preparation and model reaction of 2-31. 
  
Imide 2-30 was reduced with sodium borohydride, followed by methanol exchange to give 
methoxylactam 2-33 in 40% overall yield (Scheme 2-20).   
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Scheme 2-20. Preparation of lactam 2-33.  
  
Treatment of a solution of AlMe3 (3 eq.), H2O (1 eq.) and zirconocene dichloride (10 mol%) 
with methoxylactam 2-33 returned only starting material with no evidence for elimination or 
carboalumination (Scheme 2-21).   
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Scheme 2-21.  Attempted cascade cyclization of 2-33. 
  
It was anticipated that a phenoxy group would be a better leaving group.  This lead to the 
synthesis of lactam 2-34.  Treatment of 2-32 with SOCl2 and catalytic DMF furnished the 
corresponding unstable chloride, which was immediately treated with phenol in the presence of 
triethylamine to yield phenoxy lactam 2-34 in 34% yield (Scheme 2-22).74   
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Scheme 2-22.  Preparation of phenoxy lactam 2-34. 
  
Addition of 2-34 to a solution of AlMe3 (3 eq.), H2O (1 eq.) and zirconocene dichloride (10 
mol%) furnished alkylated lactam 2-35 (10%), starting material (52%), and decomposition products 
(Scheme 2-23).   
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Scheme 2-23.  Attempted cascade cyclization of 2-34. 
  
These experiments demonstrated that the functionality present in these substrates was 
inhibiting the usually fast carboalumination.  It was postulated that the amide group was inhibiting 
carbometallation, and a series of GC experiments were performed to test this hypothesis.  An alkyne, 
which was known to undergo rapid water-accelerated carboaluminations, was submitted to the 
standard water-accelerated carboalumination conditions in the presence of lactam 2-33.  A control 
experiment demonstrated that the carboalumination of heptyne with AlMe3 (3 eq.), H2O (1 eq.), and 
Cp2ZrCl2 (10 mol %) proceeded to completion in under 5 min at low temperatures (-78 °C to -25 °C) 
to furnish a 97:3 mixture of regioisomers by GC (Scheme 2-24).   
 
AlMe3, H2O
Cp2ZrCl2
-78 oC to RT
97:3
100% in <5 min
+
 
Scheme 2-24.  GC control experiment of the water-accelerated carboalumination of heptyne. 
 
Conducting the identical experiment in the presence of 1 eq. of methoxylactam 2-33 
dramatically inhibited carboalumination, with only 4.4% of heptyne undergoing conversion after 1 h 
(Scheme 2-25).   
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 AlMe3, H2O
Cp2ZrCl2
-78 oC to RT
4.4% after 60 min
N
O
OMe
5
2-33
 
Scheme 2-25.  GC analysis of the water-accelerated carboalumination of heptyne in the presence of 
2-33. 
 
One possibility for this inhibition is that highly Lewis basic functionality coordinates to 
AlMe3 oligomers, thus inhibiting alkyne carboalumination.  This could explain why one equivalent 
of lactam can inhibit 3 equivalents of AlMe3.   
Due to the lack of reactivity in the carboalumination approach, hydrozirconation was chosen 
as an alternative, known to be quite tolerant of diverse functionality.75  Pivaloate lactam 2-36 was 
synthesized in an attempt to increase the rate of elimination.  Unfortunately, when lactam 2-33 or 2-
36 was treated with Cp2ZrHCl, only the corresponding alkene was recovered (Scheme 2-26). 
Treatment of the intermediate alkenylzirconocene with AgClO4 or trimethylaluminum also provided 
no desired cyclization products.  Highly concentrated reaction mixtures or prolonged heating 
resulted only in slow methyl group addition.  Possibly, the ring strain present in the desired products 
is too high to allow the reaction to proceed under these conditions.  
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2-33, R = OMe 
2-36, R = OPiv
2-37
N
O
OH
N
O
OPiv
PivCl, Et3N
THF
2-32 2-3683%
 
Scheme 2-26.  Attempted hydrozirconation and medium ring formation. 
 
2.2.3 Intermolecular Alkenylation of N-Acyl Iminium Ions 
Since the intramolecular cyclizations proved elusive, we turned our attention toward an 
alternative construction of these systems starting with an intermolecular addition process.  
Intermolecular alkenylation of N-acyliminium ions can often require harsh reaction conditions such 
as extended periods of heating,76 or unusual anomeric leaving groups (Scheme 2-27).77   
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NH
O
OMe
MgBr
THF, reflux
NH
O70%
NH
O
SO2Ph
NH
O
MgBr
THF, −20 °C
74%
2-38 2-39
2-40 2-41  
Scheme 2-27.   Selected literature examples of intermolecular alkenylation. 
An exception to this trend is the mild intermolecular addition of alkenyl boronates reported 
by Batey.78  For example, when aminal 2-42 was treated with alkenyl boronate 2-43 and BF3•Et2O, 
addition product 2-44 was isolated in 99% yield as a > 98:2 ratio of diastereomers (Scheme 2-28).   
 
N
Cbz
Me
OH OAc
B
O
O
BF3•Et2O, CH2Cl2
-78 °C to rt
99% (d.r. > 98 : 2)
N
Cbz
Me
OAc
2-42 2-44
2-43
 
Scheme 2-28.  Alkenylation with alkenyl boronates. 
 
For model purposes, lactams 2-46 to 2-48 were chosen, bearing methoxy, acetoxy and 
pivaloyl leaving groups, respectively.  Each of these substrates was made using standard procedures 
(Scheme 2-29). 
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2) AcCl, Et3N,
    DMAP, THF
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two steps
NBn
O
OAc
2-45 2-47
NBn
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2) PivCl, Et3N,
    DMAP, THF
80% over 
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NBn
O
OPiv
2-45 2-48
NBn
O
O
1) NaBH4, MeOH
2) MeOH, TsOH
76% over 
two steps
NBn
O
OMe
2-45 2-46
1) NaBH4, MeOH
1) NaBH4, MeOH
 
Scheme 2-29.  Preparation of model lactams. 
 
The hydrozirconation of terminal alkynes was first explored as a method to generate alkenyl 
nucleophiles (Table 2-1).  Hydrozirconation of 1-hexyne, followed by treatment with silver 
perchlorate79 and lactam 2-46 yielded only a trace of addition product after 24 h at rt (entry 1, Table 
2-1).  Transmetallation to dimethylzinc also proved unsuccessful (entry 2, Table 2-1). Gratifyingly, 
hydrozirconation-transmetallation to trimethylaluminum80 generated an alkenylalane that reacted 
with lactam 2-46 in a moderate 43% yield (entry 3, Table 2-1).  The leaving group ability was 
further increased by using acetate 2-47; however, product 2-49 was only formed in 30% yield while 
the remaining starting material was consumed (entry 4, Table 2-1).  Attempts to perform this 
reaction in THF or toluene led to recovered starting material. Pivaloate 2-48, when treated with the 
in situ generated alane, provided hexenyl isoindolinone 2-49 in 81% yield without any observed 
isomerization of the alkene moiety (entry 5, Table 2-1). Attempts to achieve this transformation 
under cationic conditions with silver perchlorate led to complex mixtures, seemingly arising from 
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alkene isomerization (entry 6, Table 2-1).  The mild conditions under which the addition proceeds 
and the ability to utilize readily available alkynes and pivaloate iminium ion precursors encouraged 
further exploration.   
 
Table 2-1.  Optimization of the intermolecular alkenylation of acyl-iminium ions to generate 
isoindolinones.  
NBn
O
R
C4H9
Conditions
NBn
O
C4H9
Cp2ZrHCl
CH2Cl2
2-46 - 2-48
2-49
 
1
2
3
Entry Substrate
43b
-
tracea
Yield (2-49, %)Conditions
2-46
2-46
2-46
i
ii
iii
Reaction Conditions:  (i) AgClO4  (ii)Me2Zn (iii) 
Me3Al. a Product was formed as a mixture of
alkene isomers. b Starting material observed
after 12 h.  ND = not determined.
4
5
6
81
302-47
2-48
2-48
iii
iii
i NDa
 
 
Among the numerous methods known for the synthesis of substituted isoindolinones,81 only 
a few examples of Heck-type coupling install an alkenyl moiety at the 3-position.82  The synthesis of 
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isoindolinones presents significant opportunities for preparing biologically active molecules as well.  
Isoindolinones demonstrate a remarkably wide array of biological activities, including anti-
inflammatory,83 antihypertensive,84 antipsychotic,85 vasodilatory,86 and antileukemic87 effects. 
The modularity of the current approach warranted further investigation into the substrate 
scope of this process.  As shown in Table 2-2, silyl ether, carbamate, and sulfonamide functionalities 
are well tolerated, generating functionalized isoindolinones in a high yielding, one-pot procedure.  
 
Table 2-2.  Addition of various alkenyl nucleophiles to generate isoindolinones. 
NBn
O
OPiv
R
Me3Al, rt
NBn
O
R
Cp2ZrHCl
CH2Cl2
2-48  
Entry R (alkyne) Product [%] 
1 C4H9 2-49 [81] 
2 c-C6H11 2-50 [79] 
3 CH2CH2OTBDPS 2-51 [71] 
4 CH2CH2N(CO2Me)Ts 2-52 [62] 
 
To further probe the scope of this reaction, succinimide-derived pivaloate 2-54 was 
synthesized from dimethyl succinic anhydride (2-53) and subjected it to the optimized conditions 
(Scheme 2-30). Addition product 2-55 was isolated in 83% yield which bodes well for the extension 
of the cyclic iminium ion alkenylation methodology toward a broad class of heterocyclic 
electrophiles.   
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OPiv
C4H9
Me3Al, rt
83%
NBn
O
C4H9
1. Cp2ZrHCl, CH2Cl2
2.
2-54
2-55
NBn
O
OPiv
O
O
O
1) BnNH2, Δ
2) NaBH4, then 
    PivCl, Et3N,
    DMAP, THF
2-53 2-5425%
 
Scheme 2-30.  Preparation of 2-55.  
 
The use of trisubstituted alkenes was also investigated in this transformation.  Although the 
lactam functionality had prevented an intramolecular addition, pre-forming the alkenylalane under 
water-accelerated conditions, followed by addition of 2-48, provided isoindolinones 2-56 and 2-57 in 
77% yield after only 15 minutes (Table 2-3).   
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Table 2-3.  Addition of trisubstituted alkenyl alanes to provide isoindolinones 2-56 and 2-57. 
NBn
O
OPiv
R
NBn
O
R
Me3Al, Cp2ZrCl2
H2O
2-48
 
Entry R Product [%] 
1 C4H9 2-56 [77] 
2 Ph 2-57 [77]a 
                            a Product contains ~5% of a carbometallation regioisomer.   
 
Since this strategy provided a rapid access toward alkenyl-functionalized phthalimides, the 
initial goal of generating medium rings was revisited. As a model system, alkyne 2-59 was prepared 
by alkylation of alkynol 2-22, and allyl-pivaloate 2-61 was synthesized using the standard method 
(Scheme 2-31).   
 
Ph Br OH Ph O
NaOH
TBAI (5 mol %)
hexanes
69%
2-58 2-22 2-59
+
N
O
O
NaBH4, then
PivCl, Et3N
DMAP, THF
83% over
two steps
N
O
OPiv
2-60 2-61
 
Scheme 2-31.  Preparation of alkyne 2-59 and pivaloate 2-61. 
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 Subsequently, 2-60 and 2-61 were subjected to the hydrozirconation-transmetallation 
conditions to generate 2-62 in 55% yield accompanied by considerable amounts of methyl addition 
side product (Scheme 2-32).  It should be noted that carboalumination of 2-59 failed and the rate of 
addition for the alkenylalane generated via the transmetallation reaction was retarded due to the 
presence of the ether functionality.  With 2-62 in hand, conditions were screened to form the desired 
12-membered macrocycle.  Although ring closing metathesis methodology has been found to 
perform well for the synthesis of a variety of macrocycles,88 a rapid formation of the undesired 5-
membered ring 2-63 was observed.89  Increasing dilution, change of metathesis catalyst, addition of 
Ti(OiPr)4,90 or varying solvents did not influence the reaction pathway.   
 
N
O
O
Ph
O
Ph
Cp2ZrHCl;  Me3Al
then
N
O
OPiv
O
O
N
O
N
not observed
61%
2-61
2-59 2-62
2-63
Ru
Cl
Cl
PCy3
Ph
NMesMesN
; 55%
 
Scheme 2-32.  Preparation of 2-62 and attempted macrocyclization via alkene metathesis.  
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Due to the ease of formation of pyrrolizidine 2-63, a more generalized synthesis of this 
compound was explored.  Addition of hexenylalane to 2-61 furnished diene 2-64, which smoothly 
underwent the metathesis in 75% yield to furnish pyrrolizidine 2-63 (Scheme 2-33).   
 
Ru
Cl
Cl
PCy3
Ph
NMesMesN
C4H9
Me3Al, rt
73%
Cp2ZrHCl
CH2Cl2
N
O
C4H9
N
O
OPiv
O
N2-61
2-64 2-63
CH2Cl2
75%
 
Scheme 2-33.  Preparation of 2-63. 
 To access the desired medium ring systems through this approach, imide 2-66 was prepared 
via Mitsunobu alkylation (Scheme 2-34).  Reduction of 2-66 and acylation proceeded in 76% over 
the two steps to provide 2-67.   
 
NH
O
O
HO N
O
O
+ DIAD, PPh3
THF
88%2-65 2-66
N
O
O 2-66
N
O
OPiv
2-67
NaBH4, then
PivCl, Et3N
DMAP, THF
76% over
two steps  
Scheme 2-34.  Preparation of pivaloate 2-67. 
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The synthesis of fused azepines was achieved from indolinone 2-68, prepared from 2-67 and 
1-hexyne in 72% yield (Scheme 2-35).  Ring closing metathesis of 2-68 proved to be problematic in 
CH2Cl2 with several ruthenium catalysts, yielding only starting material or decomposition products.  
Addition of Ti(OiPr)4 in toluene at room temperature resolved these issues and yielded 67% of 2-69.  
Possible deactivation of the metathesis intermediate by the neighboring amide carbonyl could 
explain the difficulty in this transformation.91  While not fully optimized, these reactions provide 
proof of concept for the conversion of our phthalimide substrates to structurally diverse tricyclic 
products.   
 
C4H9
Me3Al, rt
72%
Cp2ZrHCl
CH2Cl2
N
O
N
O
OPiv
O
N
2-692-68
2-67
Ti(OiPr)4
toluene
67%
Ru
Cl
Cl
PCy3
Ph
NMesMesN
 
Scheme 2-35.  Synthesis of azepine 2-69 via ring ing metathesis. 
 
2.2.4 Conclusions 
In situ generated alkenylalanes constitute versatile nucleophiles for additions to N-
acyliminium ions.  While direct intramolecular cyclization strategies suffer from inhibition of the 
carboalumination reaction by Lewis basic functional groups, preforming alkenylalanes via 
hydrozirconation-transmetallation or carboalumination and subsequent addition to the lactam acetal 
substrates yields functionalized isoindolinones.  This method applies easily prepared or 
-clos
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commercially available starting materials that provide opportunities for diversification at numerous 
points and yields synthetically useful heterocyclic products in a one-pot transformation.  Further 
elaboration of the alkenyl heterocycles through the use of ring closing metathesis leads to tricyclic 
products that are common motifs in natural products and drug-like molecules. 
 62 
3. SPRIOKETALS VIA OXIDATIVE REARRANGEMENT OF ENOL ETHERS 
3.1  INTRODUCTION 
3.1.1 Barton’s Proposal for the Biosynthesis of Acutumine 
Acutumine (3-1, Scheme 3-1) is a chlorinated tetracyclic alkaloid whose isolation was first 
reported in 1929.92  Although the structure was initially misassigned, a series of chemical and X-ray 
structures established the correct structure of acutumine in 1967.93  
 
NMe
Cl
OH
O
OMe
OMe
O
MeO
MeO
NMe
O OMe
Acutumine (3-1)
Proposed
Pathway
Biosynthetic
3-2
OMe
O
 
Scheme 3-1.  Barton's proposed biosynthetic precursor of acutumine (3-1). 
 
Shortly thereafter, Sir Derek Barton proposed a biosynthesis for the spiro-fused vinylogous 
ester moiety of acutumine.94 In this proposal, Barton suggested spirodienone 3-2 as a possible 
biosynthetic branching point (Scheme 3-1).  As shown in Scheme 3-2, Barton proposed that double 
epoxidation of 3-3 followed by a hydrolytic Favorskii-type rearrangement would give acid 3-5.  
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Decarboxylation and epoxide opening affords allylic diol 3-6, which is only a single oxidation level 
below vinylogous ester 3-7.  
 
O
OMe
O
OMe
O O O
OMeHO2C
OH
HO
OH
OMe
O
OH
OMe
Oxidation Hydrolytic
Cleavage
Oxidation−CO2
3-4 3-5
3-6 3-7
3-3
 
Scheme 3-2.  Proposed mechanistic conversion of 3-3 to 3-7. 
 
Barton’s proposal contained several interesting components, including the Favorskii-type 
ring contraction.  At the time of publication, it was the first proposed Favorskii rearrangement in a 
biosynthesis.  Since Barton’s proposal, the Favorskii rearrangement has rarely been proposed in 
biosynthetic sequences, and has therefore been controversial.  In 1975, the Favorskii rearrangement 
was proposed by Simpson during the biosynthesis of pyrone containing polyketides.  For example, a 
polyketide such as 3-8 with a non-specified leaving group (LG) was proposed to undergo a 
hydrolytic Favorskii-type rearrangement to furnish the branched polyketide 3-9 (Scheme 3-3).95 
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O
O
HO
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HO2C
OO
HO
O
O
Favorskii-type
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3-8 3-9LG = leaving group  
Scheme 3-3.  Proposed Favorskii-type rearrangement to generate branched polyketides. 
 
 A similar rearrangement was postulated by Kakinuma to account for the unusual 17-
membered carbocyclic ring system in the lankacidin anitibiotics.  Macrocycle 3-10 was proposed to 
undergo a non-specific oxidation to the cyclopropanone intermediate 3-11, which would be opened 
with hydroxide to effect a one-carbon ring contraction and furnish acid 3-12 (Scheme 3-4).96 
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3-10 3-11 3-12
[O] -OH
 
Scheme 3-4.  Proposed Favorskii-type rearrangement to effect ring contraction in a polyketide. 
 
 The Favorskii-type rearrangement has recently been proposed by Wright to account for 
carbon deletions in the biosynthesis of the polyketide shellfish toxins DTX-1 and DTX-2.  Wright 
proposed that an α-diketone, such as 3-13, would undergo intramolecular closure to furnish 
cyclopropanone 3-14 (Scheme 3-5).97  Attack by a peroxide and collapse of the peroxy-ketal 3-15 
generates ketone 3-16 after the extrusion of CO2.   
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Scheme 3-5.  Wright’s proposed Favorskii-type rearrangement to effect carbon deletion in 
polyketide natural prouducts. 
 
Barton’s proposal represented a key unsolved  problem (or unconfirmed proposal) in natural 
product chemistry.  Combined with our interest in densely oxygenated natural products, we began 
investigations into this hypothesis.  An examination of the literature reveals a previous attempt to 
model the Barton proposal in 1984.  The Matoba group treated enone 3-17 with m-CPBA in 
refluxing trichloroethane and assigned the product as 3-18 (Scheme 3-6).98  Based on the results 
presented herein, it appears that compound 3-18 was incorrectly assigned. 
 
OMe
3-17
O
O
O
O
OMe
3-1873%
m-CPBA (3 eq.)
1,1,1-trichloroethane
reflux
 
Scheme 3-6.  Attempted modeling of Barton’s proposal by Matoba. 
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3.2 RESULTS AND DISCUSSION 
Due to the ready access to dienones of type 3-3 in Barton’s proposed biosynthesis,99 this 
hypothetical ring contraction provides an attractive entry to the acutumine skeleton.  Our first 
approach to model this proposal began with dienone 3-19 (Scheme 3-7).  Epoxidation of 3-19 
provided epoxyketone 3-20, a theoretical intermediate in Barton’s proposed biosynthesis.  When 3-
20 was treated with 3 equivalents of m-CPBA buffered by Na2HPO4, we expected that the 
intermediate bis-epoxide would undergo Barton’s proposed cascade, however we isolated only 
epoxy lactone 3-21 in 80% yield as a single diastereomer, which was characterized by X-ray 
crystallography.  It was determined that the crude diastereoselectivity of the reaction in the absence 
of a basic workup was only 2:1, although this mixture equilibrated to a single diastereomer after 
washing with aqueous NaHCO3. 
 
O
OMe
O
OMe
O
O
O
O
O
OMe
3-19 3-20 3-2167% 80%
dr 1:0
H2O2
K2CO3
THF, 40 °C
m-CPBA (3 eq.)
Na2HPO4 (3 eq.)
CH2Cl2, 25 °C
X-ray
 
Scheme 3-7.  Preparation of model epoxy ketone 3-20 and attempted rearrangement. 
 
In order to prepare another substrate for experimentation, epoxy alcohol 3-22 was prepared 
from intermediate 3-20 by the addition of MeLi, which proceeded in 91% yield (Scheme 3-8).  With 
a small collection of substrates in hand, the scope of the oxidative rearrangement was probed. 
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Scheme 3-8.  Preparation of ketone 3-22. 
 
Enone 3-17 lacking the epoxide underwent rearrangement to lactone 3-23 in 75% yield, 
while five-membered enone 3-24 was converted to lactone 3-25 in only 35% yield, although the 
reaction does generate a tetrasubstituted carbon (Scheme 3-9).100  To ascertain whether the carbonyl 
functionality was needed to facilitate rearrangement, 3-22 was submitted to the oxidative 
rearrangement and was converted to hemiacetal 3-26 in only 21% yield as a single diastereomer, 
which was characterized by X-ray crystallography.  The above preliminary results were obtained by 
Corey R. J. Stephenson while working as a graduate student in the Wipf group. 
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Conditions:  (a) m-CPBA (3 eq.), Na2HPO4 (3 eq.), 
CH2Cl2, 18h.  
Scheme 3-9.  Examples of oxidative rearrangement of enol ethers. 
  
A proposal for the oxidative rearrangement of 3-17 is outlined in Scheme 3-10. The epoxy 
ether intermediate 3-27 opens to the alkoxycarbenium ion 3-28 in the presence of a proton donor.  
This species is then intercepted by another equivalent of peracid to give peroxy ketal 3-29. A methyl 
ether assisted acyl shift generates the seven-membered lactone 3-30 which can undergo a ring 
contraction to generate the product lactone ester 3-23, which is epimerizable at the α-position to the 
ester moiety, resulting in the thermodynamically more stable equatorial ester after basic workup and 
isolation. This sequence constitutes a net addition of two oxygen atoms concomitant with a skeletal 
rearrangement.101 
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Scheme 3-10.  Proposed mechanism for oxidative rearrangement of enol ethers. 
 
Due to their occurrence in many biologically active molecules,102 the potential formation of 
acetals and ketals such as 3-18 appeared to offer convenient access to these motifs.  There are 
several known methods for the formation of spiroketals,103 many based on the cyclization of 
hydroxy ketones.  For example, in Marshall’s synthesis of a fragment of tautomycin, ketone 3-31 
was converted through in-situ deprotection of the silyl ethers and subsequent intramolecular 
ketalization to 3-32 in 92% yield (Scheme 3-11).104 
 
OBn
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O
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Me Me
HCl/MeOH
92%
3-31 3-32  
Scheme 3-11.  Acid-promoted tandem deprotection-ketalization by Marshall.  
 
A similar method was used by Kiyota’s group during their approach to spirofungins A and 
B.105  When bisketal 3-33 was subjected to acidic conditions, the deprotected secondary hydroxy 
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group underwent transketalization in 82% overall yield to furnish the spiroketal 3-34 as the major 
product (Scheme 3-12). 
 
O
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Me
OH Me
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CHCl3
82%3-33 3-34  
Scheme 3-12.  Acid-promoted transketalization to form 3-34 by Kiyota. 
 
Forsyth and co-workers took a different approach during their approach to a family of fly 
phermones.106  For example, ketone 3-35 was treated with CSA in methanol to induce deprotection 
of the silyl ethers (Scheme 3-13).  A solvent switch to benzene facilitated double Michael addition of 
the hydroxy groups to provide the spiroketal 3-36 in 70% yield.   
 
OTBS
TBSO
O
CSA, MeOH
then benzene
O
O
O
70%3-35 3-36  
Scheme 3-13.  Tandem Michael addition to form ketal 3-36 by Forsyth.  
 
Although many ketalization methods proceed under dehydrating or oxidative conditions, 
Jorgenson and co-workers have reported a hetero Diels-Alder pathway mediated by copper 
catalysis.107  Upon treatment with chiral copper catalyst 3-39, ketoester 3-37 and vinyl ether 3-38 
underwent cycloaddition in 84% yield to provide ester 3-40 as the major product in 74% ee (Scheme 
3-14).  The epimer at the ketal center constituted the remaining material. 
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Scheme 3-14.  Copper-catalyzed enantioselective cycloaddition to form ketal 3-40 by Jorgenson. 
 
Although the oxidative rearrangement of 3-22 proceeded in low yield (as shown in Scheme 
3-9), it was hypothesized that masking the free alcohol as a cyclic ether would improve the 
efficiency of the reaction by avoiding the formation of sensitive hemiacetals.  Toward this end,  
cyclopentanone was treated with 5-lithio-2,3-dihydrofuran according to a protocol by Paquette,108 
which furnished an intermediate tertiary allylic alcohol which could be rearranged under acidic 
catalysis to the spirocyclic ketone 3-41 in 65% yield overall (Scheme 3-15).  At this stage, all that 
was required to set up the oxidative rearrangement was O-alkylation of the corresponding enolate of 
3-41.  Following treatment with KHMDS, addition of DMF and dimethylsulfate furnished the 
methyl enol ether 3-42 in 83% yield.  When 3-42 was submitted to the oxidative rearrangement, the 
volatile spiroketal 3-43 was obtained as the sole product in 52% yield.   
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Scheme 3-15.  Preparation of spiroether 3-42 and rearrangement to spiroketal 3-43.  
 
Seeking to expand this spiroketal methodology, methyl enol ethers 3-44, 3-46 and 
androsterone-based 3-48 were prepared in an identical fashion to 3-42.109  When 3-44 was submitted 
to the rearrangement, volatile spiroketal 3-45 was isolated in 48% yield as a modest 2:1 mixture of 
diastereomers (Scheme 3-16).  Methyl enol ether 3-46 smoothly underwent rearrangement in 53% 
yield, and 3-47 was isolated as a single diastereomer.  Additionally, 3-48 was converted to 
pentacyclic spiroketal 3-49 in 76% yield as a single diastereomer.  The configurations of 3-45, 3-47, 
and 3-49 were assigned in analogy to 3-21 and 3-26, which were characterized by X-ray analysis. 
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Conditions:  (a) m-CPBA (3 eq.), Na2HPO4 (3 eq.), CH2Cl2, 18h.
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Scheme 3-16.  Oxidative rearrangement of various enol ethers to spiroketals. 
 
In conclusion, an efficient oxidative rearrangement of alkyl enol ethers to lactone and 
spiroketal esters has been demonstrated.  This method allows rapid access to these common 
structural subunits under relatively mild conditions.  Although this investigation was inspired by 
Barton’s proposal for the biosynthesis of acutumine, no experimental support for the dienone 
diepoxide rearrangement was achieved.  It appears that α-epoxy ethers of type 3-27 prefer 
alternative rearrangements to a migratory ring contraction.  The recent isolation of acutudaurin (3-
54, Scheme 3-17),110 a possible precursor of acutumine-type natural products, lends support to a 
modified biosynthetic pathway.  As shown in scheme 3-17, the tricarbonyl tyrosine dimer 3-50 can 
be envisioned as a direct precursor of acutumine (3-1) after oxidation and benzilic acid 
rearrangement (3-51 to 3-52), followed by decarboxylation to generate the cyclopentanone subunit 
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3-53.  This pathway is supported by experimental observations in the literature,111 and the 
oxygenation pattern on spirocycle 3-54 is in good agreement with the structure of acutudaurin. 
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Scheme 3-17.  Revised biosynthetic proposal for acutumine (3-1). 
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4. TOTAL SYNTHESIS OF DIAZONAMIDE A 
4.1 INTRODUCTION 
4.1.1 Isolation and Structure 
 The diazonamides (4-1 and 4-2, Scheme 4-1) were isolated in 1991 from Diazona angulata, a 
rare marine ascidian found in the coastal caves of Siquijor island, Philippines.112  The structure of 
diazonamide A was assigned as 4-3 by 1H NMR analysis and spectral similarity to diazonamide B 
(4-2).  The first and only synthesis of 4-3 was reported 10 years later by Harran and revealed a 
structural misassignment.113  Harran then proposed 4-1 as the correct structure of diazonamide A 
based on the reported X-ray data and 1H NMR studies of related compounds.114  Nearly two years 
later, Nicolaou reported the first total synthesis of diazonamide A, and confirmed 4-1 as the correct 
structure.115  
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Scheme 4-1.  Originally proposed and revised structures of diazonamide A and B. 
 
 The diazonamides possess unique structures which include ten rings spanning two 
macrocyclic domains (Scheme 4-2).  These domains are anchored by the C10 quaternary center, 
which lies deep within the core of the molecule.  Three biaryl bonds link together the lower 
polyaromatic domain that exists as a single atropisomer.  Additionally, the diazonamides were the 
first natural products isolated to contain the bis-indole, bis-oxazole motif.   
 77 
HN
O
O
N
Cl
HN
O
N
H
NH
O
H
H
N
H
O
OH
ClO NH
O N
NH
O
N Cl
Cl
N
O
H
N
O
HO
H
H
A
B
C
D
E
F
G
H
4-64-5
10
37
 
Scheme 4-2.  Ring lettering and perspective view of diazonamide A. 
 
As part of his structural reassignment, Harran suggested a biosynthetic pathway for 4-1.115 The 
complex structure of diazonamide A was proposed to be derived from five simple components, along 
with multiple oxidation state changes (Scheme 4-3).   
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Scheme 4-3.  Biosynthetic origin of diazonamide A as proposed by Harran. 
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4.1.2 Biological Activity 
Diazonamide A possesses not only a tremendously complex structure, but is also 
significantly cytotoxic.  Initial assays revealed IC50 values against HCT-116 human colon carcinoma 
and B-16 murine melanoma cell lines of less than 15 ng/mL, with diazonamide B less potent.113  
Assays at the National Cancer Institute indicated that diazonamide A had a mean GI50 of 4.9 nM 
against a standardized panel of human cancer cell lines.114  Cruz-Montseratte reported detailed 
studies which indicated that 4-1 arrests cells at the G2/M phase of the cell cycle through inhibition of 
tubulin assembly.116  The Nicolaou group also tested diazonamide A (and its C37 epimer) against six 
human cancer cell lines, four of which were standard:  1A9 human ovarian carcinoma, PC-3 human 
prostate carcinoma, MCF-7 human breast carcinoma, and A549 human lung carcinoma.117  Two 
were drug-resistant cell lines from 1A9 parental cells, one with a multidrug resistant phenotype due 
to high expression of the drug-efflux pump P-glycoprotein (PGP) and the other Taxol-resistant 
because of an acquired β-tublin mutation.  Diazonamide A demonstrated IC50 values of 2-5 nM 
against every cell line except the multidrug resistant cell line, suggesting that diazonamide is a 
substrate for PGP.  The C37 epimer of diazonamide was 3- to 5-times less potent.  Interestingly, 
diazonamide A and its C37 epimer were active against the taxol-resistant cell line, suggesting that 
diazonamide had a binding site on tublin distinct from taxol.  Recently, Harran reported that 
diazonamide A blocks mitotic spindle assembly through binding to ornithine δ-amino transferase 
(OAT).118  To confirm the mechanism, it was demonstrated using RNAi that OAT knockdown 
“blocks cell division and causes cell death, the effects largely phenocopying diazonamide A 
treatment”.  This study revealed a new role for OAT in mitosis and makes it a target for drug 
development.   
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 Harran has also reported that diazonamide analog 4-7, which lacks chlorination, is as potent 
as diazonamide A against multiple cancer types, yet displays no toxicity (Scheme 4-4).119  Analog 4-
7 demonstrated anti-cancer activity in animals with xenografted tumors that was comparable to 
taxanes or vinca alkaloids.  Mice treated with 4-7 demonstrated no weight loss, no change in 
appearance, and no evidence of white-blood cell loss.  This exciting result suggests that 4-7 could 
have potential in a clinical setting.  
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Scheme 4-4.  Diazonamide analog developed by Harran. 
4.1.3 Previous Total Syntheses 
 Diazonamide attracted the attention of the synthesis community immediately, and several 
groups have reported progress toward its total synthesis.120  Despite this intense effort, only two 
groups have reported successful total syntheses, and one has reported a formal synthesis.  Only the 
work resulting in total (or formal) syntheses will be addressed here. 
The Harran group approached the originally proposed structure of diazonamide by utilizing a 
Heck macrocyclization to construct triarylalkene 4-9 from 4-8 (Scheme 4-5).  This brought together 
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the components of diazonamide’s macrolactam ring, but still required some skeletal rearrangement 
to install the C10 quaternary center.   
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Scheme 4-5.  Macrocyclic Heck cyclization utilized during Harran’s synthesis of the originally 
proposed structure of diazonamide A. 
 
Following protection of the free phenol, Harran dihydroxylated alkene 4-10 to provide diol 4-
12 in excellent yield and diastereoselectivity (Scheme 4-6).114  Treatment of diol 4-12 with p-TsOH 
in toluene initiated a ring-contracting pinacol rearrangement to furnish aldehyde 4-13, containing the 
proper architecture required for the macrolactam region of diazonamide.   
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Scheme 4-6.  Key dihydroxylation and pinacol rearrangement in Harran's total synthesis of the 
originally proposed structure of diazonamide A. 
 
After converting aldehyde 4-13 to indole-containing 4-14, Harran utilized a photochemical 
Witkop-type cyclization to forge the C16-C18 bond in ~ 35% yield (Scheme 4-7).  This 
transformation is proposed to proceed through intermediates 4-16 and 4-17, with a final 
aromatization to furnish the product.  This operation completed the polyaromatic lower domain of 
diazonamide and provided a unique approach to the biaryl linkage between the D and E rings of 
diazonamide. 
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Scheme 4-7.  Witkop-type cyclization developed by Harran to form C16-C18 bond. 
 
 Harran converted 4-15 to the proposed structure for diazonamide A through 6 steps (Scheme 
4-8).  Upon completion, 4-3 neither matched the reported data for diazonamide nor was stable for 
significant periods of time.  Upon comparison of the reported spectral data for diazonamide as well 
as the X-ray data, Harran proposed 4-1 (See Scheme 4-1) as the correct structure of diazonamide 
A.115 Once again, a total synthesis of 4-1 would be required to confirm this assignment. 
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Scheme 4-8.  Final conversion of Witkop product 4-15 to the originally proposed structure of 
diazonamide A. 
 
 The Nicolaou group had been working towards diazonamide when the structure revision was 
published by Harran.  A revised strategy toward the complex elements of the diazonamide skeleton 
began by adding oxazole dianion 4-20 to isatin 4-19, which proceeded in 73% yield and provided a 
1:1 mixture of diastereomers (Scheme 4-9).116  
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Scheme 4-9.  Formation of key tertiary alcohol 4-21 in Nicolaou’s first total synthesis of 
diazonamide A. 
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Upon treatment with p-TsOH, a mixture of tertiary alcohol 4-21 and N-Cbz-Tyr-OMe 
furnished triaryl lactam 4-22 in 47% yield and as a 1:1 mixture of diastereomers (Scheme 4-10).  
This transformation installed the critical C10 quaternary center, although only half of the material 
had the configuration required for the natural product.   
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Scheme 4-10.  Formation of C10 center during Nicolaou's first total synthesis of diazonamide A. 
 
Having installed diazonamide’s C10 center, Nicolaou then turned to closing the macrolactam 
region of the molecule.  With amino acid 4-23 in hand, macrocyclization proceeded in 36% yield, 
since only the correct diastereomer required for diazonamide cyclized (Scheme 4-11).  Material 
containing the incorrect configuration was reported to dimerize or oligomerize.   
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Scheme 4-11.  Macrolactamization in Nicolaou's first total synthesis of diazonamide A. 
 
With one of the major domains in place, Nicolaou turned to Harran’s method to form the 
lower, polyaromatic domain.  Compound 4-25, when irradiated at 200 nm, underwent the Witkop-
type cyclization to furnish 4-26 in 33% yield (Scheme 4-12).  The low yield reflects the highly 
strained nature of the large rings being formed.  After 5 more straightforward steps, the Nicolaou 
group completed the first total synthesis of diazonamide A, confirming Harran’s revised structure (4-
1). 
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Scheme 4-12.  Nicolaou's use of Witkop-type cyclization to form lower macrocycle and completion 
of diazonamide A. 
 
Shortly after the Nicolaou group confirmed the assignment of diazonamide A, they reported 
another approach which also resulted in a successful total synthesis.121  The key C10 quaternary 
center was formed through a two-step hydroxymethylation of oxindole 4-27 (Scheme 4-13).  As in 
their first synthesis, the Nicolaou group chose to form the C10 center in a non-selective fashion. 
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Scheme 4-13.  Formation of the C10 quaternary center in Nicolaou's second total synthesis of 
diazonamide A. 
 
Oxindole 4-28 was readily converted to the oxime 4-29 through a biaryl coupling at the C16-
C18 bond, which set the stage for a hetero-pinacol macrocyclization.  Following treatment with 
SmI2, the macrocyclization proceeds smoothly to yield amino alcohol 4-30 in excellent yield 
(Scheme 4-14).  This approach allows for a convergent approach to the polyaromatic core of 
diazonamide A.  The Nicolaou group carried out the remaining macrolactamazation and structural 
elaboration to complete a second total synthesis of diazonamide A.   
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Scheme 4-14.  SmI2-mediated heteropinacol macrocyclization in Nicolaou's second total synthesis of 
diazonamide A. 
 
The Harran group continued their investigations into the revised structure of diazonamide 
and published an extremely efficient approach in 2003.122  Readily prepared 4-31, when treated with 
PhI(OAc)2, underwent oxidative cyclization to form 4-32 in 20-25% yield as a single diastereomer 
(Scheme 4-15).  Despite the low yield, this represents the most effective approach to diazonamide 
reported to date.  Harran carried 4-32 on to complete his total synthesis of diazonamide A, utilizing 
the Witkop-type macrocyclization to append the remainder of the molecule.   
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Scheme 4-15.  Harran's key oxidative cyclization in his total synthesis of diazonamide A. 
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In 2007, Magnus reported a formal synthesis of diazonamide A, intercepting an intermediate 
in Nicolaou’s first synthesis.123  Magnus’ approach relied on a thermal O- to C-aryl migration.  
Specifically, when 4-33 was refluxed in CHCl3, migration of the aryl ring to form 4-34 in 
quantitative yield as an 84:16 ratio of diastereomers (only major is drawn, Scheme 4-16).  A formal 
synthesis required 3 synthetic operations to reach macrolactam 4-24 (see Scheme 4-11).  
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Scheme 4-16.  Magnus' O- to C-aryl migration to form the C10 quaternary center in his formal 
synthesis of diazonamide A. 
4.2 RESULTS AND DISCUSSION 
4.2.1 Previous Work Towards Diazonamide A in the Wipf group 
Diazonamide presented a difficult problem, and therefore an exciting opportunity to construct 
a complex array of heterocycles within a dense, rigid framework.  Additionally, its potent biological 
activity encouraged work in the Wipf group directed at the originally proposed (incorrect) structure.  
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An approach based upon an enantioselective Heck cyclization was reported in 1998 and is shown in 
Scheme 4-17.124  Ester 4-35 underwent Heck cyclization to furnish model lactone 4-36 in 47% yield, 
but only 19% ee.  This transformation established a model for generating the C10 quaternary center, 
although the structure revision would render this approach unusable.   
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Scheme 4-17.  Enantioselective Heck cyclization reported by Wipf as an approach to the originally 
proposed structure of diazonamide A. 
 
Additional work in the Wipf group developed a method for installing the central oxazole of 
the diazonamide skeleton utilizing a Chan-type rearrangement.125  The key to this approach was the 
rapid preparation of the α-amino ketone motif required for the central oxazole.  Towards this end, 
Boc-imide 4-37 was treated with LDA to furnish the intermediate anion 4-38 (Scheme 4-18).  
Immediate acyl migration resulted in aminoketone 4-39 in 78% yield.  Subsequent deprotection, 
coupling to Cbz-protected valine and cyclodehydration provided the bis-oxazole 4-40 in 41% over 
the three steps, and provided a model for constructing this region of the molecule once the C10 
quaternary center had been formed. 
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Scheme 4-18.  Wipf's Chan rearrangement approach to the indole bis-oxazole motif in diazonamide 
A. 
 
4.2.2 Retrosynthetic Analysis 
The planned approach to diazonamide A centered on forming the C10 center using an 
enantioselective Heck cyclization.  In the retrosynthetic sense, diazonamide can be stripped of its 
adorning acyl- and chlorine substituents, and opened at the peptide bond to furnish 4-41 (Scheme 4-
19).  Cleavage through the indole-indole biaryl axis and central oxazole excises valine and reveals 
Chan-rearrangement product 4-42.  Rupture of the aminal linkage and hydrolytic cleavage of the 
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peptide bond reveals the key C10 anchored acid 4-44 and known indole-oxazole fragment 4-45.  
Acid 4-44 is accessible from Heck cyclization product 4-46 through oxidative cleavage of an alkene.  
The required Heck precursor 4-47 is easily deconstructed as the condensation product of an ester (4-
48) and a functionalized aniline 4-49.  
 93 
O NH
O N
NH
O
N Cl
Cl
N
O
H
N
O
HO
H
O NH
O N
NH
O
N
H2N
NHP
PO
Macrolactamization
Acylation
Chlorination Oxazole
Formation
Biaryl Coupling
Diazonamide A (4-1)
O OH
H2N
O NH
O NH2
NH
O
N
PHN
PO
Chan 
Rearrangement
X
O NH
O HN
X
PHN
PO
NH
N
O
Aminal
Formation
Peptide
Coupling
H2N
NH
N
O
HO NH
O
PHN
PO
OH
X
O
Oxidative
Cleavage
HO NH
PHN
PO
X
O
Halogen-Selective Asymmetric
Heck Cyclization
HO
PO
PHN
O
N
H
X
Y
Amidation
HO
PO
PHN
O
OR
NH2
XY
4-41
4-42 4-43
4-44
4-45
4-46
4-47
4-48
4-49
  
Scheme 4-19.  Retrosynthetic analysis for diazonamide A. 
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4.2.3 Preparation of Aniline 4-51  
An ideal aniline fragment would allow for selective insertion of palladium during the Heck 
cyclization, and allow a handle for the palladium-mediated formation of the indole-indole biaryl 
linkage later in the synthesis (Scheme 4-20).  Aniline 4-51 was chosen as a suitable target since the 
halogen substituents would be relatively stable during synthetic operations (as opposed to a triflate), 
yet provide sufficient reactivity in a complex system.   
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4-50 4-51  
Scheme 4-20.  Requirement for aniline fragment to be selectively activated by Pd(0). 
  
Perusal of the literature revealed a single method for constructing mixed 2,6-dihaloanilines, 
consisting of 5 to 7 steps and requiring tedious separation throughout the sequence.126  Furthermore, 
compound 4-51 itself had never been reported, indicating potential difficulty in its preparation.  
Therefore, a new preparation was developed utilizing an N- to C-silyl transfer reaction.127  
Commercially available 2,6-dibromoaniline (4-52) was doubly silylated to provided 4-53 in 99% 
yield (Scheme 4-21).  Treatment with 2 eq of s-BuLi generated intermediate lithiate 4-54 which 
induced migration of one silyl group from nitrogen, which furnished the key differentially 
substituted aniline 4-55 upon acidic workup.  This crude material rapidly underwent iododesilylation 
with ICl to provide the desired aniline 4-51 in 90% yield over the two steps.  This approach has 
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proven to be very scalable, and a simple recrystallization of 4-51 makes the final purification simple 
and effective.   
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Scheme 4-21.  Preparation of aniline 4-51 utilizing an N- to C-silane transfer. 
4.2.4 Incorporation of Tyrosine Backbone and Installation of C10 Quaternary 
Center 
As shown in Scheme 4-22, ester 4-48 was required to complete the synthesis of the key Heck 
cyclization precursor.  An sp2-sp2 coupling was initially employed to access to this fragment. 
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Scheme 4-22.  Retrosynthetic analysis for key intermediate 4-47. 
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 Toward this end, iodoenoate 4-58 was prepared from ethyl ester 4-56 beginning with a 
palladium-catalyzed hydrostannylation to furnish crude stannane 4-57 followed by 
iododestannylation in 68% yield (Scheme 4-23).128   
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Scheme 4-23.  Hydrostannylation of 4-56 and iodination of stannane 4-57. 
 
Preparation of the coupling partner for 4-58 began with Boc protection of L-Tyr-OMe-HCl to 
furnish 4-60 (Scheme 4-24).  Reduction of crude 4-60 with LiBH4 followed by protection of the 
amino alcohol as the isopropylidene aminal generated 4-61 in 70% over the three steps.  Subsequent 
protection of the crude phenol as the MOM-ether furnished the desired coupling partner 4-62 in 91% 
yield.  A Negishi coupling was employed to couple 4-62 and 4-58.129  Thus, directed ortho-lithiation 
with n-BuLi followed by transmetallation to zinc generated an arylzinc reagent that smoothly 
underwent cross-coupling with vinyl iodide 4-58 in the presence of Pd(PPh3)4 to furnish enoate 4-63 
in 76% yield.130   
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Scheme 4-24.  Preparation of ester 4-63. 
 
With ester 4-63 in hand, condensation of aniline 4-51 in the presence of AlMe3 proceeded 
unreliably in 10-50% yield, and furnished only material lacking the MOM ether (Scheme 4-25).  
Unfortunately, any attempt to couple aniline 4-51 to any derivative of ester 4-63 was unsuccessful, 
including the acid, mixed anhydride, acyl fluoride and chloride.   
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Scheme 4-25.  Condensation of aniline 4-51 with ester 4-63. 
 
Given the clear lability of the MOM ether during the aluminum mediated condensation, the 
corresponding benzyl ether was prepared as shown in Scheme 4-26.  Beginning with commercial 3-
iodo-L-tyrosine (4-65), the free acid was converted to the methyl ester with SOCl2 in methanol.  
Subsequent Boc-protection of the nitrogen furnished 4-66.  Crude ester 4-66 was reduced with 
LiBH4 and the resulting amino alcohol protected as the isopropylidene ketal to generate the phenol 
4-67 in 92% yield over four steps.  This crude phenol was then benzylated to provide 4-68 in 87% 
yield.  Subsequent Stille coupling to stannane 4-57 proceeded in 73% yield to furnish the desired 
benzyl protected enoate 4-69.131 
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Scheme 4-26.  Preparation of the O-benzyl protected ester 4-69. 
 
Ester 4-69 resisted aluminum-mediated condensation with aniline 4-51 under any set of 
stoichiometry, solvent or temperature conditions applied (Scheme 4-27).  Given the necessity of this 
transformation, further optimization of the ester substrate was attempted.  This time, the alkene 
geometry would be reversed to trans, moving the methyl group away from the sterically 
encumbering cis orientation. 
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Scheme 4-27.  Attempted condensation of aniline 4-51 with ester 4-69. 
 
Benzylated phenol 4-68 provided an ideal starting point for the preparation of the desired 
ester.  Conversion of the iodide to the corresponding pinacol boronate ester 4-70 proceeded in 70% 
yield (Scheme 4-28).  Subsequent Suzuki coupling with iodide 4-71 generated the desired trans ester 
4-72 in 51% yield.132  Surprisingly, ester 4-72 also proved to be unreactive under any set of 
amidation conditions applied. 
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Scheme 4-28.  Preparation of ester 4-72 containing the (E) alkene geometry and attempted 
condensation with aniline 4-51. 
 
This result suggests that the MOM ether may be necessary for condensation to occur.  It is 
conceivable that an in situ lactonization is required and that the lactone intermediate is the actual 
substrate undergoing amidation (Scheme 4-29).  Additional concerns about material throughput 
 102 
prompted a revised approach to this critical fragment that would include the MOM functionality, 
avoid tedious separations, and provide substantial amounts of material. 
 
4-63 4-73
O
N
Boc
O
O
O
N
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O
OEt
 
Scheme 4-29.  Possible intermediate required for successful amidation of esters of type 4-63. 
 
As before, carrying commercial 3-iodo-L-tyrosine (4-65)  through to intermediate 4-67 and 
subsequent protection as the MOM ether generated 4-74.  Crude MOM ether 4-74 underwent a 
Sonagashira coupling with propyne to furnish 4-75 which was pure enough to carry on crude 
(Scheme 4-30). This alkyne was hydrostannylated under palladium catalysis and the resulting 
alkenylstanne was iodinated to furnish alkenyiodide 4-76 in 71% yield over the 8 steps from 3-iodo-
L-tyrosine.  This approach allowed the installation of the desired alkenyl moiety in a very high-
yielding sequence, although it was slightly longer than the previous approach.  On large scale, the 
chemistry could be performed reliably with only a single purification of the alkenyliodide on SiO2, 
and proceeded in 70-80% over 8 steps, or about 97% per synthetic step.  The operational benefits of 
this approach far outweighed the additional steps.  
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Scheme 4-30.  Preparation of vinyl iodide 4-76. 
 
With alkenyliodide 4-76 in hand, continued elaboration to the desired Heck cyclization 
precursor was required.  Any attempt to perform lithium-halogen exchange on iodide 4-76 was met 
with failure.  Therefore, a palladium-catalyzed carbonylation was performed in methanol, which 
gave rise to methyl ester 4-77 in 71% yield (Scheme 4-31).133,134  
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Scheme 4-31.  Carbonylation of vinyl iodide 4-76 to prepare key ester 4-77. 
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Ester 4-77 now contained all of the attributes that were presumed to aid the aluminum-
mediated amidation:  MOM-protection on the phenol, trans alkene geometry and the methyl (as 
opposed to ethyl) ester.  Optimization of the amidation with ester 4-77 gave rise to anilide 4-78 in 
67% yield, which varied only slightly on differing scales (Scheme 4-32).  Double benzylation of 
anilide 4-78 furnished the desired Heck cyclization precursor 4-79 in 90% yield.    
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Scheme 4-32.  Condensation of aniline 4-51 with ester 4-77 and subsequent elaboration to key Heck 
cyclization precursor 4-79. 
 
The critical enantioselective Heck cyclization was investigated next.135  Initially employing 
Overman’s Ag-promoted conditions with rac-BINAP as the ligand and DMA as solvent provided 
the desired cyclization product 4-80 in 53% yield, with some evidence of decomposition, most likely 
from the prolonged heating (Entry 1, Table 4-1).  Performing the reaction with (S)-BINAP and 
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reducing the reaction time provided an improved yield (63%) but the enantioselectivity (ee) was 
poor and some starting material remained (Entry 2).136  A switch to “base-promoted” conditions 
dramatically increased the yield to 97%, yet the ee remained at 30% (Entry 3).  A switch to NMP as 
solvent dramatically increased the ee (60%) reduced the reaction time to ~3.5 h and provided an 
excellent yield (Entry 4).  A decrease in ee from 60 to 50% was observed when (S)-Tol-BINAP was 
employed as the ligand (Entry 5).  The temperature dependence of the cyclization was investigated 
next.  Conducting the reaction at 95 °C required 6 h, and the ee dropped to 41% (Entry 6); however, 
at 135 °C the reaction proceeded in only 1h, and the ee was 55% (Entry 7).  Thus, the optimal 
conditions chosen were (S)-BINAP as the ligand, PMP as the additive, NMP as solvent and a 
reaction temperature of ~110 °C.  These conditions proved to be amenable to scale-up as 
demonstrated in entries 8-11, where increasingly larger scale reactions provided consistent yields 
and enantioselectivities.  The optimized Heck cyclization did not perform at extreme levels of 
efficiency in terms of enantioselectivity, but effectively provided an average of 68% of the desired 
stereoisomer required for diazonamide A (based on the average yield and ee in Entries 8-11).  Given 
the substantial challenges that were ahead in the synthesis, the optimized conditions would provide 
sufficient material throughput.  Although attempts to confirm the relative stereochemistry of 4-80 by 
X-ray crystallography failed, the stereochemistry was assigned based on analogy to several similar 
substrates reported by Overman.136 
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Table 4-1. Enantioselective Heck cyclization to set the C10 quaternary center of diazonamide A.  
BnO
O
N
Boc
O
N
Bn
Br
I
Pd Source
N
Bn
Br
OBnO
O
BocN
Conditions
4-79 4-80  
Entry 
Pd 
Source Ligand Additive Solvent 
Temp 
(°C) time (h) yield (%)a 
ee 
(%)f 
1 a rac-BINAP Ag3PO4 DMA 100 20 53% 0 
2 b (S)-BINAP Ag3PO4 DMA 95 12 68 + SM 30 
3 b (S)-BINAP PMP DMA 110 6 97 30 
4 b (S)-BINAP PMP NMP 110 3.5 99 60 
5 b (S)-Tol-BINAP PMP NMP 110 3.5 86 50 
6 b (S)-BINAP PMP NMP 95 6 90 41 
7 b (S)-BINAP PMP NMP 135 1 78 55 
8b b (S)-BINAP PMP NMP 110 2.5 88 53 
9c b (S)-BINAP PMP NMP 110 3.5 84 54 
10d b (S)-BINAP PMP NMP 110 3.5 87 54 
11e b (S)-BINAP PMP NMP 110 3.5 94 54 
Reaction conditions:  Pd source (10 mol %) (a = Pd2dba3 or b = Pd2dba3•CHCl3), ligand (22 
mol %), additive Ag3PO4 (2 eq.) or PMP (4 eq.), ~0.1 M in degassed solvent.  aStereochemistry 
assigned by analogy to similar substrates reported for this transformation by Overman.136  bReaction 
performed on 0.6 mmol scale.  cReaction performed on 3.52 mmol.  dReacion performed on 4.76 
mmol scale.  eReaction performed on 5.03 mmol scale.  fEnantioselectivity determined by HPLC on 
a Chiracel OD column, 10% i-PrOH/hexanes, flow rate 1 mL/min.   
 
4.2.5 Installation of Diazonamide’s Central Oxazole 
With a reliable route to significant quantities of oxindole 4-80, the oxidative cleavage of its 
alkene was investigated, as this was our key fragment (see retrosynthetic analysis, Scheme 4-19).  
Not surprisingly, any attempted cleavage of the alkene in the presence of the lactam carbonyl 
resulted in decomposed material, presumably through decarboxylation.  Therefore, the lactam would 
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be reduced to eliminate this undesired β-keto acid-type arrangement.  Treatment of oxindole 4-80 
with LAH in Et2O or THF resulted in the desired reduction, along with unexpected debromination as 
indicated by 1H NMR and MS analysis (Scheme 4-33, δ 6.46 (d, 1 H, J = 7.8 Hz, m/z = 631.5 
([M+H]+ for 4-81). 
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Scheme 4-33.  Debromination observed during attempted reduction of oxindole 4-80. 
 
 To circumvent the debromination issue, DIBAL was employed and delivered the desired 
hydroindole 4-82 in 77% yield (Scheme 4-34).  Although this reaction was plagued by 
decomposition issues at room temperature, immediately heating the reaction mixture at reflux under 
concentrated conditions (~0.5 M) resulted in shorter reaction times and improved the recovery of the 
product. 
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Scheme 4-34.  Reduction of oxindole 4-80 with DIBAL. 
 
Hydroindole 4-82 was now ready to be converted to the corresponding acid through oxidative 
cleavage of the alkene.  A two-step dihydroxylation-oxidative cleavage furnished the desired 
aldehyde 4-83 in 83% yield over the two steps (Scheme 4-35).  Surprisingly, aldehyde 4-83 could 
not be converted to the corresponding acid under any conditions that were attempted, including:  Cr- 
and Ru- based oxidants, O3, Oxone®, NaClO2, NaClO, and Br2.  The product of nearly all of these 
attempts was indole 4-85.  Strictly controlling stoichiometry did not alter the reaction outcome to 
any detectable extent.  The intermediacy of 4-84 is presumed to be the culprit in this 
decarboxylation.  This result effectively terminated our Chan rearrangement approach to the central 
oxazole of diazonamide A, making aldehyde 4-83 a critical intermediate from which to proceed. 
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Scheme 4-35.  Oxidative cleavage of alkene 4-82 and unexpected decarboxylation during attempted 
oxidation of aldehyde 4-83. 
 
A revised approach to the α-amino ketone motif required for the central oxazole of 
diazonamide centered on an aldol-type addition of a glycine equivalent to aldehyde 4-83 (Scheme 4-
36).  This would allow for construction of the lower indole-containing subunit by appending 4-88 to 
the substrate.    
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Scheme 4-36.  Revised retrosynthetic analysis for diazonamide A. 
 
The literature revealed several suitable glycine equivalents, such as 4-90 and 4-91,137 which 
could serve as nucleophiles (Scheme 4-37).  Any attempted addition of their corresponding enolates 
consistently returned only starting materials.  Henry-type additions of nitroethane (4-92) or N-
benzylphthalimide (4-93) also returned only starting materials.  These results were somewhat 
surprising, but appear to be due to the sterically hindered nature of the aldehyde increasing the 
potential for retro-aldol fragmentation.   
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Scheme 4-37.  Attempted addition to aldehyde 4-83. 
 
If retro-aldol fragmentation was indeed the obstacle to enolate addition, then in situ trapping 
of the alkoxide intermediate would disable this pathway.  Methyl isocyanoacetate was chosen since 
it contained a trapping function along with the desired α-amino substitution.  Indeed, upon treatment 
with DBU, a mixture of aldehyde 4-83 and methyl isocyanoacetate rapidly condensed to furnish 
oxazoline 4-94 in 99% yield as a mixture of several diastereomers (Scheme 4-38).   
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Scheme 4-38.  Preparation of oxazoline 4-94. 
 
In an effort to access the corresponding free amino alcohol, oxazoline 4-94 was hydrolyzed 
with dilute aqueous HCl to furnish formamide 4-95 in 99% yield (Scheme 4-39).  Attempted 
deformylation of this substrate proved difficult, as the strongly acidic conditions typically applied 
rapidly decomposed the molecule.  However, immediate deformylation with NaOMe furnished only 
the retro-aldol product 4-83 in 92% yield, which provided some indirect evidence that fragmentation 
of this delicate intermediate was indeed a favored pathway. 
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Scheme 4-39.  Hydrolysis of oxazoline 4-94 and attempted deformylation of 4-95. 
 
An alternative use of oxazoline 4-94 was required that would circumvent the formation of 
sensitive intermediates.  Inspiration from N-acyl pyridine chemistry led to the attempted direct 
acylation of the oxazoline nitrogen with the acyl chloride derived from Fmoc-protected valine.138  
When treated with Fmoc-Val-Cl, oxazoline 4-94 was rapidly consumed according to TLC analysis, 
presumably converted to chloroaminal 4-96 (Scheme 4-40).  Hydrolytic workup of the reaction 
mixture revealed formate 4-97, which was immediately deformylated in basic methanol to provide 
alcohol 4-98 in 66% yield over the two steps as a mixture of several diastereomers.  This method 
provided a rapid method to incorporate the valine residue required for diazonamide A.  
Unfortunately, the analytical data for 4-94 and subsequent intermediates is poorly resolved due to the 
mixtures of diastereomers present (melting ranges are also very large), although the 1H and 13C 
spectra are consistent with the assigned structures.   
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Scheme 4-40.  Installation of valine residue through acylation of oxazoline 4-94. 
 
With alcohol 4-98 in hand, cyclization of diazonamide’s central oxazole seemed within 
reach.  Oxidation of the secondary alcohol with Dess-Martin periodinane furnished the 
corresponding crude ketone (structure tentatively assigned based on MS analysis) which was poised 
for cyclodehydration to 4-99, a substrate containing the fully functionalized quaternary center 
required for diazonamide A (Scheme 4-41).  Unfortunately, under any of the cyclodehydration 
conditions applied including POCl3, PPh3/Cl3CCCl3, PPh3/BrCl2CCCl2Br, Burgess reagent, and 
TsOH/toluene only decomposed or starting material was recovered.  Mass analysis of the crude 
reaction mixtures indicates some partial loss of H2O when POCl3 in pyridine conditions are applied, 
but none of the desired oxazole has been recovered.  This lack of reactivity has been observed by the 
Nicolaou and MacMillan groups in similar systems.139   
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Scheme 4-41.  Oxidation of alcohol 4-98 and cyclodehydration to key oxazole 4-99. 
 
 Several potential solutions to the oxazole cyclization problem remain to be explored.  
Although the issues preventing cyclodehydration in Scheme 4-41 are currently unknown, substrate 
4-100 lacking ester substitution could be accessed by addition of allyl isocyanide to aldehyde 4-83.  
Conversely, polycycle 4-101 containing a fused H-ring may reduce the steric bulk around the C10 
center and aid in cyclodehydration.   
 
N
Bn
Br
BnO
O
BocN
HO HN
O
NH
Fmoc
4-100
O
N
R
H
O
BocN
HO HN
CO2Me
O
NH
Fmoc
Br
4-101
H
 
Scheme 4-42.  Alternative substrates to proceed to the late stages of the synthesis. 
 
 Preliminary results toward an alternative cyclodehydration substrate have been achieved 
(although the structures are tentative until full characterization can be performed).  Beginning with 
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cinnamyl bromide, displacement with NaN3 yielded cinnamyl azide which was reduced with 
P(OMe)3 and the resulting amine isolated as tosylate salt 4-102 in 87% overall (Scheme 4-43).  
Subsequent condensation with ethyl formate furnished formamide 4-103, which was dehydrated to 
the corresponding isocyanide 4-104 in 78% yield. 
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Scheme 4-43.  Preparation of isocyanide 4-104. 
 
 The potassium anion of isocyanide 4-104 condensed with aldehyde 4-83 in 44% yield to 
furnish oxazoline 4-105 (Scheme 4-44).  Acylation of the oxazoline with Fmoc-Val-Cl and 
subsequent hydrolysis provided alcohol 4-106 in only 15% yield (unoptimized).  Alcohol 4-106 
could be potentially be cyclized directly to the corresponding oxazoline and then oxidized to the 
desired oxazole.  Conversely, it could be oxidized to the ketone and cyclodehydrated to the 
corresponding oxazole.   
 
 117 
N
Bn
Br
BnO
O
BocN
HO HN
O
NH
Fmoc
Ph
N
Bn
Br
BnO
O
BocN
O N
Ph
Fmoc-Val-Cl
then Et3N, H2O
then KHCO3, MeOH
15%
N
Bn
Br
BnO
O
BocN
O N
N
Bn
Br
BnO
O
BocN
O
H KHMDS
Ph N
Ph
44%
4-83
4-104
4-105
4-105 4-106  
Scheme 4-44.   Preparation of oxazoline 4-105 and subsequent acylation. 
4.2.6 Conclusions 
An approach to advanced intermediates for the synthesis of diazonamide has been developed 
that allows for the convenient preparation of multigram quantities of late stage material.  Several 
key elements have been introduced, including the C10 quaternary center which was installed 
using an enantioselective Heck cyclization.  Additionally, the valine residue has been efficiently 
introduced utilizing an N-acyl iminium ion cascade.  The remainder of the molecule is fully 
functionalized in terms of appending the remainder of the diazonamide skeleton, and work 
continues toward this goal. 
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5. EXPERIMENTAL SECTION 
 
All moisture sensitive reactions were performed under an N2 atmosphere and all glassware was 
flame dried under vacuum prior to use.  THF and Et2O were dried by distillation over 
Na/benzophenone under a nitrogen atmosphere.  Dry CH2Cl2 and Et3N were obtained by distillation 
from CaH2.  All reactions were monitored by TLC analysis until the starting material had been 
consumed.  Unless otherwise stated, solvents or reagents were used as received without further 
purification.  Analytical thin layer chromatography (TLC) was performed on pre-coated silica gel 60 
F-254 plates (particle size 0.040-0.055 mm, 230-400 mesh) and visualization was accomplished 
using UV light or by staining with basic KMnO4 or anisaldehyde dye.  NMR spectra were recorded 
at 300 MHz/75 MHz (1H/13C NMR) in CDCl3 unless otherwise stated on either a Bruker AVANCE 
300 MHz or a Bruker QM-300 MHz spectrometer at 23 °C.  Chemical shifts (δ) are reported in parts 
per million and the residual solvent peak was used as an internal standard (δ 7.261/77.0, 1H/13C 
NMR).  Data are reported as follows:  Chemical shift, multiplicity (s = singlet, d = doublet, t = 
triplet, q = quartet, p = pentet, s = sextet, m = multiplet, b = broad, app = apparent), integration, and 
coupling constant(s) (Hz).  IR spectra were obtained on a Nicolet AVATAR 360 FT-IR E.S.P 
spectrometer.  Mass spectra were obtained on a Micromass Autospec double focusing instrument.  
Melting points were determined using a Laboratory Devices Mel-Temp II and are uncorrected.   
 119 
Authors note:  Compounds 2-36, 2-48, 2-49, 2-50, 2-51, 2-52, 2-59, 2-61, 2-63, 2-69 and 
relevant precursors thereof were prepared by Joshua G. Pierce, University of Pittsburgh.  
Compounds 3-21, 3-23, 3-25, 3-26 and relevant precursors thereof were prepared by Corey R. J. 
Stephenson, University of Pittsburgh. 
 
5.1 WATER ACCELERATED CASCADE REACTIONS 
 
Ph O  
1-((E)-3-(Vinyloxy)prop-1-enyl)benzene (1-30).140  To a solution of cinnamyl alcohol (5.80 
g, 43.3 mmol) in ethyl vinyl ether (90 mL) at ambient temperature was added Hg(OAc)2 (5.11g, 16.0 
mmol).  The reaction mixture was heated at reflux for 4 h, cooled, treated with K2CO3 (2 g) and 
filtered through a pad of Al2O3.  The filtrate was concentrated, dissolved in hexanes (10 mL) and 
filtered through a 1.5 inch pad of SiO2.  The filtrate was concentrated to provide allylic vinyl ether 1-
30 (4.02 g, 25.1 mmol, 58%) as a colorless oil:  1H NMR δ 7.51-7.33 (m, 5 H), 6.75 (d, 1 H, J = 16.0 
Hz), 6.64 (dd, 1 H, J = 14.3, 6.8 Hz), 6.41 (dt, 1 H, J = 16.0, 5.8 Hz), 4.47 (dd, 2 H, J = 5.9, 1.4 Hz), 
4.41 (dd, 1 H, J = 14.3, 2.1 Hz), 4.20 (dd, 1 H, J = 6.8, 2.1 Hz); 13C NMR δ 151.3, 136.3, 132.6, 
128.4 (2 C), 127.7, 126.4 (2 C), 124.2, 87.1, 68.6.  
   
Ph OH
C4H9
Ph OH
C4H9
+
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(E,3S*,5R*)-7-Methyl-3-phenylundeca-1,6-dien-5-ol (1-31a) and (E,3S*,5S*)-7-methyl-3-
phenylundeca-1,6-dien-5-ol (1-31b).  General Protocol A.  To a -30 °C solution of AlMe3 (540 
mg, 7.35 mmol) and Cp2ZrCl2 (85.8 mg, 0.294 mmol)  in CH2Cl2 (6 mL) was added H2O (66.1 μL, 
3.67 mmol) dropwise.  The reaction mixture was warmed to ambient temperature and then cooled to 
0 °C and treated with 1-hexyne (676 μL, 5.88 mmol).  The mixture was stirred for 30 min, cooled to 
-78 °C, and treated with vinyl ether 1-30 (470 mg, 2.94 mmol) in CH2Cl2 (1.5 mL).  The mixture 
was warmed to ambient temperature over 10 min and quenched with 1 M Rochelle’s salt (3 mL).  
The aqueous layer was extracted with CH2Cl2 (3 x 5 mL) and the combined organic layers were 
washed with brine, dried (MgSO4), and concentrated.  The residue was chromatographed on SiO2 
(hexanes/EtOAc, 5:1) to furnish alcohols 1-31a and 1-31b as a colorless oil which was a 1:1 mixture 
of inseparable diastereomers as indicated by 1H NMR analysis:  (1:1 mixture of diastereomers) IR 
(neat) 3334, 2956, 2929, 1452, 996, 913, 700 cm-1; 1H NMR δ 7.34-7.18 (m, 5 H), 6.03-5.92 (m, 1 
H), 5.22-5.17 (m, 1 H), 5.11-5.02 (m, 2 H), 4.31-4.26 (m, 1 H), 3.49-3.39 (m, 1 H), 2.09-1.96 (m, 3 
H), 1.88-1.74 (m, 1 H), 1.54 (2 br s, 3 H), 1.42-1.20 (m, 4 H), 0.94 (t, 1.5 H, J = 4.7 Hz), 0.91 (t, 1.5 
H, J = 4.5 Hz); 13C NMR δ 143.8 (2 C), 142.3, 141.9, 139.5, 139.0, 128.4 (4 C), 127.6 (5 C), 127.2, 
126.2 (2 C), 114.2, 114.0, 66.6, 66.4, 46.2, 46.1, 43.0, 42.9, 39.2 (2 C), 29.9 (2 C), 22.3 (2 C), 16.5 
(2 C), 13.9 (2 C); MS (EI) m/z (rel intensity) 240 ([M-H2O]+, 34), 201 (30), 183 (62), 155 (16), 117 
(100); HRMS (EI) m/z calcd for C18H26O 258.1984, found 258.1982.   
     
N
O
O+
_
 
(E)-(Carboxyvinyl)trimethylammonium betaine (1-33).141  To a mixture of ethyl 
propiolate (5.32 g, 54.0 mmol) in CH2Cl2 (3 mL) and H2O (90 mL) at 5 °C was added Me3N (25% 
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solution in water, 18.0 mL, 75.6 mmol) dropwise over 30 min.  The temperature was kept under 30 
°C during the addition.  The mixture was warmed to ambient temperature and stirred for 3 h.  The 
organic layer was separated and the aqueous layer was washed with CH2Cl2 (2 x 15 mL).  The 
aqueous layer was azeotroped to dryness with 1,4-dioxane and the resulting solid washed with 
CH3CN (10 mL).  The solid cake was dried in vacuo for 24 h to provide betaine 1-33 (5.25 g, 40.4 
mmol, 76%) as a beige powder:  Mp 174.1-176.0 °C (dec., 1,4-dioxane); (lit. 176-177 °C (dec.)); 1H 
NMR δ 7.07 (d, 1 H, J = 13.8 Hz), 6.57 (d, 1 H, J = 14.0 Hz), 3.49 (s, 9 H).   
   
Ph O
O
OH  
(2E)-3-(Cinnamyloxy)acrylic acid (1-34).111  Hexane-washed NaH (830 mg, 34.6 mmol) 
was suspended in THF (40 mL) and cooled to 0 °C.  A solution of cinnamyl alcohol (3.86 g, 28.8 
mmol) in THF (40 mL) was added dropwise over 30 min and the reaction mixture was warmed to 
ambient temperature and stirred for 30 min.  To this pink solution was added betaine 1-33 (4.70 g, 
36.2 mmol) in one portion.  The mixture was heated at reflux for 4 h, cooled to ambient temperature 
and treated with water (10 mL).  The aqueous layer was washed with Et2O (2 x 100 mL), acidified to 
pH 1 with 10.0 M hydrochloric acid, extracted with Et2O (3 x 100 mL), dried (MgSO4), and 
concentrated.  The resulting white powder was dried at 0.1 mmHg for 24 h to furnish 1-34 (5.23 g, 
25.6 mmol, 95%) as a white powder: Mp 139.0-141.9 °C (Et2O); (lit. 140-141.5 °C); 1H NMR δ 
12.00 (br s, 1 H), 7.73 (d, 1 H, J = 12.5 Hz), 7.43-7.27 (m, 5 H), 6.69 (d, 1 H, J = 16.0 Hz), 6.30 (dt, 
1 H, J = 15.9, 6.2 Hz), 5.29 (d, 1 H, 12.5 Hz), 4.58 (dd, 2 H, J = 6.0, 0.7 Hz). 
 
Ph O
O
OMe  
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(2E)-Methyl 3-(cinnamyloxy)acrylate (1-35).  A solution of acid 1-34 (500 mg, 2.45 mmol) 
in MeOH (5 mL) and benzene (19 mL) was treated at ambient temperature with TMSCHN2 (2.0 M 
solution in hexanes, 1.72 mL, 3.43 mmol) and stirred for 90 min.  The reaction mixture was 
concentrated and chromatographed on SiO2 (hexanes/EtOAc, 3:1) to yield 1-35 (530 mg, 2.45 mmol, 
99%) as a colorless oil: IR (neat) 1710, 1643, 1624, 1190, 1137, 967, 745 cm-1; 1H NMR δ 7.62 (d, 1 
H, J = 12.6 Hz), 7.42-7.19 (m, 5 H), 6.68 (d, 1 H, J = 15.9 Hz), 6.29 (dt, 1 H, J = 15.9, 6.0 Hz), 5.30 
(d, 1 H, J = 12.4 Hz), 4.55 (dd, 2 H, J = 6.1, 1.2 Hz), 3.71 (s, 3 H); 13C NMR δ 168.1, 162.0, 135.8, 
134.4, 128.6 (2 C), 128.3, 126.6 (2 C), 122.5, 96.9, 71.6, 51.1; MS (EI) m/z (rel intensity) 218 ([M]+, 
41), 200 (14), 158 (8), 129 (12), 117 (100), 91 (49); HRMS (EI) m/z calcd for C13H14O3  218.0942, 
found 218.0932. 
 
Ph O
O
N
 
(2E)-3-(Cinnamyloxy)-N,N-dimethylacrylamide (1-36).  Acid 1-34 (1.08 g, 5.27 mmol), 
EDCI (1.31 g, 6.85 mmol), DMAP (64.3 mg, 0.53 mmol), and dimethylamine hydrochloride (1.07 g, 
13.2 mmol) were combined in CH2Cl2 (10 mL) at ambient temperature and DIPEA (3.4 mL, 18.4 
mmol) was added dropwise over 5 min.  The reaction mixture was stirred for 30 h and quenched 
with H2O (5 mL).  The aqueous layer was extracted with CH2Cl2 (4 x 10 mL) and the combined 
organic extracts were washed with brine, dried (MgSO4), filtered and concentrated.  The resulting 
residue was chromatographed on SiO2 (EtOAc) to give amide 1-36 (624 mg, 2.70 mmol, 48%) as a 
white solid: mp 58.4-59.6 °C (EtOAc); IR (KBr) 2931, 1651, 1591, 1495, 1449, 1254, 1119, 967, 
746 cm-1; 1H NMR δ 7.53 (d, 1 H, J = 11.8 Hz), 7.34-7.22 (m, 5 H), 6.60 (d, 1 H, J = 15.9 Hz), 6.22 
(dt, 1 H, J = 15.9, 6.1 Hz), 5.67 (d, 1 H, J = 11.8 Hz), 4.48 (dd, 2 H, J = 6.1, 1.2 Hz), 2.93 (s, 6 H); 
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13C NMR δ 166.9, 160.4, 135.7, 133.8, 128.4 (2 C), 127.9, 126.4 (2 C), 122.9, 96.4, 71.9, 36.9, 35.1; 
MS (EI) m/z (rel intensity) 231 ([M]+, 12), 203 (21), 117 (100), 91 (36), 72 (15); HRMS (EI) m/z 
calcd for C14H17NO2 231.1260, found 231.1250. 
 
O
MeO C4H9  
(2E,4E)-Methyl 5-methylnona-2,4-dienoate (1-37).  According to the general protocol A, 
AlMe3 (206 mg, 2.88 mmol), Cp2ZrCl2 (33.6 mg, 0.115 mmol), H2O (25.9 μL, 1.44 mmol), 1-
hexyne (264 μL, 2.30 mmol) and ester 1-35 (250 mg, 1.15 mmol) afforded dienoate 37 (79 mg, 
0.193 mmol, 37%) as a colorless oil:  1H NMR δ 7.58 (dd, 1 H, J = 15.1, 11.6 Hz), 5.98 (d, 1 H, J = 
11.3 Hz), 5.77 (d, 1 H, J = 15.1 Hz), 3.73 (s, 3 H), 2.13 (t, 2 H, J = 7.2 Hz), 1.88 (br s, 3 H), 1.49-
1.39 (m, 2 H), 1.36-1.24 (m, 2 H), 0.90 (t, 3 H, J = 7.2 Hz); 13C NMR δ 168.0, 150.4, 141.2, 122.9, 
118.1, 51.2, 39.8, 29.7, 22.3, 17.2, 13.8; MS (EI) 182 ([M]+, 23), 167 (15), 151 (23), 125 (85), 111 
(39). 
 
Ph
N
OH
Ph
O
Ph
N
OH
Ph
O
+
 
(E,2S*,3S*)-3-Hydroxy-N,N-dimethyl-5-phenyl-2-((R*)-1-phenylallyl)hex-4-enamide (1-
38) and (E,2S*,3R*)-3-hydroxy-N,N-dimethyl-5-phenyl-2-((R*)-1-phenylallyl)hex-4-enamide (1-
39).  According to the general protocol A, AlMe3 (645 mg, 8.96 mmol), Cp2ZrCl2 (26.2 mg, 0.0896 
mmol), H2O (64.5 μL, 0.0896 mmol), phenylacetylene (197 μL, 1.79 mmol) and amide 1-36 (207 
mg, 0.896 mmol) afforded, after chromatography on SiO2 (hexanes/EtOAc, 3:1), hydroxy amides 1-
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38 and 1-39 (31.9 mg, 0.0914 mmol, 10%) as a white solid which was a 5:1 mixture (1-38:1-39) of 
partially separable diastereomers by 1H NMR analysis of the crude reaction mixture.  1-38:  Mp 
142.8-145.9 °C (hexanes/EtOAc); IR (KBr) 3388, 3059, 3028, 2930, 1614, 1494, 1445, 1147, 1051, 
760, 702 cm-1; 1H NMR δ 7.33-7.22 (m, 10 H), 6.21 (ddd, 1 H, J = 17.0, 10.0, 9.4 Hz), 5.72 (dd, 1 H, 
J = 8.4, 1.3 Hz), 5.43 (d, 1 H, J = 17.0 Hz), 5.33 (dd, 1 H, J = 10.2, 1.5 Hz), 5.20 (d, 1 H, J = 9.9 Hz, 
exchanges with D2O), 4.87-4.80 (m, 1 H), 4.06 (dd, 1 H, J = 9.5, 9.5 Hz), 3.05 (dd, 1 H, J = 11.1, 2.7 
Hz), 2.63 (s, 3 H), 2.48 (s, 3 H), 2.11 (d, 3 H, J = 1.3 Hz); 13C NMR δ 174.3. 142.9, 141.6, 137.3, 
135.6, 130.3, 128.3 (2 C), 128.2 (2 C), 127.9 (2 C), 127.2, 126.8, 125.7 (2 C), 118.2, 67.9, 49.9, 
49.6, 37.4, 35.1, 16.2; MS (EI) m/z (rel intensity) 259 ([M-C3H8O2N]+, 34), 240 (21), 232 (32), 176 
(12), 131 (15), 117 (63), 72 (100); HRMS (EI) m/z calcd for C20H19 [M-C3H8O2N] 259.1487, found 
259.1475.  Characteristic data for 1-39:  1H NMR δ 7.50 (d, 2 H, J = 7.0 Hz), 6.51 (dt, 1 H, J = 17.0, 
10.1 Hz), 3.90 (app t, 1 H, J = 10.1 Hz), 3.25 (dd, 1 H, J = 10.0, 8.5 Hz), 2.37 (s, 3 H), 1.90 (d, 3 H), 
1.51 (s, 3 H). 
 
Ph O OH  
(2E)-3-(Cinnamyloxy)prop-2-en-1-ol (1-40).  A solution of ester 1-35 (10.2 g, 47.3 mmol) 
in CH2Cl2 (50 mL) was treated at -78 °C with DIBAL-H (1.0 M solution in hexanes, 99.2 mL, 99.2 
mmol).  The reaction mixture was allowed to warm to ambient temperature over 25 min and 
quenched with 1 M NaOH (10 mL).  The aqueous layer was extracted with CH2Cl2 (5 x 35 mL).  
The combined organic layers were washed with water and brine, dried (MgSO4), and concentrated.  
The residue was chromatographed on SiO2 (Et2O/hexanes, 3:1) to yield 1-40 (2.61 g, 13.7 mmol, 
29%) as a white solid:  Mp 49.5-51.4 °C (Et2O/hexanes); IR (KBr) 3325, 2909, 2863, 1652, 1449, 
1181, 971, 744 cm-1; 1H NMR δ 7.41-7.25 (m, 5 H), 6.66 (d, 1 H, J = 15.9 Hz), 6.57 (d, 1 H, J = 12.6 
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Hz), 6.30 (dt, 1 H, J = 15.9, 5.9 Hz), 5.13 (dt, 1 H, J = 12.5, 7.5 Hz) 4.42 (d, 2 H, J = 6.0 Hz), 4.07 
(app t, 2 H, J = 5.7 Hz) 1.14 (t, 1 H, J = 5.6 Hz); 13C NMR δ 149.3, 136.1, 133.0. 128.4 (2 C), 127.8, 
126.4 (2 C), 124.0, 103.4, 69.7, 60.2; MS (EI) m/z (rel intensity) 190 ([M]+, 15), 172 (47), 159 (88), 
117 (100), 91 (34); HRMS (EI) m/z calcd for C12H14O2  190.0993, found 190.0984. 
 
Ph O OMe  
1-((1E)-3-((E)-3-Methoxyprop-1-enyloxy)prop-1-enyl)benzene (1-41).  To a suspension of 
NaH (30.3 mg, 1.26 mmol) in THF (3 mL) at ambient temperature was added a solution of alcohol 
1-40 (200 mg, 1.05 mmol) in THF (2 mL).  The reaction mixture was stirred at ambient temperature 
for 45 min and treated with CH3I (164 μL, 2.63 mmol) over 3 min.  The mixture was stirred at 
ambient temperature for 12 h and quenched with H2O (1 mL).  The aqueous layer was extracted with 
Et2O (3 x 2 mL).  The combined organic layers were washed with brine, dried (Na2SO4), filtered and 
concentrated.  The residue was chromatographed on SiO2 (hexanes/EtOAc, 3:1) to yield methyl ether 
1-41 (207 mg, 1.02 mmol, 97%) as a colorless oil: IR (neat) 3060, 2924, 2855, 2821, 1652, 1496, 
1383, 1174, 1086, 967, 745 cm-1; 1H NMR δ 7.42-7.28 (m, 5 H), 6.65 (d, 1 H, J = 16.0 Hz), 6.57 (d, 
1 H, J = 12.6 Hz), 6.31 (dt, 1 H, J = 15.9, 5.9 Hz), 5.04 (dt, 1 H, J = 12.6, 7.4 Hz), 4.41 (dd, 2 H, J = 
5.9, 1.3 Hz), 3.86 (dd, 2 H, J = 7.4, 0.8 Hz), 3.31 (s, 3 H); 13C NMR δ 149.9, 136.1, 132.8, 128.3 (2 
C), 127.7, 126.3 (2 C), 123.9, 100.2, 69.7, 69.5, 56.8; MS (EI) m/z (rel intensity) 204 ([M]+, 16), 186 
(16), 172 (31), 159 (72), 148 (70), 131 (42), 117 (100), 91 (15); HRMS (EI) m/z calcd for C11H11O 
[M-C2H5O] 159.0809, found 159.0797. 
 
Ph O OTIPS  
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((2E)-3-(Cinnamyloxy)allyloxy)triisopropylsilane (1-42).  A solution of imidazole (101 
mg, 1.47 mmol), TIPSCl (235 μL, 1.10 mmol), and DMAP (13.4 mg, 0.112 mmol) in CH2Cl2 (3 
mL) was cooled to 0 °C and treated with a solution of alcohol 1-40 (200 mg, 1.05 mmol) in CH2Cl2 
(2 mL).  The reaction mixture was warmed to ambient temperature, stirred for 4 h, and quenched 
with H2O (1 mL).  The aqueous layer was extracted with CH2Cl2 (3 x 2 mL) and the combined 
organic layers were washed with brine, dried (Na2SO4), filtered and concentrated.  The residue was 
chromatographed on SiO2 (hexanes/EtOAc, 9:1) to yield silyl ether 1-42 (338 mg, 0.974 mmol, 
93%) as a colorless oil:  IR (neat) 2942, 2891, 2865, 1672, 1652, 1463, 1283, 1181, 1054, 965, 690 
cm-1; 1H NMR δ 7.40-7.24 (m, 5 H), 6.64 (d, 1 H, J = 16.0 Hz), 6.53 (d, 1 H, J = 12.6 Hz), 6.30 (dt, 
1 H, J = 15.9, 5.9 Hz), 5.06 (dt, 1 H, J = 12.5, 6.6 Hz), 4.39 (dd, 2 H, J = 5.9, 1.3 Hz), 4.20 (dd, 2 H, 
J = 6.5, 1.2 Hz), 1.18-1.03 (m, 21 H); 13C NMR δ 147.8, 136.4, 132.9, 128.5 (2 C), 127.8, 126.5 (2 
C), 124.4, 104.2, 69.7, 61.1, 18.0, 12.0; MS (EI) m/z (rel intensity) 347 ([M]+, 9), 303 (27), 247 (24), 
145 (6), 117 (100), 84 (25); HRMS (EI) m/z calcd for C21H34O2Si 347. 2406, found 347.2396. 
 
Ph OH
OH
C4H9
Ph OH
OH
C4H9+
 
 (E,2R*,3S*)-5-Methyl-2-((R*)-1-phenylallyl)non-4-ene-1,3-diol (1-43) and (E,2R*,3R*)-
5-methyl-2-((R*)-1-phenylallyl)non-4-ene-1,3-diol (1-44).  According to general protocol A, 
AlMe3 (2.12 g, 29.5 mmol), Cp2ZrCl2 (215 mg, 0.737 mmol), H2O (265 μL, 14.7 mmol), 1-hexyne 
(1.69 mL, 14.7 mmol) and alcohol 1-40 (1.40 g, 7.37 mmol) afforded, after chromatography on SiO2 
(hexanes/EtOAc, 3:1), diols 1-43 and 1-44 (636 mg, 2.21 mmol, 30%) as a colorless oil which was a 
10:1 mixture (1-43:1-44) of inseparable diastereomers as indicated by 1H NMR analysis.  1-43:  IR 
(neat) 3342, 2956, 2929, 1453, 1034, 915, 759, 700 cm-1; 1H NMR δ 7.33-7.18 (m, 5 H), 6.09 (dt, 1 
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H, J = 16.9, 9.8 Hz), 5.48 (d, 1 H, J = 8.5 Hz), 5.21 (d, 1 H, J = 17.1 Hz), 5.13 (dd, 1 H, J = 10.1, 1.2 
Hz), 4.80-4.77 (m, 1 H), 3.93 (br d, 1 H, J = 11.1 Hz), 3.79 (t, 1 H, J = 9.6 Hz), 3.38-3.31 (m, 1 H), 
2.92-2.90 (m, 1 H, exchanges with D2O), 2.56 (br d, 1 H, J = 4.1 Hz, exchanges with D2O), 2.02 (t, 2 
H, J = 7.0 Hz), 1.81-1.71 (m, 1 H), 1.64 (s, 3 H), 1.46-1.36 (m, 2 H), 1.34-1.24 (m, 2 H), 0.91 (t, 3 
H, J = 7.1 Hz); 13C NMR δ 142.6, 140.5, 138.6, 128.6 (2 C), 128.0 (2 C), 126.7, 126.4, 115.9, 70.3, 
61.3, 49.3, 48.8, 39.3, 29.9, 22.3, 16.5, 13.9; MS (EI) m/z (rel intensity) 270 ([M-H2O]+, 18), 252 
(52), 240 (52), 209 (36), 195 (61), 155 (56), 117 (100); HRMS (EI) m/z calcd for C19H26O [M-H2O] 
270.1984, found 270.1982.  Characteristic data for 1-44:  1H NMR δ 5.39 (d, 1 H, J = 7.4 Hz), 2.41 
(br d, 1 H, J = 3.4 Hz, exchanges with D2O); 13C NMR δ 143.1, 139.3, 138.4, 127.8, 70.5, 61.4, 
49.6, 16.2. 
 
Ph
Ph
OH
Ph
Ph
Ph
OH
Ph
+
 
(2E,4R*,5S*,7E)-2,8-Diphenyl-5-((R*)-1-phenylallyl)nona-2,7-dien-4-ol  (1-45) and 
(2E,4S*,5S*,7E)-2,8-diphenyl-5-((R*)-1-phenylallyl)nona-2,7-dien-4-ol (1-46).  According to 
general protocol A, AlMe3 (58.3 mg, 0.810 mmol), Cp2ZrCl2 (10.7 mg, 0.0368 mmol), H2O (7.29 
μL, 0.405 mmol), phenylacetylene (101 μL, 0.920 mmol) and methyl ether 1-41 (75.0 mg, 0.368 
mmol) afforded, after chromatography on SiO2 (hexanes/EtOAc, 5:1), alcohols 1-45 and 1-46 (18.0 
mg, 0.044 mmol, 12%) as a colorless oil which was an 8:1 mixture (1-45:1-46) of inseparable 
diastereomers as indicated by 1H NMR analysis:  1-45:  1H NMR δ 7.50-7.29 (m, 15 H), 6.38 (dt, 1 
H, J = 15.6, 9.8 Hz), 6.14 (dd, 1 H, J = 8.4, 1.3 Hz), 5.93-5.88 (m, 1 H), 5.37 (dd, 1 H, J = 16.8, 1.1 
Hz), 5.30 (dd, 1 H, J = 10.0, 1.7 Hz), 5.08-5.05 (m, 1 H), 3.73 (t, 1 H, J = 4.9 Hz), 2.59-2.49 (m, 1 
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H), 2.41-2.28 (m, 2 H), 2.18 (d, 3 H, J = 1.2 Hz), 2.01 (s, 3 H), 1.82 (d, 1 H, J = 4.8 Hz, exchanges 
with D2O); MS (EI) m/z (rel intensity) 390 ([M-H2O]+, 43), 285 (41), 155 (79), 131 (89), 105 (96), 
91 (100).  Characteristic data for 1-46:  1H NMR δ 6.06 (dd, 1 H, J = 8.2, 1.3 Hz), 1.97 (d, 3 H, J = 
1.2 Hz). 
 
Ph OH
OTIPS
C4H9
Ph OH
OTIPS
C4H9+
 
(E,2R*,3S*)-5-Methyl-2-((R*)-1-phenylallyl)non-4-ene-1-triisopropylsilyloxy-3-ol (1-47) 
and (E,2R*,3R*)-5-methyl-2-((R*)-1-phenylallyl)non-4-ene-1-triisopropylsilyloxy-3-ol (1-48).  
According to general protocol A, AlMe3 (39.1 mg, 0.258 mmol), Cp2ZrCl2 (7.53 mg, 0.0258 mmol), 
H2O (4.64 μL, 0.258 mmol), 1-hexyne (59.4 μL, 0.517 mmol) and silyl ether 1-42 (89.4 mg, 0.258 
mmol) afforded, after chromatography on SiO2 (hexanes/EtOAc, 9:1), alcohols 1-47 and 1-48 (68.1 
mg, 0.153 mmol, 60%) as a colorless oil which was a 10:1 mixture (1-47:1-48) of inseparable 
diastereomers as indicated by 1H NMR analysis.  1-47:  IR (neat) 3508, 2929, 2866, 1464, 1071, 
882, 700 cm-1; 1H NMR δ 7.38-7.33 (m, 3 H), 7.28-7.24 (m, 2 H), 6.17 (dt, 1 H, J = 16.9, 9.8 Hz), 
5.57 (d, 1 H, J = 8.2 Hz), 5.28 (d, 1 H, J = 17.0 Hz), 5.18 (dd, 1 H, J = 10.1, 1.2 Hz), 4.79 (td, 1 H, J 
= 8.1, 3.5 Hz), 4.10 (dd, 1 H, J = 10.2, 2.9 Hz), 3.92 (t, 1 H, J = 9.5 Hz), 3.84 (d, 1 H, J = 8.1 Hz, 
exchanges with D2O), 3.65 (dd, 1 H, J = 10.1, 3.7 Hz), 2.09 (t, 2 H, J = 7.8 Hz), 1.93-1.86 (m, 1 H), 
1.80 (s, 3 H), 1.54-1.44 (m, 2 H), 1.41-1.34 (m, 2 H), 1.06-1.04 (m, 21 H), 0.98 (t, 3 H, J = 7.2 Hz); 
13C NMR δ 142.6, 140.7, 136.9, 128.5 (2 C), 128.2 (2 C), 127.6, 126.3, 115.9, 69.7, 62.9, 48.7, 48.6, 
39.3, 29.8, 22.4, 17.9 (6 C), 16.4, 14.0, 11.7 (3 C); MS (EI) m/z (rel intensity) 444 ([M]+, 5), 401 
(42), 383 (8), 309 (21), 253 (13), 117 (100); HRMS (EI) m/z calcd for C28H48O2Si 444.3424, found 
444.3408.  Characteristic data for 1-48:  1H NMR δ 5.47 (d, 1 H, J = 7.6 Hz). 
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(E,2R*,3S*)-5-Methyl-2-((R*)-1-phenylallyl)non-4-ene-1,3-diol (1-43).  To a solution of 
1-47 and 1-48 (48.0 mg, 0.108 mmol) in THF (1.1 mL) at ambient temperature was added TBAF 
(1.0 M solution in THF, 216 μL, 0.216 mmol).  The reaction mixture was stirred for 1 h and 
quenched with H2O (1 mL).  The mixture was extracted with Et2O (3 x 3 mL) and the combined 
organic layers were washed with H2O, brine, dried (Na2SO4) and concentrated.  The residue was 
chromatographed on SiO2 (hexanes/EtOAc, 5:1) to yield diol 1-43 (22.9 mg, 0.0795 mmol, 74%) as 
a colorless oil.  
 
Ph O  
1-((E)-3-(Prop-1-en-2-yloxy)prop-1-enyl)benzene (1-51).110  To a solution of cinnamyl 
alcohol (1.00 g, 7.46 mmol) in isopropenyl methyl ether (3 mL) was added Hg(OAc)2 (1.19 g, 3.73 
mmol) at ambient temperature.  The mixture was allowed to stir for 30 h treated with solid K2CO3 (1 
g) and filtered.  The filtrate was evaporated and the residue chromatographed on SiO2 
(hexanes/EtOAc, 9:1) to yield vinyl ether 1-51 (483 mg, 2.78 mmol, 45%) as a colorless oil:  1H 
NMR δ 7.45-7.28 (m, 5 H), 6.69 (d, 1 H, J = 15.9 Hz), 6.44-6.34 (m, 1 H), 4.41 (dd, 2 H, J = 6.0, 1.2 
Hz), 3.96 (d, 2 H, J = 4.2 Hz), 1.92 (s, 3 H); 13C NMR δ 159.5, 136.6, 132.6, 128.5 (2 C), 127.7, 
126.5 (2 C), 124.7, 81.8, 67.9, 21.0.   
 
  
 Ph O  
 130 
1-((E)-3-(Allyloxy)prop-1-enyl)benzene (1-52).142  To suspension of NaH (752 mg, 31.1 
mmol) in THF (5 mL) at ambient temperature was added a solution of cinnamyl alcohol (3.00 g, 
22.4 mmol) in THF (10 mL) dropwise over 10 min. The reaction mixture was stirred for 40 min, 
cooled to 0 °C, treated with allyl iodide (2.47 mL, 26.9 mmol) and warmed to ambient temperature 
and stirred overnight.  The reaction mixture was quenched with H2O (5 mL) and the aqueous layer 
extracted with hexanes/EtOAc (1:1, 3 x 25 mL).  The combined organic layers were washed with 
H2O, brine, dried (MgSO4) and concentrated.  The residue was chromatographed on SiO2 
(hexanes/EtOAC, 9:1) followed by Kugelrohr distillation to yield allyl ether 1-52 (3.90 g, 22.4 
mmol, 97%) as a colorless oil: bp 82 °C (0.1 mmHg); 1H NMR δ 7.44-7.24 (m, 5 H), 6.65 (d, 1 H, J 
= 15.9 Hz), 6.33 (dt, 1 H, J = 15.9, 5.9 Hz), 6.06-5.94 (m, 1 H), 5.36 (dd, 1 H, J = 17.1, 1.5 Hz), 5.25 
(dd, 1 H, J = 10.4, 0.7 Hz), 4.17 (dd, 2 H, J = 5.8, 1.0 Hz), 4.06 (d, 2 H, J = 5.5 Hz); 13C NMR δ 
136.5, 134.5, 132.0, 128.3 (2 C), 127.4, 126.2 (2 C), 125.8, 116.8, 70.8, 70.4. 
 
Ph O
 
1-((1E)-3-(Prop-1-enyloxy)prop-1-enyl)benzene (1-53).  To a solution of 1-52 (241 mg, 
1.39 mmol) and NiCl2(dppb)42 (77.3 mg, 0.139 mmol) in THF (700 μL) at -5 °C was added 
Li(Et)3BH (1.0 M solution in THF, 139 μL, 0.139 mmol) dropwise.  The reaction mixture was 
stirred for 25 min and filtered through basic Al2O3 (hexanes) and celite (hexanes).  The filtrate was 
concentrated and the residue chromatographed on SiO2 (hexanes/EtOAc, 20:1) to furnish vinyl ether 
1-53 (120 mg, 0.690 mmol, 50%) as a 94:6 mixture of (Z:E) isomers (as indicated by 1H NMR 
analysis) and starting material (103 mg, 0.592 mmol, 43%):  (E,Z)-1-53:  IR (neat) 3028, 2918, 2863, 
1668, 1356, 1131, 1077, 966, 692 cm-1; 1H NMR δ 7.44-7.24 (m, 5 H), 6.65 (d, 1 H, J = 15.9 Hz), 
6.32 (dt, 1 H, J = 15.9, 5.9 Hz), 6.06 (dq, 1 H, J = 6.2, 1.7 Hz), 4.48 (qd, 1 H, J = 6.8, 0.6 Hz), 4.44 
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(dd, 2 H, J = 5.8, 1.4 Hz), 1.66 (dd, 3 H, J = 6.8, 1.7 Hz); 13C NMR δ 145.0, 136.4, 132.6, 128.5 (2 
C), 127.8, 126.5 (2 C), 125.3, 101.4, 72.2, 9.3; MS (EI) m/z (rel intensity) 174 ([M]+, 17), 131 (11), 
117 (100), 104 (12); HRMS (EI) m/z calcd for C12H14O 174.1045, 174.1050.  Characteristic 1H 
NMR data for (E,E)-1-53:  1H NMR δ 1.60 (dd, 3 H, J = 6.7, 1.6 Hz).  
  
I  
(E)-1-Iodohex-1-ene (1-54).143 To a solution of 1-hexyne (4.10 g, 49.9 mmol) in n-heptane 
(10 mL) at ambient temperature was added DIBAL-H (1.0 M solution in hexanes, 50.0 mL, 50.0 
mmol) dropwise with the temperature not rising above 40 °C.  The reaction mixture was heated at 50 
°C for 2 h.  The n-heptane and hexane were distilled off and the residue was dissolved in THF (20 
mL) and cooled to -78 °C.  A solution of I2 (14.1 g, 54.9 mmol) in THF (25 mL) was added 
dropwise. The reaction mixture was warmed to ambient temperature after the addition, quenched 
with 10% HCl until gas evolution ceased, poured into a slurry of 10% HCl and ice and extracted 
with pentane (3 x 20 mL).  The combined organic layers were washed with sat. Na2S2O3, sat. 
NaHCO3, dried (MgSO4), filtered and concentrated.  The residue was distilled to furnish vinyl iodide 
1-54 (6.92 g, 33.0 mmol, 66%) as a light yellow oil:  bp 56-58 °C (2 mmHg), (lit.59 50-52 °C, 3 
mmHg); 1H NMR δ 6.50 (dt, 1 H, J = 14.1, 7.2 Hz), 5.97 (dt, 1 H, J = 14.3, 1.3 Hz), 2.06-2.01 (m, 2 
H), 1.42-1.27 (m, 4 H), 0.89 (t, 3 H, J = 4.9 Hz).   
 
Ph O
C4H9  
1-((1E)-3-((E)-Hex-1-enyloxy)prop-1-enyl)benzene (1-56).  A suspension of cinnamyl 
alcohol (2.00 g, 14.9 mmol), vinyl iodide 1-54 (1.57 g, 7.46 mmol), Cs2CO3 (3.64 g, 11.2 mmol), 
CuI (142 mg, 0.750 mmol) and 3,4,7,8-tetramethyl-1,10-phenanthroline (353 mg, 1.49 mmol) in 
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toluene (5 mL) was heated, open to air, at 80 °C for 24 h.  The mixture was cooled and filtered 
through a pad of SiO2, eluting with Et2O (15 mL).  The filtrate was concentrated and 
chromatographed on SiO2 (hexanes/EtOAc, 9:1) to give allylic vinyl ether 1-56 (270 mg, 1.25 mmol, 
17%) as a light yellow oil which was a single geometric isomer (E,E): IR (neat) 3057, 3027, 2956, 
2925, 2854, 1671, 1651, 1449, 1166, 965, 735 cm-1; 1H NMR δ 7.53-7.36 (m, 5 H), 6.76 (d, 1 H, J = 
16.0 Hz), 6.46-6.38 (m, 2 H), 5.00 (dt, 1 H, J = 12.5, 7.4 Hz), 4.46 (dd, 2 H, J = 5.8, 1.0 Hz), 2.07-
2.03 (m, 2 H), 1.49-1.44 (m, 4 H), 1.03 (t, 3 H, J = 5.3 Hz); 13C NMR δ 145.5, 136.5, 132.6, 128.4 (2 
C), 127.7, 126.4 (2 C), 124.9, 105.1, 69.7, 32.8, 27.3, 22.0, 13.9; MS (EI) m/z  (rel intensity) 216 
([M]+, 11), 160 (45), 131 (14), 117 (100), 91 (24), 65 (5); HRMS (EI) m/z calcd for C15H20O 
216.1514, found 216.1515. 
 
Ph OH
Ph
Ph OH
Ph
+
 
(E,4R*,6S*)-4-Methyl-2,6-diphenylocta-2,7-dien-4-ol (1-57) and (E,4S*,6S*)-4-methyl-
2,6-diphenylocta-2,7-dien-4-ol (1-58).  According to the general protocol A, AlMe3 (131 mg, 1.82 
mmol), Cp2ZrCl2 (25.3 mg, 0.0868 mmol), H2O (15.6 μL, 0.868 mmol), phenylacetylene (190 μL, 
1.74 mmol) and vinyl ether 1-51 (151 mg, 0.868 mmol) afforded, after chromatography on SiO2 
(hexanes/EtOAc, 5:1), alcohols 1-57 and 1-58 (189 mg, 0.647 mmol, 75%) as a colorless oil which 
was an 3:2 mixture (diastereomers unassigned) of inseparable diastereomers as indicated by 13C 
NMR analysis.  Mixture of diastereomers:  IR (neat) 3565, 3446, 2927, 1599, 1493, 1377, 914, 755, 
699 cm-1; 1H NMR δ 7.36-7.19 (m, 10 H), 6.21-6.02 (m, 1 H), 5.78 (dd, 1 H, J = 10.3, 1.1 Hz), 5.17-
5.03 (m, 2 H), 3.72-3.62 (m, 1 H), 2.30-2.19 (m, 5 H), 1.43 (2 s, 3 H); 13C NMR δ 144.9 (2 C), 
144.7, 143.8, 143.2, 136.9, 136.7, 134.7, 134.5, 128.8 (2 C), 128.7 (2 C), 128.1 (4 C), 127.8 (2 C), 
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127.4 (2 C), 126.8 (2 C), 126.6 (2 C), 126.4, 125.9 (4 C), 114.8, 113.9, 74.5, 74.3, 49.5, 48.9, 47.0, 
46.4, 27.8, 29.6, 16.8 (2 C); MS (EI) m/z (rel intensity) 292 ([M]+, 13), 274 (18), 161 (62), 117 
(100); HRMS (EI) m/z calcd for C21H24O 292.1827, found 292.1833.  
  
Ph OH
Ph
Ph OH
Ph +
 
(E,4S*,5R*,6R*)-5-Methyl-2,6-diphenylocta-2,7-dien-4-ol (1-59) and (E,4R*,5R*,6R*)-5-
methyl-2,6-diphenylocta-2,7-dien-4-ol (1-60).  According to the general protocol A, AlMe3 (31.3 
mg, 0.434 mmol), Cp2ZrCl2 (6.04 mg, 0.0207 mmol), H2O (3.91 μL, 0.217 mmol), phenylacetylene 
(45.4 μL, 0.414 mmol) and vinyl ether 1-53 (36.0 mg, 0.207 mmol) afforded, after chromatography 
on SiO2 (hexanes/EtOAc, 5:1), alcohols 1-59 and 1-60 (39.3 mg, 0.135 mmol, 65%) as a colorless 
oil which was a 10:1 mixture (1-59:1-60) of inseparable diastereomers as indicated by 1H NMR 
analysis.  1-59:  IR (neat) 3393, 2974, 1637, 1493, 1451, 977, 757, 700 cm-1; 1H NMR δ 7.44-7.22 
(m, 10 H), 6.04 (dt, 1 H, J = 17.5, 9.5 Hz), 5.89 (dd, 1 H, J = 8.2, 1.1 Hz), 5.13 (dd, 1 H, J = 7.4, 1.7 
Hz), 5.08 (s, 1 H), 4.31-4.28 (m, 1 H), 3.42 (app t, 1 H, J = 9.3 Hz), 2.03-1.95 (m, 1 H), 1.85 (d, 3 H, 
J = 1.1 Hz), 1.39 (br s, 1 H, exchanges with D2O), 1.10 (d, 3 H, J = 6.8 Hz); 13C NMR δ 143.9, 
143.1, 140.2, 136.3, 130.3, 128.6 (2 C), 128.2 (2 C), 127.8 (2 C), 127.1, 126.3, 125.8 (2 C), 115.8, 
69.6, 53.5, 43.8, 16.2, 11.1; MS (EI) m/z (rel intensity) 292 ([M]+, 13), 274 (9), 147 (100), 117 (39); 
HRMS (EI) m/z calcd for C21H24O2 292.1827, found 292.1825.  Characteristic data for 1-60:  0.84 
(d, 3 H, J = 6.9 Hz).  
 
  Ph
C4H9
OH
C4H9
Ph
C4H9
OH
C4H9 +
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(E,5S*,6R*)-8-Methyl-5-((R*)-1-phenylallyl)dodec-7-en-6-ol (1-61) and (E,5S*,6S*)-8-
methyl-5-((R*S*)-1-phenylallyl)dodec-7-en-6-ol (1-62a/b).  According to general protocol A, 
AlMe3 (79.1 mg, 1.10 mmol), Cp2ZrCl2 (15.3mg, 0.0523 mmol), H2O (9.42 μL, 0.523 mmol), 1-
hexyne (120 μL, 1.05 mmol) and vinyl ether 1-56 (113 mg, 0.523 mmol) afforded alcohols 1-61 and 
1-62 (147 mg, 0.468 mmol, 90%,) as a colorless oil which was a 10:1:0.8 mixture (1-61:1-62a/b) of 
inseparable diastereomers as indicated by 1H NMR analysis of derivative 1-78.  1-61:  IR (neat) 
3444, 3062, 3027, 2928, 2858, 1635, 1600, 1454, 994, 701 cm-1; 1H NMR δ 7.34-7.20 (m, 5 H), 6.21 
(dt, 1 H, J = 17.0, 9.9 Hz), 5.39 (dd, 1 H, J = 8.6 1.2 Hz), 5.19-5.00 (m, 2 H), 4.65-4.61 (m, 1 H), 
3.45 (t, 1 H, J = 4.2 Hz), 2.02 (m, 2 H), 1.90-1.83 (m, 1 H), 1.59 (d, 3 H, J = 1.2 Hz), 1.46-1.14 (m, 8 
H), 0.94 (t, 3 H, J = 7.1 Hz), 0.78 (t, 3 H, J = 6.1 Hz); 13C NMR δ 143.8, 141.5, 138.0, 128.4 (2 C), 
128.0 (2 C), 126.3, 126.1, 115.2, 69.4, 52.9, 48.9, 39.3, 30.9, 29.8, 27.0, 22.9, 22.3, 16.4, 13.9, 13.8; 
MS (EI) m/z (rel intensity) 296 ([M-H2O]+, 14), 239 (9), 197 (21), 179 (100), 155 (17), 127 (88); 
HRMS (EI) m/z calcd for C22H32 [M-H2O] 296.2504, found 296.2502.  Characteristic data for 1-62a:  
1H NMR δ 6.06-5.91 (m, 1 H), 4.21-4.17 (m, 1 H), 1.63 (d, 3 H, J = 1.2 Hz).  Characteristic data for 
1-62b:  1H NMR δ 4.44-4.39 (m, 1 H).  Characteristic data for 1-62a/b:  13C NMR δ 141.2, 125.4, 
52.1, 31.9, 27.8.  
 
Ph
O
O  
(E)-Ethyl 5-phenylpent-2-enoate (1-63).144  To a suspension of NaH (1.95 g, 81.3 mmol) in 
THF (200 mL) at 0 °C was added triethylphosphonoacetate (16.0 mL, 80.8 mmol) over 10 min and 
the mixture was warmed to ambient temperature.  After 15 min, the solution was cooled to 0 °C, 
hydrocinnamaldehyde (10.32 g, 77.0 mmol) was added dropwise over 10 min, and the mixture was 
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warmed to ambient temperature.  After 14 h, the solution was poured into H2O (100 mL) and 
extracted with EtOAc (4 x 20 mL).  The combined organic layers were washed with brine, dried 
(MgSO4), filtered, concentrated and the residue was chromatographed on SiO2 (hexanes/EtOAc, 
17:3) to yield (E)-1-63 (10.5 g, 51.5 mmol, 72%) as a colorless oil:  1H NMR δ 7.34-7.18 (m, 5 H), 
7.04 (dt, 1 H, J = 15.6, 6.8 Hz), 5.88 (dt, 1 H, J = 15.7, 1.4 Hz), 4.20 (q, 2 H, J = 7.1 Hz), 2.78 (t, 2 
H, J = 7.3 Hz), 2.56-2.49 (m, 2 H), 1.30 (t, 3 H, J = 7.1 Hz); 13C NMR δ 166.2, 147.7, 140.5, 128.2 
(2 C), 128.1 (2 C), 125.9, 121.7, 59.8, 34.1, 33.6, 14.0. 
 
Ph OH  
(E)-5-Phenylpent-2-en-1-ol (1-64).114  To a flask containing DIBAL-H (1.0 M solution in 
hexanes, 54.0 mL, 53.9 mmol) at -78 °C was added a solution of ester 1-63 (5.00 g, 24.5 mmol) in 
CH2Cl2 (30 mL) over 30 min.  The reaction mixture was stirred at -78 °C for 30 min, treated with 1 
M HCl (10 mL), and warmed to ambient temperature, and the solid salts were filtered off.  The 
filtrate was extracted with CH2Cl2 (2 x 25 mL) and the combined organic layers were washed with 
brine, dried (MgSO4), filtered, and concentrated. The residue was chromatographed on SiO2 
(hexanes/EtOAc, 5:1) to yield allylic alcohol 1-64 (3.97 g, 24.5 mmol, 100%) as a colorless oil:  1H 
NMR δ 7.34-7.20 (m, 5 H), 5.79-5.65 (m, 2 H), 4.08 (d, 2 H, J = 5.0 Hz), 2.74 (t, 2 H, J = 15.6 Hz), 
2.45-2.37 (m, 2 H), 2.07-2.00 (m, 1 H, exchanges with D2O); 13C NMR δ 141.6, 131.9, 129.5, 128.3 
(2 C), 128.2 (2 C), 125.8, 63.4, 35.4, 33.9. 
 
 
Ph O  
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1-((E)-5-(Vinyloxy)pent-3-enyl)benzene (1-65).  A solution of allylic alcohol 1-64 (158 mg, 
0.975 mmol) in ethyl vinyl ether (4 mL) at ambient temperature was treated with Hg(OAc)2 (208 
mg, 0.653 mmol) and stirred for 24 h.  K2CO3 (500 mg) was added and the mixture was filtered 
through Al2O3, eluting with hexanes (5 mL).  The filtrate was concentrated and the residue was 
chromatographed on SiO2 (hexanes/EtOAc, 9:1) to yield allylic vinyl ether 1-65 (86.0 mg, 0.457 
mmol, 47%) as a colorless oil:  IR (neat) 3027, 2926, 2857, 1635, 1613, 1496, 1454, 1320, 1196, 
1049, 970, 699 cm-1; 1H NMR δ 7.37-7.24 (m, 5 H), 6.52 (dd, 1 H, J = 14.3, 6.8 Hz), 5.90-5.83 (m, 1 
H), 5.76-5.69 (m, 1 H), 4.28 (dd, 1 H, J = 14.3, 2.0 Hz), 4.23 (d, 2 H, J = 5.8 Hz), 4.09 (dd, 1 H, J = 
6.8, 2.0 Hz), 2.79 (t, 2 H, J = 7.3 Hz), 2.50-2.43 (m, 2 H); 13C NMR δ 151.4, 141.5, 134.3, 128.3 (2 
C), 128.2 (2 C), 125.8, 125.3, 86.9, 68.7, 35.3, 34.0; MS (EI) m/z (rel intensity) 144 ([M-C2H4O]+, 
14), 129 (7), 91 (100); HRMS (EI) m/z calcd for C11H12 [M- C2H4O] 144.0939, found 144.0932. 
 
Ph O N
O
 
(2E)-3-((E)-5-Phenylpent-2-enyloxy)-N,N-dimethylacrylamide (1-67).  To a suspension of 
NaH (42.4 mg, 1.77 mmol) in THF (1.5 mL) at ambient temperature was added alcohol 1-64 (220 
mg, 1.36 mmol) as a solution in THF (2.5 mL). The reaction mixture was stirred for 45 min, treated 
with betaine 1-33 (247 mg, 1.90 mmol) in one portion and heated at reflux for 14 h.  The cooled 
mixture was poured into H2O (20 mL) and the aqueous layer was washed with Et2O (2 x 5 mL) and 
then acidified to pH = 4 with 10% HCl (~15 drops).  The mixture was extracted with Et2O (3 x 5 
mL) and the combined organic layers were washed with H2O, brine, dried (Na2SO4) and 
concentrated.  The unstable crude acid 1-66 was added to a solution of EDCI (202 mg, 1.05 mmol), 
DMAP (9.98 mg, 0.0810 mmol), and dimethylamine hydrochloride (165 mg, 2.03 mmol) in CH2Cl2 
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(8 mL) at ambient temperature.  DIPEA (564 μL, 3.24 mmol) was added dropwise over 5 min and 
the reaction mixture was stirred for 24 h and quenched with H2O (2 mL). The aqueous layer was 
extracted with CH2Cl2 (3 x 5 mL) and the combined organic layers were washed with brine, dried 
(Na2SO4), concentrated and chromatographed on SiO2 (hexanes/EtOAc, 1:4) to yield amide 1-67 
(126 mg, 0.485 mmol, 36% over two steps) as a yellow oil:  IR (neat) 3026, 2926, 1652, 1594, 1496, 
1454, 1396, 1115, 968, 700 cm-1; 1H NMR δ 7.51 (d, 1 H, J = 11.8 Hz), 7.29-7.14 (m, 5 H), 5.82 (dt, 
1 H, J = 15.4, 6.6 Hz), 5.67-5.58 (m, 2 H), 4.31 (d, 2 H, J = 6.1 Hz), 2.97 (br s, 6 H), 2.69 (t, 2 H, J = 
7.3 Hz), 2.39-2.34 (m, 2 H); 13C NMR δ 167.1, 160.5, 141.2, 135.4, 128.2 (4 C), 125.7, 124.4, 96.2, 
72.0, 37.0, 35.2, 35.0, 33.8; MS (EI) m/z (rel intensity) 259 ([M]+, 48), 231 (80), 216 (50), 188 (9), 
115 (12), 91 (100); HRMS (EI) m/z calcd for C16H21NO2 259.1572, found 259.1557. 
 
Ph O OH  
(2E)-3-((E)-5-Phenylpent-2-enyloxy)prop-2-en-1-ol (1-69).  To a solution of ethyl 
propiolate (2.51 g, 25.6 mmol) and allylic alcohol 1-64 (4.36 g, 26.9 mmol) in CH2Cl2 (250 mL) at 0 
°C was added Et3N (4.28 mL, 30.7 mmol) dropwise over 15 min.  The reaction mixture was stirred 
at ambient temperature for 14 h and quenched with 10% HCl (50 mL).  The aqueous layer was 
extracted with CH2Cl2 (3 x 25 mL) and the combined organic layers were washed with 10% HCl, 
brine and dried (MgSO4).  The solution was filtered, concentrated and the residue was 
chromatographed on SiO2 (hexanes/EtOAc, 5:1) to furnish ester 1-68 (5.67 g, 21.8 mmol, 81%) as a 
colorless oil which contained ~15% of an unknown impurity.  This mixture was carried directly into 
the next step without further purification.  A solution of ester 1-68 (1.51 g, 5.81 mmol) in toluene 
(12 mL) was cooled to -78 °C and treated dropwise over 5 min with a solution of DIBAL-H (1.0 M 
solution in hexanes, 12.8 mL, 12.8 mmol).  The reaction mixture was stirred for 2 h at -78 °C, 
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warmed to ambient temperature, and quenched with 1 M Rochelle’s Salt (10 mL).  The aqueous 
layer was extracted with CH2Cl2 (3 x 10 mL) and the combined organic layers were washed with 
brine, dried (MgSO4), concentrated, filtered and chromatographed on SiO2 (Et2O/hexanes, 3:1) to 
yield alcohol 1-69 (573 mg, 2.63 mmol, 45%) as a colorless oil:  IR (neat) 3361, 3061, 2924, 2859, 
1652, 1496, 1175, 997, 747 cm-1; 1H NMR δ 7.35-7.20 (m, 5 H), 6.50 (d, 1 H, J = 12.6 Hz), 5.83 (dt, 
1 H, J = 15.4, 6.5 Hz), 5.65 (dt, 1 H, J = 15.4, 6.0 Hz), 5.07 (dt, 1 H, J = 12.6, 7.4 Hz), 4.20 (dd, 2 H, 
J = 5.9, 0.7 Hz), 4.04 (d, 2 H, J = 7.3 Hz), 2.75 (t, 2 H, J = 7.3 Hz), 2.46-2.38 (m, 2 H), 2.30 (br s, 1 
H, exchanges with D2O); 13C NMR δ 149.2, 141.3, 134.4, 128.2 (2 C), 128.1 (2 C), 125.7, 125.1, 
103.1, 69.7, 60.1, 35.1, 33.8; MS (EI) m/z (rel intensity) 218 ([M]+, 1), 169 (8), 145 (69), 144 (100), 
129 (49); HRMS (EI) m/z calcd for C11H12 [M-C3H6O2] 144.0939, found 144.0934. 
 
Ph
OH
Ph
Ph
OH
Ph
+
 
(E,4R*,6S*)-6-Phenethyl-2-phenylocta-2,7-dien-4-ol (1-70) and (E,4S*,6S*)-6-
phenethyl-2-phenylocta-2,7-dien-4-ol (1-71).  According to the general protocol A, AlMe3 (169 
mg, 2.34 mmol), Cp2ZrCl2 (31.0 mg, 0.106 mmol), H2O (21.0 μL, 1.17 mmol), phenylacetylene (257 
μL, 2.34 mmol) and vinyl ether 1-65 (200 mg, 1.06 mmol) afforded, after chromatography on SiO2 
(hexanes/EtOAc, 5:1), alcohols 1-70 and 1-71 (major:  153 mg, 0.500 mmol, 47%, Rf = 0.31, minor:  
102 mg, 0.333 mmol, 31%, Rf = 0.21) as colorless oils (diastereomers unassigned):  Major 
diastereomer:  IR (neat) 3376, 2924, 1495, 1453, 1029, 998, 913, 757, 697 cm-1; 1H NMR δ 7.42-
7.15 (m, 10 H), 5.80 (dd, 1 H, J = 8.5, 1.3 Hz), 5.68 (dt, 1 H, J = 15.9, 9.0 Hz), 5.19 (s, 1 H), 5.14 
(dd, 1 H, J = 7.2, 2.0 Hz), 4.66-4.57 (m, 1 H), 2.7 (ddd, 1 H, J = 13.7, 10.4, 5.4 Hz), 2.57 (ddd, 1 H, 
J = 13.7, 10.2, 6.5 Hz), 2.43-2.33 (m, 1 H), 2.07 (d, 3 H, J = 1.3 Hz), 1.81-1.45 (m, 4 H); 13C NMR δ 
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142.9, 142.6, 142.2, 136.3, 131.0, 128.4 (2 C), 128.3 (2 C), 128.2 (2 C), 127.2, 125.8 (2 C), 125.6, 
115.8, 66.9, 42.7, 40.3, 37.3, 33.5, 16.2; MS (EI) m/z (rel intensity) 306 ([M]+, 15), 288 (37), 201 
(33), 183 (23), 147 (77), 129 (63), 105 (89), 91 (100); HRMS (EI) m/z calcd for C22H26O 306.1984, 
found 106.1976.  Minor diastereomer:  IR (neat) 3346, 3061, 2922, 1495, 1453, 1029, 997, 913, 758 
cm-1; 1H NMR δ 7.40-7.16 (m, 10 H), 5.77-5.65 (m, 2 H), 5.11 (dd, 1 H, J = 10.2, 1.9 Hz), 5.04 (dd, 
1 H, J = 17.3, 1.9 Hz), 4.64-4.56 (m, 1 H), 2.67 (ddd, 1 H, J = 13.8, 10.3, 5.5 Hz), 2.54 (ddd, 1 H, J 
= 14.0, 10.1, 6.4 Hz), 2.18-2.06 (m, 1 H), 2.08 (d, 3 H, J = 1.3 Hz), 1.84-1.50 (m, 4 H); 13C NMR δ 
143.0, 142.8, 142.5, 130.5, 128.4 (2 C), 128.3 (3 C), 128.2 (2 C), 127.3, 125.9 (2 C), 125.7, 115.4, 
67.5, 43.1, 40.9, 37.1, 33.3, 16.5; MS (EI) m/z (rel intensity) 306 ([M]+, 18), 288 (14), 201 (23), 147 
(100), 129 (63), 105 (96), 91 (100); HRMS (EI) m/z calcd for C22H26O 306.1984, found 306.1979. 
 
 
Ph
OH
Ph
OH
Ph
OH
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OH
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(E,2R*,3S*)-5-Phenyl-2-((R*)-5-phenylpent-1-en-3-yl)hex-4-ene-1,3-diol (1-72) and 
(E,2R*,3S*)-5-Phenyl-2-((R*S*)-5-phenylpent-1-en-3-yl)hex-4-ene-1,3-diol (1-73a/b).  
According to general protocol A, AlMe3 (373 mg, 5.17 mmol), Cp2ZrCl2 (37.7 mg, 0.129 mmol), 
H2O (46.6 μL, 2.59 mmol), phenylacetylene (284 μL, 2.59 mmol) and alcohol 1-69 (282 mg, 1.29 
mmol) afforded, after chromatography on SiO2 (hexanes/EtOAc, 2:1), diols 1-72 and 1-73 (72.0 mg, 
0.214 mmol, 17%) as a colorless oil which was a 10:0.8:0.5 mixture of inseparable diastereomers as 
indicated by 1H NMR analysis.  1-72:  IR (neat) 3334, 2922, 1495, 1445, 1030, 999, 758, 697 cm-1; 
1H NMR δ 7.40-7.15 (m, 10 H), 5.95 (dd, 1 H, J = 9.8, 1.2 Hz), 5.80 (dt, 1 H, J = 17.0, 9.2 Hz), 
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5.25-5.14 (m, 2 H), 4.89-4.83 (m, 1 H), 4.06-3.99 (m, 1 H), 3.91-3.83 (m, 1 H), 2.89 (t, 1 H, J = 5.6 
Hz, exchanges with D2O), 2.76-2.67 (m, 1 H), 2.52-2.38 (m, 3 H, one hydrogen exchanges with 
D2O), 2.03 (d, 3 H, J = 1.3 Hz), 1.98-1.87 (m, 1 H), 1.63-1.49 (m, 2 H); 13C NMR δ 142.7, 142.3, 
140.8, 136.8, 129.9, 128.3 (4 C), 128.2, 127.3, 125.8, 125.7, 116.7, 62.0, 49.3, 42.4, 33.9, 32.5, 16.2; 
MS (EI) m/z (rel intensity) 336 ([M]+, 54), 318 (83), 300 (61), 183 (15), 147 (54), 105 (62), 91 (100); 
HRMS (EI) m/z calcd for C23H28O2 336.2089, found 336.2085. Characteristic data for 1-73a:  1H 
NMR δ 2.11 (d, 3 H, J = 1.1 Hz). Characteristic data for 1-73b: 1H NMR δ 2.09 (d, 3 H, J = 1.3 Hz). 
 
N
OH
Ph
O N
OH
Ph
O
+
Ph Ph  
(E,2S*,3S*)-3-Hydroxy-N,N-dimethyl-5-phenyl-2-((R*)-5-phenylpent-1-en-3-yl)hex-4-
enamide (1-74) and (E,2S*,3R*)-3-hydroxy-N,N-dimethyl-5-phenyl-2-((R*S*)-5-phenylpent-1-
en-3-yl)hex-4-enamide (1-75a/b).  According to the general protocol A, AlMe3 (27.7 mg, 0.385 
mmol), Cp2ZrCl2 (1.12 mg, 0.00385 mmol), H2O (2.77 μL, 0.154 mmol), phenylacetylene (8.53 μL, 
0.0769 mmol) and amide 1-67 (10.0 mg, 0.0385 mmol) furnished, after chromatography on SiO2 
(hexanes/EtOAc 1:2), amide alcohols 1-74 and 1-75a/b (5.0 mg, 0.0133 mmol, 34%) as a light 
yellow oil which was a 100:43:13 mixture of inseparable diastereomers as indicated by 1H NMR 
analysis.  1-74:  IR (neat) 3395, 2926, 1620, 1495, 1399, 1143, 917, 760, 699 cm-1; 1H NMR δ 7.42 
(m, 10 H), 6.10 (d, 1 H, J = 8.8 Hz), 5.78-5.63 (m, 1 H), 5.23-5.14 (m, 2 H), 4.82 (br t, 1 H, J = 7.0 
Hz), 4.75 (d, 1 H, J = 2.8 Hz, exchanges with D2O), 3.09 (s, 3 H), 2.96 (s, 3 H), 2.78-2.59 (m, 2 H), 
2.54-2.39 (m, 1 H), 2.07 (s, 3 H), 1.89-1.79 (m, 1 H), 1.70-1.64 (m, 1 H), 1.56-1.41 (m, 1 H); 13C 
NMR δ 173.2, 143.1, 142.4, 140.7, 137.8, 128.4 (2 C), 128.3 (2 C), 127.2, 125.8, 125.7, 117.4, 70.0, 
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50.8, 44.5, 38.2, 35.7, 34.0, 33.6, 16.4; MS (EI) m/z (rel intensity) 377 ([M]+, 52), 286 (36), 232 
(77), 126 (99), 91 (77); HRMS (EI) m/z calcd for C24H31NO2 377.2355, found 377.2372.  
Characteristic data for 1-75a:  1H NMR δ 5.92 (d, 1 H, J = 8.7 Hz), 5.38 (m, 2 H), 2.99 (s, 3 H), 2.94 
(s, 3 H).  Characteristic data for 1-75b:  1H NMR δ 3.04 (s, 3 H), 2.90 (s, 3 H).  Characteristic data 
for 1-75a/b:  13C NMR δ 175.0, 142.8, 142.2, 138.8, 135.4, 130.3, 127.5, 48.9, 16.1. 
    
Ph OH
Ph
OH
 
(E,2R*,3S*)-5-Phenyl-2-((R*)-1-phenylallyl)hex-4-ene-1,3-diol (1-76).  According to the 
general protocol A, AlMe3 (790 mg, 11.0 mmol), Cp2ZrCl2 (91.4 mg, 0.313 mmol), H2O (84.6 μL, 
4.70 mmol), phenylacetylene (687 μL, 6.26 mmol) and alcohol 1-40 (595 mg, 3.13 mmol) afforded, 
after chromatography on SiO2 (hexanes/EtOAc, 4:1), diol 1-76 (222 mg, 0.721 mmol, 23%) as a 
colorless oil which was a 95:5 mixture of inseparable diastereomers as indicated by  1H NMR 
analysis.  1-76:  IR (neat) 3342, 3028, 1493, 1032, 758, 700 cm-1; 1H NMR δ 7.43-7.19 (m, 10 H), 
6.14 (ddd, 1 H, J = 17.0, 10.0, 9.2 Hz), 6.10-6.06 (m, 1 H), 5.27 (ddd, 1 H, J = 17.0, 1.6, 0.9 Hz), 
5.18 (dd, 1 H, J = 10.1, 1.2 Hz), 5.02-4.96 (m, 1 H), 4.00 (ddd, 1 H, J = 11.3, 3.8, 2.4 Hz), 3.87 (app 
t, 1 H, J = 9.7 Hz), 3.46-3.38 (m, 1 H), 2.54 (d, 1 H, J = 5.2 Hz, exchanges with D2O), 2.46 (dd, 1 H, 
J = 6.8, 3.9 Hz, exchanges with D2O), 2.07 (d, 3 H, J = 1.3 Hz), 1.94-1.86 (m, 1 H); 13C NMR δ 
142.7, 142.3, 140.3, 136.2, 130.2, 128.6 (2 C) 128.2 (2 C), 128.0 (2 C), 127.2, 126.4, 125.7 (2 C), 
116.2, 70.6, 61.3, 48.9, 48.7, 16.2 ; MS (EI) m/z (rel intensity) 308 ([M]+, 6), 290 (17), 260 (49), 215 
(70), 117 (100); HRMS (EI) m/z calcd for C21H24O2 308.1776, found 308.1788.  
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(E,2R*,3S*)-5-Phenyl-2-((R*)-1-phenylallyl)hex-4-ene-3-p-bromobenzoyloxy-1-ol (1-77).  
To a solution of diol 1-76 (67.0 mg, 0.217 mmol) and Et3N (70.7 μL, 0.500 mmol) in CH2Cl2 (2.2 
mL) at ambient temperature was added p-bromobenzoyl chloride (143 mg, 0.652 mmol).  The 
reaction mixture was stirred for 12 h and quenched with H2O (1 mL).  The aqueous layer was 
extracted with CH2Cl2 (4 x 3 mL) and the combined organic layers were washed with brine, dried 
(Na2SO4), filtered and concentrated.  The residue was chromatographed on SiO2 (hexanes/EtOAc, 
3:1) to furnish the corresponding bis-ester (110 mg, 0.163 mmol, 75%) and the mono-acylated 
alcohol 77 (20.0 mg, 0.0407 mmol, 18%) as colorless solids of which only the mono-acylated 
product was characterized as a single diastereomer.  Mp 114.0-116.0 °C (CDCl3/MeOH); IR (neat) 
3502, 2920, 2851, 1718, 1590, 1271, 1012, 757 cm-1; 1H NMR δ 7.67 (d, 2 H, J = 8.6 Hz), 7.39 (d, 2 
H, J = 7.4 Hz), 7.31-7.25 (m, 10 H), 6.19 (dt, 1 H, J = 16.8, 9.9 Hz), 6.01 (dd, 1 H, J = 8.3, 1.3 Hz), 
5.26 (d, 1 H, J = 16.9 Hz), 5.18 (dd, 1 H, J = 10.0, 1.5 Hz), 4.99-4.96 (m, 1 H), 4.38 (d of AB, 1 H, J 
= 11.6, 6.9 Hz), 4.30 (d of AB, 1 H, J = 11.6, 4.3 Hz), 3.66 (t, 1 H, J = 9.6 Hz), 2.50-2.42 (m, 1 H), 
2.04 (d, 3 H, J = 1.2 Hz), 1.83 (br s, 1 H, exchanges with D2O); 13C NMR δ 165.7, 142.6, 142.2, 
140.2, 136.4, 131.6 (2 C), 131.0 (2 C), 129.8, 128.7 (2 C), 128.3 (2 C), 127.9 (2 C), 127.7, 127.3, 
126.8, 125.7 (2 C), 116.4, 68.4, 63.5, 50.5, 47.9, 16.2; MS (EI) m/z (rel intensity) 490 ([M-H]+, 15), 
386 (51), 272 (26), 183 (67), 117 (100); HRMS (EI) m/z calcd for C28H26BrO3 [M-H] 490.1144, 
found 490.1166. 
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(2R*,3R*)-2-Methyl-3-phenylpent-4-enal (1-80).  A solution of vinyl ether 1-53 (5.0 mg, 
0.0287 mmol) in MeOH-d4 (1 mL) was heated at 140 °C in a microwave (150 W) for 10 min.  The 
solvent was evaporated and the residue was chromatographed on SiO2 (hexanes/EtOAc, 15:1) to 
furnish aldehyde 1-80 (3.0 mg, 0.0172 mmol, 60%) as a colorless oil which was an inseparable 10:1 
mixture of diastereomers as indicated by 1H NMR analysis.  1-80:  IR (neat) 3082, 3028, 2977, 2875, 
1724, 1493, 1453, 994, 919, 702 cm-1; 1H NMR δ 9.55 (d, 1 H, J = 2.4 Hz), 7.35-7.29 (m, 2 H), 7.25-
7.17 (m, 3 H), 6.03-5.91 (m, 1 H), 5.16 (d, 1 H, J = 0.7 Hz), 5.11-5.07 (m, 1 H), 3.59 (app t, 1 H, J = 
8.7 Hz), 2.87-2.72 (m, 1 H), 1.13 (d, 3 H, J = 7.0 Hz); 13C NMR δ 204.2, 141.3, 138.0, 128.7 (2 C), 
126.8 (2 C), 116.9, 51.4, 50.4, 11.9; MS (EI) m/z (rel intensity) 174 ([M]+, 7), 159 (7), 131 (7), 117 
(100).  Characteristic data for minor diastereomer:  1H NMR δ 9.70 (d, 1 H, J = 2.9 Hz); 13C NMR δ 
204.6, 140.7, 139.0, 128.0, 116.3, 12.5.      
OH
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(1R*,4S*,5R*)-5-Butyl-4-phenylcyclopent-2-enol (1-83a) and (1S*,4R*S*,5R*)-5-butyl-4-
phenylcyclopent-2-enol (1-83b/c).  To a solution of allylic alcohol 1-61/1-62 (41.0 mg, 0.130 mmol 
in CH2Cl2 (2 mL) at room temperature was added Grubbs’ second generation catalyst ((1,3-bis-
(2,4,6-trimethylphenyl)-2-imidazolidinylidene)-dichloro-(phenylmethylene)-(tricyclohexylphosphine 
) ruthenium) (11.1 mg, 0.0130 mmol). The reaction mixture was stirred for 4 h, the volatiles were 
evaporated, then CH2Cl2 (2 mL) and activated charcoal (100 mg) were added. The suspension was 
stirred for 12 h and filtered through SiO2 (eluting with hexanes/EtOAc, 1:1, 5 mL).  The filtrate was 
 144 
evaporated and chromatographed on SiO2 (hexanes/EtOAc, 9:1) to yield cyclopentene 1-83 (26.0 
mg, 0.110 mmol, 87%) as a colorless oil which was a 10:1:0.8 mixture of inseparable diastereomers 
as indicated by 1H NMR analysis.  1-83a:  IR (neat) 3331, 3058, 2956, 2925, 2856, 1601, 1492, 
1454, 1075, 700 cm-1; 1H NMR δ 7.42-7.24 (m, 5 H), 5.94 (dt, 1 H, J = 5.6, 2.0 Hz), 5.87 (dt, 1 H, J 
= 5.6, 1.5 Hz), 4.61 (dd, 1 H, J = 5.2, 1.5 Hz), 3.41 (dd, 1 H, J = 6.3, 1.8 Hz), 1.94-1.86 (m, 1 H), 
1.71-1.60 (m, 2 H), 1.49-1.19 (m, 4 H), 0.90 (t, 3 H, J = 7.0 Hz); 13C NMR δ 144.7, 136.6, 133.8, 
128.4 (2 C), 127.6 (2 C), 126.4, 83.2, 59.0, 56.7, 32.9, 29.9, 23.0, 14.0; MS (EI) m/z (rel intensity) 
216  ([M-H2O]+, 24), 198 (25), 173 (40), 159 (90), 155 (78), 115 (48), 91 (100); HRMS (EI) m/z 
calcd for C15H18 [M-H2O]  216.1514, found  216.1513.  Characteristic data for 1-83b:  1H NMR δ 
4.82 (d, 1 H, J = 5.8 Hz), 3.58 (d, 1 H, J = 7.0 Hz).  Characteristic data for 1-83c:  1H NMR δ 4.72 
(dd, 1 H, J = 5.0, 2.0 Hz).  
O
Ph
 
1-(Cyclopropyl(vinyloxy)methyl)benzene (1-85).  A solution of cyclopropyl alcohol 1-84 
(1.00 g, 6.75 mmol) in ethyl vinyl ether (14 mL) at ambient temperature was treated with Hg(OAc)2 
(1.44 g, 4.52 mmol) and heated at reflux for 4 h.  K2CO3 (1 g) was added and the mixture was 
filtered through Al2O3, eluting with hexanes (20 mL).  The filtrate was concentrated and the residue 
was purified by chromatography on SiO2 (hexanes/EtOAc/Et3N, 95:4:1) to yield cyclopropyl vinyl 
ether 1-85 (1.11 g, 6.45 mmol, 96%) as a colorless oil:  IR (neat) 3083, 3008, 1636, 1615, 1492, 
1453, 1186, 1023, 865, 700 cm-1; 1H NMR δ 7.43-7.32 (m, 5 H), 6.39 (dd, 1 H, J = 14.1, 6.6 Hz), 
4.31 (dd, 1 H, J =14.1, 1.8 Hz), 4.25 (d, 1 H, J = 7.7 Hz), 4.02 (dd, 1 H, J = 6.6, 1.6 Hz), 1.37-1.26 
(m, 1 H), 0.76-0.67 (m, 1 H), 0.60-0.53 (m, 2 H), 0.47-0.39 (m, 1 H); 13C NMR δ 150.7, 141.0, 
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128.3 (2 C), 127.6, 126.3 (2 C), 89.3, 85.1, 17.5, 3.8, 2.3; MS (EI) m/z (rel intensity) 174 ([M]+, 21), 
156 (26), 131 (100), 115 (32); HRMS (EI) m/z calcd for C12H14O 174.1045, found 174.1038. 
Ph OH
C3H7
 
(E)-1-Cyclopropyl-5-methyl-1-phenyloct-4-en-3-ol (1-88).  According to the general 
protocol A, AlMe3 (288 mg, 4.00 mmol), Cp2ZrCl2 (29.2 mg, 0.100 mmol), H2O (36.0 μL, 2.00 
mmol), 1-pentyne (197 μL, 2.00 mmol) and cyclopropyl vinyl ether 1-85 (174 mg, 1.00 mmol) 
afforded, after chromatography on SiO2 (hexanes/EtOAc, 5:1), alcohol 1-88 (136 mg, 0.527 mmol, 
53%) as a colorless oily a 1:1 mixture of inseparable diastereomers as indicated by 1H NMR 
analysis:  (1:1 mixture of diastereomers) IR (neat) 3363, 3076, 2958, 2930, 2871, 1494, 1453, 1380, 
1017, 742, 700 cm-1; 1H NMR δ 7.34-7.16 (m, 5 H), 5.18 (dd, 0.5 H, J = 8.5, 1.2 Hz), 5.13 (dd, 0.5 
H, J = 9.0, 1.1 Hz), 4.31 (ddd, 0.5 H, J  = 7.8, 6.5, 6.5 Hz), 4.25-4.16 (m, 0.5 H), 2.21-1.79 (m, 5 H), 
1.48 (d, 1.5 H, J = 1.2 Hz), 1.47 (d, 1.5 H, J = 1.2 Hz), 1.45-1.33 (m, 2 H), 1.05-0.95 (m, 2 H), 0.89 
(t, 1.5 H, J = 7.3 Hz), 0.86 (t, 1.5 H, J = 7.2 Hz), 0.65-0.54 (m, 1 H), 0.41-0.30 (m, 1 H), 0.29-0.19 
(m, 1 H), 0.14-0.05 (m, 1 H); 13C NMR δ 145.5, 145.4, 139.3, 138.1, 128.3 (2 C), 127.6 (4 C), 126.1 
(2 C), 66.7, 66.5, 47.4, 47.3, 44.6, 44.4, 41.7, 41.5, 20.8, 20.7, 17.9 (2 C), 16.4, 16.3, 13.7 (2 C), 5.5, 
5.4, 4.0, 3.6; MS (EI) m/z (rel intensity) 258 ([M]+, 8), 240 (28), 215 (97), 131 (100), 113 (18); 
HRMS (EI) m/z calcd for C18H26O 258.1984, found 258.1971. 
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5.2 AZA-COPE REARRANGEMENTS AND N-ACYL IMINIUM ION CHEMISTRY 
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O
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1-(But-3-ynyl)pyrrolidine-2,5-dione (2-10).145  To a solution of succinimide (2.17 g, 31.0 
mmol), DEAD (3.47 mL, 31.0 mmol) and PPh3 (5.76 g, 31.0 mmol) in THF (31 mL) was added 3-
butyn-1-ol (1.65 mL,  32.6 mmol) at 0 °C.  The reaction mixture was warmed to ambient 
temperature and stirred for 36 h.  The solvent was evaporated in vacuo, the residue was suspended in 
hexanes/EtOAc (1:1, 10 mL) and the mixture was filtered.  The filtrate was allowed to stand for 12 
h, filtered, dried (MgSO4), and concentrated.  The residue was chromatographed on SiO2 
(hexanes/EtOAc, 1:5) to furnish imide 2-10 (1.37 g, 9.07 mmol, 42%) as a colorless oil:  IR (neat) 
3273, 2948, 1775, 1699, 1435, 1404, 1166, 1077, 821 cm-1; 1H NMR δ 3.53 (t, 2 H, J = 7.1 Hz), 2.60 
(s, 4 H), 2.36 (td, 2 H, J = 7.1, 2.7 Hz), 1.88 (t, 1 H, J = 2.5 Hz).  
 
N
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1-(But-3-ynyl)-5-methoxypyrrolidin-2-one (2-11).  To a 0 °C solution of imide 90 (1.49 g, 
9.87 mmol) in MeOH (20 mL) was added NaBH4 (375 mg, 9.87 mmol) in one portion.  The reaction 
mixture was stirred for 1 h, the solvent was evaporated and the residue was partitioned between H2O 
(10 mL) and CH2Cl2 (10 mL).  The aqueous layer was extracted with CH2Cl2 (3 x 10 mL), and the 
combined organic layers were washed with H2O, brine, dried (Na2SO4), filtered and evaporated.  The 
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residue was chromatographed on SiO2 (EtOAc containing 1% Et3N) to furnish the corresponding 
hydroxy lactam (920 mg, 6.01 mmol, 61%) as a colorless oil which was used directly in the next 
step.  The reaction was repeated to generate material with identical results.  A solution of the 
hydroxylactam (1.50 g, 9.87 mmol) in MeOH (90 mL) at ambient temperature was treated with 
TsOH (187 mg, 0.987 mmol) in one portion.  The reaction mixture was stirred for 8 h and the MeOH 
was evaporated in vacuo.  The residue was chromatographed on SiO2 (EtOAc containing 1% Et3N) 
to furnish methoxy lactam 2-11 (1.19 g, 7.13 mmol, 45% over two steps) as a colorless oil:  IR (neat) 
3249, 2118, 1697, 1420, 1171, 1076, 884 cm-1; 1H NMR δ 5.08 (dd, 1 H, J = 6.2, 1.4 Hz), 3.64 (ddd, 
1 H, J = 13.4, 7.4, 5.7 Hz), 3.37-3.28 (m, 1 H),3.28 (s, 3 H), 2.57-2.28 (m, 5 H), 2.23-2.10 (m, 1 H), 
1.98 (t, 1 H, J = 2.4 Hz); 13C NMR δ 175.1, 90.6, 81.6, 69.7, 53.0, 39.4, 28.8, 23.9, 18.0; MS (EI) 
m/z (rel intensity) 167 ([M]+, 11), 151 (19), 135 (29), 96 (100); HRMS (EI) m/z calcd for C9H13NO2 
167.0946, found 167.0946. 
 
N
O  
1-(But-3-ynyl)-5-methylpyrrolidin-2-one (2-12).  Characteristic data:  1H NMR δ 1.26 (d, 3 
H, J = 7.4 Hz). 
 
N
O
O
 
1-(Pent-4-yn-2-yl)pyrrolidine-2,5-dione (2-14).  To a solution of succinimide (2.20 g, 22.2 
mmol), 2-13 (2.20 mL, 22.2 mmol), and PPh3 (5.83 g, 22.2 mmol) in THF (200 mL) at 0 °C was 
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added DEAD (3.52 mL, 22.2 mmol) dropwise over 10 min.  The reaction mixture was stirred for 36 
h, the solvent was removed in vacuo and the residue was dissolved in hexanes/EtOAc 1:1, 20 mL). 
The solids were filtered off the filtrate was evaporated. The residue was  chromatographed on SiO2 
(hexanes/EtOAc, 1:3) to furnish imide 2-14 (1.19 g, 7.21 mmol, 32%) as a colorless oil:  IR (neat) 
3276, 2984, 2942, 1773, 1693, 1371, 1183 cm-1; 1H NMR δ 4.34-4.22 (m, 1 H), 2.74 (ddd, 1 H, J = 
16.7, 9.2, 2.5 Hz), 2.57 (s, 3 H), 2.46 (ddd, 1 H, J = 16.8, 6.6, 2.6 Hz), 1.86 (t, 1 H, J = 2.6 Hz), 1.29 
(d, 3 H, J = 7.0 Hz); 13C NMR δ 176.9 (2 C), 80.3, 69.8, 46.5, 27.7 (2 C), 22.3, 16.8; MS (EI) m/z 
165 ([M]+, 15), 150 (14), 126 (100), 100 (48); HRMS (EI) m/z calcd for C9H11NO2 165.0790, found 
165.0788.  
 
N
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5-Methoxy-1-(pent-4-yn-2-yl)pyrrolidin-2-one (2-15).  To a 0 °C solution of imide 2-14 
(759 mg, 4.60 mmol) in MeOH (10 mL) was added NaBH4 (511 mg, 13.8 mmol) in one portion.  
The reaction mixture was stirred for 3 h and the solvent was removed in vacuo.  The residue was 
partitioned between CH2Cl2 (5 mL) and H2O (5 mL) and the aqueous layer was extracted with 
CH2Cl2 (5 x 5 mL).  The combined organic layers were washed with brine, dried (MgSO4) filtered 
and concentrated.  The resulting crude hydroxylactam was immediately dissolved in MeOH (2 mL) 
and PPTS (49.3 mg, 0.196 mmol) was added.  The mixture was stirred for 24 h at ambient 
temperature and the MeOH was removed in vacuo.  The residue was partitioned between CH2Cl2 (5 
mL) and H2O (5 mL) and the aqueous layer was extracted with CH2Cl2 (4 x 5 mL).  The combined 
organic layers were washed with brine, dried (Na2SO4), evaporated and the residue was 
chromatographed on SiO2 (hexanes/EtOAc, 1:1) to yield methoxylactam 2-15 (200 mg, 1.10 mmol, 
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56%) as a colorless oil which was a 1:1 mixture of inseparable diastereomers as indicated by 1H 
NMR:  IR (neat) 3251, 2980, 2938, 2829, 2118, 1697, 1418, 1376, 1075 cm-1; 1H NMR δ 5.10 (dd, 
0.5 H, J = 5.7, 1.2 Hz), 4.97 (dd, 0.5 H, J = 5.9, 1.4 Hz), 4.27-4.03 (m, 1 H), 3.27 (s, 1.5 H), 3.26 (s, 
1.5 H), 2.71 (ddd, 0.5 H, J = 16.6, 6.5, 2.7 Hz), 2.62-2.25 (m, 4 H), 2.10-1.94 (m, 3.5 H), 1.37 (d, 1.5 
H, J = 6.9 Hz), 1.33 (d, 1.5 H, J = 6.9 Hz); 13C NMR δ 175.0, 174.7, 89.7, 88.9, 81.6, 80.6, 70.1, 
69.5, 52.3, 47.5, 46.7, 29.1, 28.9, 24.6, 23.9, 23.8, 23.6, 18.3, 16.6; MS (EI) m/z (rel intensity) 181 
([M]+, 15), 166 (10), 149 (32), 110 (100); HRMS (EI) m/z calcd for C10H15NO2 181.1103, found 
181.1108. 
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2-(Pent-4-yn-2-yl)isoindoline-1,3-dione (2-16).  To a solution of phthalimide (3.24 g, 22.0 
mmol), 2-13 (2.17 mL, 22.0 mmol), and PPh3 (5.77 g, 22.0 mmol) in THF (50 mL) was added DIAD 
(4.33 mL, 22.0 mmol) at 0 °C.  The reaction mixture was warmed to ambient temperature and stirred 
for 48 h.  The solvent was removed in vacuo and the residue was dissolved in hexanes/EtOAc (1:1, 
40 mL). The solids were filtered off and the filtrate was concentrated and chromatographed on SiO2 
(hexanes/EtOAc, 3:1) to yield imide 2-16 (939 mg, 4.41 mmol, 20%) as a white solid:  Mp 97.3-99.9 
°C (hexanes/EtOAc); IR (neat) 3281, 2923, 2120, 1773, 1706, 1467, 1360, 1025, 794, 719 cm-1; 1H 
NMR δ 7.85-7.81 (m, 2 H), 7.75-7.70 (m, 2 H), 4.62-4.55 (m, 1 H), 2.95 (dd, 1 H, J = 16.6, 2.4 Hz), 
2.70 (dd, 1 H, J = 16.9, 2.5 Hz), 1.91 (t, 1 H, J = 2.3 Hz), 1.54 (d, 3 H, J = 7.2 Hz); 13C NMR δ 
168.2 (2 C), 133.9 (2 C), 131.8 (2 C), 123.2 (2 C), 80.7, 70.1, 46.4, 23.7, 18.0; MS (EI) m/z (rel 
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intensity) 213 ([M]+, 12), 198 (40), 174 (100), 147 (21), 130 (30), 102 (14); HRMS (EI) m/z calcd 
for C13H11NO2 213.0790, found 213.0783.    
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3-Hydroxy-2-(pent-4-yn-2-yl)isoindolin-1-one (2-17).  To a solution of imide 2-16 (245 
mg, 1.15 mmol) in MeOH (4 mL) at ambient temperature was added NaBH4 (46.0 mg, 1.15 mmol) 
portionwise.  The reaction mixture was stirred for 3 h, treated with H2O (1 mL) and extracted with 
CH2Cl2 (5 x 5 mL).  The organic layers were washed with brine, dried (MgSO4), concentrated and 
the residue was chromatographed on SiO2 (hexanes/EtOAc, 1:1) to yield hydroxylactam 2-17 (167 
mg, 0.777 mmol, 68%) as a white solid which was a 1:1 inseparable mixture of diastereomers as 
indicated by 1H NMR:  Mp 95.0-95.5 °C (hexanes/EtOAc); IR (KBr) 3297, 1674, 1415, 1362, 1053, 
747, 697 cm-1; 1H NMR δ 7.67-7.63 (m, 1 H), 7.55-7.43 (m, 3 H), 5.97 (d, 0.5 H, J = 9.3 Hz), 5.93 
(d, 0.5 H, J = 9.0), 4.44-4.23 (m, 1 H), 3.54 (d, 0.5 H, J = 10.9 Hz), 3.40 (d, 0.5 H, J = 11.3 Hz), 
2.86-2.75 (m, 1 H), 2.67-2.57 (m, 1 H), 1.99 (t, 0.5 H, J = 2.7 Hz), 1.96 (t, 0.5 H, J = 2.7 Hz), 1.49 
(d, 1.5 H, J = 3.5 Hz), 1.47 (d, 1.5 H, J = 3.5 Hz); 13C NMR δ 167.3, 167.2, 143.9, 143.8, 132.2 (2 
C), 131.7, 131.6, 129.8 (2 C), 123.3, 123.2, 81.9, 81.7 (2 C), 81.6, 70.5, 70.3, 47.6, 47.2, 25.2, 24.0, 
19.1, 17.8; MS (rel intensity) (EI) m/z 176 ([M-C3H3]+, 92), 133 (100), 105 (18); HRMS (EI) m/z 
calcd for C10H10NO2 [M-C3H3] 176.0712, found 176.0711.  
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3-Methoxy-2-(pent-4-yn-2-yl)isoindolin-1-one (2-18).  To a solution of hydroxylactam 2-
17 (620 mg, 2.88 mmol) in MeOH (5 mL) was added d,l-camphorsulfonic acid (116 mg, 0.288 
mmol) in one portion.  The reaction mixture was stirred at ambient temperature for 30 h and 
concentrated.  The residue was dissolved in CH2Cl2 (10 mL) and washed with H2O (5 mL).  The 
aqueous layer was extracted with CH2Cl2 (4 x 15 mL) and the combined organic layers were washed 
with brine, dried (MgSO4), and concentrated.  The residue was chromatographed on SiO2 
(hexanes/EtOAc, 5:1) to yield methoxy lactam 2-18 (502 mg, 2.19 mmol, 76%) as a white solid 
which was a 1:1 mixture of inseparable diastereomers as indicated by 1H NMR:  Mp 85.4-88.8 °C; 
IR (KBr) 3295, 2978, 2937, 2118, 1701, 1615, 1401, 1210, 1068, 748 cm-1; 1H NMR δ 7.82-7.79 (m, 
1 H), 7.60-7.47 (m, 3 H), 6.13 (s, 0.5 H), 6.02 (s, 0.5 H), 4.48-4.41 (app s, 0.5 H, J = 7.2 Hz), 4.35-
4.24 (app s, 0.5 H, J = 7.2 Hz), 2.94 (s, 1.5 H), 2.90 (s, 1.5 H), 2.85 (ddd, 0.5 H, J = 16.5, 7.7, 2.7 
Hz), 2.71 (d, 0.5 H, J = 2.6 Hz), 2.69 (d, 0.5 H, J = 2.6 Hz), 2.53 (ddd, 0.5 H, J = 16.6, 7.3, 2.7 Hz), 
1.96 (t, 0.5 H, J = 2.7 Hz), 1.94 (t, 0.5 H, J = 2.7 Hz), 1.52 (d, 1.5 H, J = 6.9 Hz), 1.45 (d, 1.5 H, J = 
6.9 Hz); 13C NMR δ 167.9, 167.7, 140.5, 140.2, 133.1, 132.8, 132.0 (2 C), 129.8 (2 C), 123.5, 123.2, 
86.8, 86.0, 81.7, 81.0, 70.5, 69.9, 49.5, 49.0, 47.9, 47.2, 24.4, 24.0, 18.3, 17.7; MS (EI) m/z (rel 
intensity) 190 ([M-C2H3]+, 11), 183 (17), 147 (45), 105 (64), 91 (100); HRMS (EI) m/z calcd for 
C12H12NO2 [M-C2H3] 190.0868, found 190.0866. 
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3-Methoxy-2-(4-methylpent-4-en-2-yl)isoindolin-1-one (2-19).  Characteristic data for 1:1 
mixture of diastereomers:  1H NMR δ 4.78 (br s, 2 H), 4.71 (br s, 2 H), 1.81 (s, 3 H), 1.75 (s, 3 H).   
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1-Oxo-2-(pent-4-yn-2-yl)isoindolin-3-yl acetate (2-20).  To a solution of hydroxylactam 2-
17 (75.0 mg, 0.349 mmol) in pyridine (2 mL) at ambient temperature was added acetic anyhydride 
(164 μL, 1.74 mmol) dropwise.  The reaction mixture was stirred for 18 h, concentrated in vacuo, 
and the residue was dissolved in CH2Cl2 (10 mL) and washed with 10% HCl, brine and dried 
(MgSO4).  The solution was filtered, concentrated and the residue was chromatographed on SiO2 
(hexanes/EtOAc, 3:1) to furnish acetoxy lactam 2-20 (75.0 mg, 0.292 mmol, 84%) as a colorless oil 
which was a 1.5:1 mixture of inseparable diastereomers as indicated by 1H NMR analysis:  IR (neat) 
3294, 2926, 2119, 1740, 1712, 1402, 1229, 1013, 756 cm-1; 1H NMR δ 7.82-7.76 (m, 1 H), 7.56-7.51 
(m, 3 H), 7.24 (s, 0.5 H), 7.12 (s, 0.5 H), 4.48-4.39 (m, 0.5 H), 4.37-4.27 (m, 0.5 H), 2.81 (ddd, 0.5 
H, J = 16.7, 7.0, 2.7 Hz), 2.66 (dd, 1 H, J = 6.9, 2.6 Hz), 2.51 (ddd, 0.5 H, J = 16.7, 7.4, 2.6 Hz), 
2.16 (s, 1.5 H), 2.14 (s, 1.5 H), 2.00 (t, 0.5 H, J = 2.6 Hz), 1.97 (t, 0.5 H, J = 2.6 Hz), 1.48 (d, 1.5 H, 
J = 7.0 Hz), 1.43 (d, 1.5 H, J = 7.0 Hz); 13C NMR δ 170.2 (2 C), 168.0, 167.8, 141.4, 141.3, 132.5 (2 
C), 132.0, 131.8, 130.2 (2 C), 123.9, 123.7, 123.5 (2 C), 81.6, 81.1, 81.0, 80.5, 70.8, 70.3, 47.9, 47.3, 
24.9, 24.2, 21.3 (2 C), 18.4, 17.6; MS (EI) m/z (rel intensity) 257 ([M]+, 12), 218 (62), 198 (20), 132 
(100), 105 (19); HRMS (EI) m/z calcd for C15H15NO3 257.1052, found 257.1050. 
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3-Methyl-2-(pent-4-yn-2-yl)isoindolin-1-one (2-21).  Characteristic data for 1:1 mixture of 
diastereomers:  1H NMR δ 4.67 (q, 1 H, J = 6.6 Hz), 4.66 (q, 1 H, J = 6.7 Hz), 1.54 (d, 3 H, J = 6.7 
Hz), 1.48 (d, 3 H, J = 6.9 Hz). 
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2-(Pent-4-ynyl)isoindoline-1,3-dione (2-23).  To a solution of phthalimide (2.00 g, 13.6 
mmol), 2-22 (1.27 mL, 13.6 mmol), and PPh3 (3.57 g, 13.6 mmol) in THF (30 mL) was added DIAD 
(2.68 mL, 13.6 mmol) at 0 °C.  The reaction mixture was warmed to ambient temperature and stirred 
for 36 h and the solvent was removed in vacuo.  The residue was dissolved in hexanes/EtOAc (1:1, 
20 mL) and the solids were filtered off.  The filtrate was concentrated and chromatographed on SiO2 
(hexanes/EtOAc, 4:1) to yield imide 2-23 (2.35 g, 11.0 mmol, 81%) as a white powder:  Mp 89.9-
91.7 °C (hexanes/EtOAc); IR 3268, 2942, 2115, 1772, 1708, 1399, 1122, 1018, 885, 722 cm-1; 1H 
NMR δ 7.74-7.70 (m, 2 H), 7.65-7.60 (m, 2 H), 3.69 (t, 2 H, J = 2.0 Hz), 2.17 (td, 2 H, J = 7.1, 2.6 
Hz), 1.88-1.78 (m, 3 H); 13C NMR δ 168.0 (2 C), 133.6 (2 C), 131.8 (2 C), 122.9 (2 C), 82.8, 68.9, 
36.9, 27.0, 16.0; MS (EI) m/z (rel intensity) 213 ([M]+, 18), 212 (23), 185 (25), 160 (100), 148 (28), 
130 (28); HRMS (EI) m/z calcd for C13H11NO2 212.0712, found 212.0708.   
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3-Methoxy-2-(pent-4-ynyl)isoindolin-1-one (2-24).  To a solution of imide 2-23 (323 mg, 
1.52 mmol) in MeOH (4 mL) at 0 °C was added NaBH4 (45.5 mg, 1.14 mmol) in one portion.  The 
reaction mixture was stirred for 30 min at 0 °C and at ambient temperature for 3 h, and quenched 
with H2O (1 mL).  The aqueous layer was extracted with CH2Cl2 (5 x 10 mL).  The combined 
organic layers were washed with brine, dried (MgSO4), and concentrated to furnish the crude 
hydroxylactam (323 mg, 1.50 mmol, 99%) which was used in the next step without further 
purification.  To a solution of the crude hydroxylactam (323 mg, 1.50 mmol) in MeOH (5 mL) at 
ambient temperature was added d,l-camphorsulfonic acid (35.0 mg, 0.150 mmol).  The reaction 
mixture was stirred for 48 h.  The solvent was removed in vacuo and the residue was partitioned 
between CH2Cl2 (10 mL) and H2O (10 mL).  The aqueous layer was extracted with CH2Cl2 (5 x  10 
mL) and the combined organic layers were washed with brine, dried (MgSO4), and concentrated to 
furnish methoxy lactam 2-24 (315 mg, 1.38 mmol, 91% over two steps) as a colorless oil:  IR (neat) 
3294, 2935, 2116, 1705, 1413, 1073, 747, 696 cm-1; 1H NMR δ 7.77 (dd, 1 H, J = 6.9, 0.8 Hz), 7.57-
7.44 (m, 3 H), 5.85 (s, 1 H), 3.79 (ddd, 1 H, J = 14.5, 7.5, 7.5 Hz), 3.34 (ddd, 1 H, J = 14.1, 7.3, 7.3 
Hz), 2.84 (s, 3 H), 2.23 (br t, 2 H, J = 7.1 Hz), 1.93-1.82 (m, 3 H); 13C NMR δ 167.6, 140.2, 132.9, 
131.9, 129.8, 123.3 (2 C), 86.3, 83.0, 68.9, 49.1, 38.6, 26.7, 16.1; MS (EI) m/z (rel intensity) 228 
([M]+, 28), 214 (70), 198 (70), 170 (91), 146 (100), 132 (47); HRMS (EI) m/z calcd for C14H15NO2 
228.1025, found 228.1025.  
 
 155 
NO
OMe
 
3-Methoxy-2-(4-methylpent-4-enyl)isoindolin-1-one (2-25).  Characteristic data:  1H NMR 
δ 4.72 (br d, 2 H, J = 8.0 Hz), 1.72 (s, 3 H).   
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3-Hydroxy-3-methyl-2-(pent-4-ynyl)isoindolin-1-one (2-26).  To a solution of imide 2-23 
(100 mg, 0.469 mmol) in THF (5 mL) at -78 °C was added MeMgBr (3.0 M solution in ether, 187 
μL, 0.563 mmol) dropwise over 3 min.  The red reaction mixture was stirred at -78 °C for 1 h and 
was quenched with sat. NH4Cl (2 mL).  The THF was removed in vacuo and the residue was 
extracted with CH2Cl2 (4 x 5 mL).  The combined organic layers were washed with brine, dried 
(Na2SO4), and concentrated to provide hydroxylactam 2-26 (108 mg, 0.469 mmol, 100%) as a light 
yellow oil which was used without further purification:  IR (neat) 3296, 2982, 2936, 2116, 1681, 
1409, 1141, 1080, 698 cm-1; 1H NMR δ 7.52-7.50 (m, 2 H), 7.48-7.46 (m, 1 H), 7.41-7.33 (m, 1 H), 
4.10 (s, 1 H, exchanges with D2O), 3.46 (ddd, 1 H, J = 14.9, 9.4, 5.8 Hz), 3.12 (ddd, 1 H, J = 15.2, 
9.3, 6.0 Hz), 2.22-2.16 (m, 2 H), 1.94 (t, 1 H, J = 2.6 Hz), 1.91-1.82 (m, 1 H), 1.80-1.70 (m, 1 H), 
1.66 (s, 3 H); 13C NMR δ 167.2, 148.2, 132.2, 130.2, 129.3, 123.1, 121.5, 88.7, 83.7, 68.9, 37.7, 
27.7, 24.3, 16.4; MS (EI) m/z (rel intensity) 228 ([M-H]+, 7), 214 (15), 186 (75), 160 (35), 147 (100), 
130 (18); HRMS (EI) m/z calcd for C14H15NO2 229.1103, found 229.1106.  
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3-Hydroxy-3-methyl-2-(4-methylpent-4-enyl)isoindolin-1-one (2-27).  Characteristic data:  
1H NMR δ 4.70 (br d, 2 H, J = 8.2 Hz), 1.83 (s, 3 H).  
 
OH
 
Hept-6-yn-1-ol (2-29).146  Li wire (483 mg, 69.6 mmol) was degreased with hexanes and 
pumped to dryness under vacuum.  Diaminopropane (34.8 mL, 41.7 mmol) was added and the 
reaction mixture was stirred at 70 °C for 2 h, cooled to room temperature and treated with solid 
KOtBu (4.33 g, 42.9 mmol).  The yellow solution was stirred for 20 min, treated with hept-3-yn-1-ol 
(1.36 mL, 10.7 mmol) and stirred for 2 h before being poured into H2O (150 mL).  After addition of 
CH2Cl2 (20 mL), the aqueous layer was extracted with CH2Cl2 (5 x 10 mL) and the combined 
organic extracts were washed with brine and dried (MgSO4).  After filtration and evaporation, the 
residue was distilled to furnish alcohol 2-29 (1.02 g, 9.12 mmol, 85%) as a colorless oil:  Bp 96 °C 
(0.1 mmHg);  1H NMR δ 3.65 (t, 2 H, J = 5.6 Hz), 2.23-2.18 (m, 2 H), 1.94 (t, 1 H, J = 2.6 Hz), 
1.63-1.54 (m, 6 H), 1.33 (br s, 1 H).  
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2-(Hept-6-ynyl)isoindoline-1,3-dione (2-30).  A solution of alcohol 2-29 (228 mg, 2.04 
mmol), phthalimide (302 mg, 2.04 mmol), and PPh3 (540 mg, 2.04 mg) in THF (20 mL) was cooled 
to 0 °C and treated with DIAD (403 μL, 2.04 mmol) over 5 min.  The reaction mixture was warmed 
to ambient temperature and stirred for 56 h.  The solvent was evaporated, the residue was dissolved 
in hexanes/EtOAc (1:1, 10 mL) and the solids were filtered off.  The filtrate was concentrated and 
chromatographed on SiO2 (hexanes/EtOAc, 5:1) to yield imide 2-30 (407 mg, 1.69 mmol, 82%) as a 
colorless oil:  IR (neat) 3466, 3283, 2941, 2862, 2115, 1772, 1709, 1615, 1397, 1046, 720 cm-1; 1H 
NMR δ 7.84-7.79 (m, 2 H), 7.72-7.67 (m, 2 H), 3.67 (t, 2 H, J = 7.1 Hz), 2.17 (td, 2 H, J = 6.8, 2.6 
Hz), 1.91 (t, 1 H, J = 2.6 Hz), 1.75-1.61 (m, 2 H), 1.58-1.51 (m, 2 H), 1.49-1.38 (m, 2 H); 13C NMR 
δ 168.3 (2 C), 133.8 (2 C), 132.1 (2 C), 123.1 (2 C), 84.2, 68.4, 37.7, 28.0, 27.9, 25.8, 18.2; MS (EI) 
m/z (rel intensity) 241 ([M]+, 11), 186 (6), 173 (10), 160 (100), 148 (31), 130 (29), 104 (27); HRMS 
(EI) m/z calcd for C15H15NO2 241.1103, found 241.1107. 
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2-(Hept-6-ynyl)-3-hydroxy-3-methylisoindolin-1-one (2-31).  Characteristic data:  1H 
NMR δ 1.64 (s, 3 H).  
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2-(Hept-6-ynyl)-3-methoxyisoindolin-1-one (2-33).  To a 0 °C solution of imide 2-30 (40.0 
mg, 0.166 mmol) in MeOH (4 mL) was added NaBH4 (4.98 mg, 0.125 mmol).  The reaction mixture 
was stirred at ambient temperature for 2.5 h, quenched with H2O (1 mL) and the MeOH was 
removed in vacuo.  The residue was extracted with CH2Cl2 (5 x 3 mL) and the combined organic 
layers were washed with brine, dried (Na2SO4),  and concentrated to provide crude the 
hydroxylactam 2-32 which was immediately dissolved in MeOH (4 mL), treated with d,l-
camphorsulfonic acid (3.85 mg, 0.0166 mmol) and stirred for 16 h.  The solvent was removed in 
vacuo and the residue was partitioned between H2O (5 mL) and CH2Cl2 (5 mL). The aqueous layer 
was extracted with CH2Cl2 (3 x 5 mL).  The combined organic layers were washed with brine, dried 
(Na2SO4), concentrated and chromatographed on SiO2 (hexanes/EtOAc, 4:1) to yield methoxy 
lactam 2-33 (17.0 mg, 0.0661 mmol, 40% over two steps) as a colorless oil:  IR (neat) 3298, 2925, 
2854, 2115, 1702, 1466, 1412, 1059, 746 cm-1; 1H NMR δ 7.84-7.80 (m, 1 H), 7.61-7.49 (m, 3 H), 
5.88 (s, 1 H), 3.79 (ddd, 1 H, J = 15.6, 8.1, 7.3 Hz), 3.24 (ddd, 1 H, J = 14.0, 8.0, 6.3 Hz), 2.87 (s, 3 
H), 2.19 (td, 2 H, J = 6.7, 2.6 Hz), 1.92 (t, 1 H, J = 2.6 Hz), 1.75-1.63 (m, 2 H), 1.62-1.43 (m, 4 H); 
13C NMR δ 167.6, 140.3, 133.2, 131.9, 129.9, 123.4 (2 C), 86.2, 84.3, 68.4, 49.1, 39.3, 28.0, 27.6, 
26.0, 18.3; MS (EI) m/z (rel intensity) 257 ([M]+,18), 242 (17), 226 (20), 176 (66), 146 (100), 132 
(39), 117 (21); HRMS (EI) m/z calcd for C16H19NO2 257.1416, found 257.1419. 
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 2-(Hept-6-ynyl)-3-phenoxyisoindolin-1-one (2-24).  A 0 °C solution of imide 2-30 
(307 mg, 1.27 mmol) in MeOH (20 mL) was treated with NaBH4 (36.3 mg, 0.953 mmol), warmed to 
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ambient temperature and stirred for 1 h.  The reaction mixture was quenched with H2O (10 mL) and 
the MeOH was removed in vacuo.  The residue was extracted with CH2Cl2 (6 x 10 mL) and the 
combined organic layers washed with brine, dried (Na2SO4) and concentrated to yield crude 
hydroxylactam 2-32 as a colorless oil.  A portion of the crude hydroxylactam (101 mg, 0.416 mmol) 
was immediately dissolved in THF (5 mL) at ambient temperature and treated with SOCl2 (30.3 μL, 
0.416 mmol) and DMF (1 drop) and stirred for 14 h.  The volatiles were removed under reduced 
pressure and the residue was dried in vacuo for 12 h.  The unstable crude chloride was obtained as a 
colorless oil and immediately dissolved in THF (4.1 mL) at ambient temperature.  This solution was 
treated with phenol (58.0 mg, 0.620 mmol) and Et3N (288 μL, 2.07 mmol) and stirred for 2 h.  The 
reaction mixture was quenched with H2O (1 mL) and the THF was removed in vacuo.  The residue 
was extracted with CH2Cl2 (4 x 5 mL) and the combined organic layers were washed with brine, 
dried (Na2SO4), and concentrated. The residue was chromatographed on SiO2 (hexanes/EtOAc, 3:1) 
to yield phenoxylactam 2-34 (45.0 mg, 1.41 mmol, 34% over two steps) as a colorless oil:  IR (neat) 
3296, 2936, 2115, 1707, 1588, 1491, 1415, 1222, 992, 780 cm-1; 1H NMR δ 7.85-7.79 (m, 1 H), 
7.53-7.46 (m, 3 H), 7.33-7.27 (m, 2 H), 7.08-6.98 (m, 3 H), 6.42 (s, 1 H), 3.80 (dt, 1 H, J = 14.2, 7.4 
Hz), 3.44 (ddd, 1 H, J = 14.0, 7.8, 6.4 Hz), 2.16 (td, 2 H, J = 6.7, 2.6 Hz), 1.91 (t, 1 H, J = 2.6 Hz), 
1.78-1.61 (m, 2 H), 1.57-1.39 (m, 4 H); 13C NMR δ 167.4, 156.3, 141.3, 132.3, 132.0, 130.0, 129.7 
(2 C), 123.5, 123.3, 123.1, 118.1 (2 C), 86.8, 84.2, 68.4, 40.0, 27.9, 27.6, 25.9, 18.2; MS (EI) m/z 
(rel intensity) 319 ([M]+, 70), 265 (28), 226 (100), 198 (8), 146 (52), 132 (65); HRMS (EI) m/z calcd 
for C21H21NO2 319.1572, found 319.1573. 
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2-(Hept-6-ynyl)-3-methylisoindolin-1-one (2-35).  Characteristic data:  1H NMR δ 4.55 (q, 
1 H, J = 6.7 Hz), 1.48 (d, 3 H, J = 6.7 Hz). 
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2-Benzyl-3-oxoisoindolin-1-yl pivaloate (2-48).  To a solution of benzyl phthalimide (8.89 
g, 37.5 mmol) in MeOH (130 mL) was added sodium borohydride (1.42 g, 37.5 mmol) at 0 °C.  The 
resulting reaction mixture was stirred at 0 °C for 2 h and carefully quenched with H2O.  The aqueous 
layer was extracted with EtOAc (2x) and the organic layer was separated, dried (MgSO4) and 
concentrated.  The residue was dried to yield a white solid which was carried on to the next step 
without further purification.  To a solution of the crude reduced phthalamide (1.00 g, 4.20 mmol) in 
THF (30 mL) was added Et3N (1.17 mL, 8.40 mmol) and pivaloyl chloride (621 μL, 5.04 mmol) at 0 
°C and the reaction mixture was allowed to warm to rt and stirred at this temperature for 4 h.  The 
mixture was quenched with sat. aq. NaHCO3, extracted with EtOAc (2x), dried (MgSO4) and 
concentrated. The residue was purified by chromatography on SiO2 (EtOAc:Hex, 3:7) to yield 1.09 g 
(80% over 2 steps) of 2-48 as a colorless solid: mp 88.1 - 89.0 °C (CH2Cl2); IR (neat) 3419, 3062, 
3031, 2973, 2934, 2872, 1717, 1408, 1276, 1122, 959, 751 cm-1; 1H NMR δ 7.92-7.84 (m, 1 H), 
7.61-7.53 (m, 2 H), 7.50-7.43 (m, 1 H), 7.38-7.22 (m, 5 H), 6.89 (s, 1 H), 5.01 (d, 1 H, J = 15 Hz), 
4.44 (d, 1 H, J = 15 Hz), 1.13 (s, 9 H); 13C NMR δ 178.4, 167.9, 141.3, 136.8, 132.5, 131.9, 130.2, 
 161 
128.7, 128.1, 127.7, 123.7, 123.7, 81.0, 44.2, 39.0, 26.8; MS (EI) m/z (rel intensity) 323 ([M]+, 35), 
221 (100), 133 (65), 91 (100); HRMS (EI) m/z calcd for C21H23NO 323.1521, found 323.1515. 
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(E)-2-Benzyl-3-(hex-1-enyl)isoindolin-1-one (2-49).  General Protocol A.  To a solution of 
1-hexyne (60.5 μL, 0.526 mmol) in CH2Cl2 (1.5 mL) was added zirconocene hydrochloride (156 mg, 
0.605 mmol) and the resulting suspension was stirred at rt for 10 min.  The resulting yellow solution 
was cooled to 0 °C and Me3Al (1.0 M in CH2Cl2, 0.605 mL, 0.605 mmol) and 2-48 (85.0 mg, 0.263 
mmol) were added.  The mixture was warmed to rt and stirred at this temperature for 1 h, quenched 
with sat. aq. NH4Cl, and extracted with CH2Cl2.  The organic layers were separated, dried (MgSO4) 
and concentrated.  The residue was purified by chromatography on SiO2 (EtOAc:Hex, 3:7) to yield 
65.1 mg (81%) of 2-49 as a colorless oil: IR (neat) 3479, 3031, 2927, 2857, 1694, 1615, 1400, 972 
cm-1; 1H NMR δ 7.91-7.86 (m, 1 H), 7.56-7.42 (m, 2 H), 7.36-7.21 (m, 6 H), 5.90 (dt, 1 H, J = 15.0, 
6.8 Hz), 5.30 (d, 1 H, J = 14.8 Hz), 5.09 (dd, 1 H, J = 15.2, 9.2 Hz), 4.70 (d, 1 H, J = 9.2 Hz), 4.17 
(d, 1 H, J = 14.9 Hz), 2.13 (app q, 2 H, J = 6.7 Hz), 1.50-1.30 (m, 4 H), 0.94 (t, 3 H, J = 7.2 Hz); 13C 
NMR δ 167.9, 145.1, 138.3, 137.5, 131.8, 131.5, 128.6, 128.3, 127.3, 126.1, 123.6, 123.0, 62.7, 
43.8, 31.8, 31.1, 22.1, 13.8; MS (EI) m/z (rel intensity) 305 ([M]+, 100), 248 (40), 237 (70), 214 (40); 
HRMS (EI) m/z calcd for C21H23NO 305.1780, found 305.1785. 
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(E)-2-Benzyl-3-(2-cyclohexylvinyl)isoindolin-1-one (2-50).  According to general protocol 
A, cyclohexylacetylene (66.9 mg, 0.618 mmol), CH2Cl2 (1.5 mL), zirconocene hydrochloride (183 
mg, 0.711 mmol), Me3Al (1.0 M in CH2Cl2, 0.711 mL, 0.711 mmol) and 2-48 (100 mg, 0.309 mmol) 
afforded 80.8 mg (79%) of 2-50 as a colorless oil after purification on SiO2 (EtOAc:Hex, 3:7): IR 
(neat) 3375, 3030, 2921, 2851, 2243, 1220, 1200, 1097, 844 cm-1; 1H NMR δ 7.92-7.86 (m, 1 H), 
7.54-7.41 (m, 2 H), 7.35-7.20 (m, 6 H), 5.85 (dd, 1 H, J = 15.3, 6.6 Hz), 5.28 (d, 1 H, J = 14.8 Hz), 
5.02 (ddd, 1 H, J = 15.3, 9.2, 1.2 Hz), 4.67 (d, 1 H, J = 9.2 Hz), 4.18 (d, 1H, J = 14.8 Hz), 2.14-1.96 
(m, 1 H), 1.85-1.60 (m, 4 H), 1.42-1.00 (m, 6 H); 13C NMR δ 167.9, 145.1, 144.1, 137.4, 131.8, 
131.4, 128.5, 128.3, 128.2, 127.3, 123.6, 122.9, 62.8, 43.8, 40.3, 32.6, 26.0, 25.8; MS (EI) m/z (rel 
intensity) 331 ([M]+, 86), 248 (40), 237 (100); HRMS (EI) m/z calcd for C23H25NO 331.1936, found 
331.1951. 
NBn
O
OTBDPS  
 
(E)-2-Benzyl-3-(4-(tert-butyldiphenylsilyloxy)but-1-enyl)isoindolin-1-one (2-51).  
According to general protocol A, O-TBDPS-3-butynol (94.4 mg, 0.306 mmol), CH2Cl2 (1 mL), 
zirconocene hydrochloride (78.9 mg, 0.306 mmol), Me3Al (1.0 M in CH2Cl2, 0.306 mL, 0.306 
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mmol) and 2-48 (50.0 mg, 0.153) afforded 57.6 mg (71%) of 2-51 as a colorless oil after purification 
on SiO2 (EtOAc:Hex, 2:8): IR (neat) 3450, 2930, 2857, 1692, 1428, 1111, 735, 701 cm-1; 1H NMR δ 
7.92-7.86 (m, 1 H), 7.72-7.65 (m, 4 H), 7.53-7.35 (m, 9 H), 7.32-7.21 (m, 5 H), 5.96 (dt, 1 H, J = 
15.3, 6.8 Hz), 5.27 (d, 1 H, J = 14.9 Hz), 5.16 (dddd, 1 H, J = 15.3, 9.1, 1.2, 1.2 Hz), 4.71 (d, 1 H, J 
= 9.1 Hz), 4.16 (d, 1 H, J = 14.9 Hz), 3.77 (dt, 2 H, J = 6.3, 1.2 Hz), 2.37 (app q, 2 H, J = 6.6 Hz), 
1.08 (s, 9 H); 13C NMR δ 168.0, 144.9, 137.5, 135.6, 134.8, 133.8, 131.9, 131.5, 129.7, 128.6, 128.4, 
128.2, 127.7, 127.4, 123.6, 123.1, 63.2, 62.6, 43.9, 35.6, 26.9, 19.2; MS (EI) m/z (rel intensity) 532 
([M]+, 35), 488 (100), 474 (45), 306 (65), 252 (75); HRMS (EI) m/z calcd for C35H37NO2Si 
532.2664, found 532.2664. 
 
NBn
O
N
Ts CO2Me  
(E)-Methyl 4-(2-benzyl-3-oxoisoindolin-1-yl)-but-3-enyl-(tosyl)-carbamate (2-52).  
According to general protocol A, methyl but-3-ynyl(tosyl)carbamate (174 mg, 0.618 mmol), CH2Cl2 
(1.5 mL), zirconocene hydrochloride (183 mg, 0.711 mmol), Me3Al (1.0 M in CH2Cl2, 0.711 mL, 
0.711 mmol) and 2-48 (100 mg, 0.309) afforded 95.1 mg (62%) of 2-52 as a colorless oil after 
purification on SiO2 (acetone:CH2Cl2, 0.3:9.7): IR (neat) 3467, 3032, 2957, 2245, 1735, 1686, 1359, 
1168, 733 cm-1; 1H NMR δ 7.92-7.78 (m, 3 H), 7.56-7.41 (m, 2 H), 7.39-7.18 (m, 9 H), 5.93 (dt, 1 H, 
J = 15.2, 7.0 Hz), 5.26 (d, 1 H, J = 14.9 Hz), 5.21 (dd, 1 H, J = 15.1, 9.1 Hz), 4.73 (d, 1 H, J = 9.0), 
4.18 (d, 1 H, J = 14.9 Hz), 3.95 (t, 2 H, J = 7.0 Hz), 3.69 (s, 3 H), 2.58 (app q, 2 H, J = 7.0 Hz), 2.43 
(s, 3 H); 13C NMR δ 168.0, 152.8, 144.8, 144.6, 137.4, 136.5, 133.0, 131.7, 131.6, 129.7, 129.4, 
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128.6, 128.3, 128.3, 127.4, 123.6, 123.2, 62.3, 53.8, 46.5, 43.8, 32.9, 21.6; MS (EI) m/z (rel 
intensity) 504 ([M]+, 50), 262 (40), 155 (100); HRMS (EI) m/z calcd for C28H28N2O5S 504.1719, 
found 504.1724. 
 
NBn
O
OPiv  
1-benzyl-4,4-dimethyl-5-oxopyrrolidin-2-yl pivalate (2-54).   A mixture of 2,2-
dimethylsuccinic anhydride (710 mg, 5.55 mmol) and benzyl amine (712 mg, 6.66 mmol, 1.2 eq) 
was heated over a bunsen burner for ~ 1 min.  The cooled mixture was purified by chromatography 
on SiO2 (1:1 Hex/EtOAc) to furnish the corresponding imide (1.14 g, 95%) as a colorless oil:  IR 
(neat) 2969, 2933, 1777, 1702, 1344, 1142, 709 cm-1; 1H NMR δ 7.29-7.21 (m, 5 H), 4.57 (s, 2 H), 
2.47 (s, 2 H), 1.22 (s, 6 H); 13C NMR δ 182.5, 175.1, 135.8, 128.3 (2 C), 128.1 (2 C), 127.5, 43.2, 
42.0, 39.7, 25.1 (2 C); MS (EI) m/z (rel intensity) 217 ([M]+, 100), 174 (33), 133 (22); HRMS (EI) 
m/z calcd for C13H15NO2 , found.  A solution of this imide (1.14 g, 5.25 mmol) in MeOH (53 mL) 
was treated with NaBH4 (200 mg, 2.62 mmol, 1 eq) at ambient temperature.  After 6 h, the reaction 
mixture was concentrated, the residue dissolved in CH2Cl2 (50 mL) and treated with aq. NH4Cl (aq.).  
The aqueous layer was separated and washed with CH2Cl2 (2 x 25 mL) and the combined organic 
layers were dried (MgSO4), filtered, concentrated and the resulting oil used without further 
purification.  The crude oil was dissolved in CH2Cl2 (50 mL) and treated sequentially with Et3N 
(2.19 mL, 15.7 mmol, 3 eq), DMAP (128 mg, 1.05 mmol, 20 mol %) and pivaloyl chloride (1.29 
mL, 10.5 mmol, 2 eq) at ambient temperature.  After 6 h, the reaction mixture was quenched with 3 
M HCl (aq., 10 mL) and the aqueous layer washed with CH2Cl2 (3 x 15 mL).  The combined organic 
layers were washed with H2O, dried (MgSO4), filtered, concentrated and the residue purified by 
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chromatography on SiO2 (2:1 Hex/EtOAc) to yield 2-54 (398 mg, 25%) as a colorless oil:  IR (neat) 
2971, 1710, 1419, 1125, 707 cm-1; 1H NMR δ 7.33-7.21(m, 5 H), 5.99 (d, 1 H, J = 6.3 Hz), 4.74 (d, 
1 H, J = 14.7 Hz), 4.15 (d, 1 H, J = 14.7 Hz), 2.14 (dd, 1 H, J = 14.1, 6.3 Hz), 1.87 (d, 1 H, J = 14.4 
Hz), 1.32 (s, 3 H), 1.22 (s, 3 H), 1.10 (s, 9 H); 13C NMR δ 180.6, 177.9, 136.6, 128.7 (2 H), 128.2 (2 
H), 127.6, 82.1, 44.8, 41.5, 39.3, 38.7, 26.8 (3 C), 26.5, 25.6; MS (EI) m/z (rel intensity) 303 ([M]+, 
36), 275 (15), 202 (85), 158 (46); HRMS (EI) m/z calcd for C18H25NO3 , found. 
 
NBn
O
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(E)-1-Benzyl-5-(hex-1-enyl)-3,3-dimethylpyrrolidin-2-one (2-55).  According to general 
protocol A, hexyne (9.77 mg, 0.119 mmol), CH2Cl2 (1 mL), zirconocene hydrochloride (30.7 mg, 
0.119 mmol), Me3Al (1.0 M in CH2Cl2, 0.119 mL, 0.119 mmol) and 2-54 (18.0 mg, 0.0593 mmol) 
afforded 14.0 mg (83%) of 2-55 as a colorless oil after purification on SiO2 (EtOAc:hex, 2.5:7.5): IR 
(neat) 2958, 2928, 2868, 1692, 1411, 1262, 972, 752 cm-1; 1H NMR δ 7.35-7.23 (m, 3 H), 7.21-7.13 
(m, 2 H), 5.53 (dt, 1 H, J = 15.0, 6.6 Hz), 5.16 (dd, 1 H, J = 15.3, 9.0 Hz), 4.94 (d, 1 H, J = 14.4 Hz), 
3.88 (d, 1 H, J = 14.4 Hz), 3.73 (app q, 1 H, J = 7.8 Hz), 2.10-1.98 (m, 2 H), 1.99 (dd, 1 H, J = 12.9, 
7.2 Hz), 1.58 (dd, 1 H, J = 12.9, 8.1 Hz), 1.42-1.28 (m, 4 H), 1.24 (s, 3 H), 1.11 (s, 3 H), 0.92 (t, 3 H, 
J = 6.9 Hz); 13C NMR δ 179.6, 137.2, 135.8, 129.8, 128.4, 128.3, 127.2, 56.9, 44.2, 42.0, 40.3, 31.8, 
31.2, 25.5, 24.7, 22.2, 13.9; MS (EI) m/z (rel intensity) 285 ([M]+, 20), 228 (20), 175 (30), 91 (100); 
HRMS (EI) m/z calcd for C19H27NO 285.2093, found 285.2090. 
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(E)-2-Benzyl-3-(2-methylhex-1-enyl)isoindolin-1-one (2-56).  General Protocol B.  To a -
30 °C solution of AlMe3 (89.0 mg, 1.24 mmol) and Cp2ZrCl2 (9.00 mg, 0.0309 mmol) in CH2Cl2 
(1.5 mL) was added H2O (11.1 mg, 0.619 mmol) dropwise.  The reaction mixture was warmed to 
ambient temperature, cooled to 0 °C, treated with 1-hexyne (71.0 μL, 0.619 mmol), stirred for 30 
min and treated with 2-48 (100 mg, 0.309 mmol).  The reaction mixture was warmed to rt and stirred 
at this temperature for 1 h, quenched with sat. aq. NH4Cl, and extracted with CH2Cl2.  The organic 
layers were separated, dried (MgSO4) and concentrated.  The residue was purified by 
chromatography on SiO2 (EtOAc:Hex, 3:7) to yield 76.0 mg (77%) of 2-56 as a colorless oil: IR 
(neat) 2956, 2929, 2858, 1694, 1468, 1401, 749, 703 cm-1; 1H NMR δ 7.89-7.50 (m, 1 H), 7.53-7.40 
(m, 2 H), 7.35-7.20 (m, 6 H), 5.31 (d, 1 H, J = 14.9 Hz), 5.06 (d, 1 H, J = 9.8), 4.81 (dq, 1 H, J = 9.8, 
1.2 Hz), 4.09 (d, 1 H, J = 14.9 Hz), 2.07 (t, 2 H, J = 7.1 Hz), 1.67 (d, 3 H, J = 1.3 Hz), 1.50-1.22 (m, 
4 H), 0.91 (t, 3 H, J = 7.2 Hz); 13C NMR δ 168.1, 145.7, 143.4, 137.5, 132.0, 131.4, 128.5, 128.2, 
128.0, 127.3, 123.6, 122.8, 120.6, 57.9, 43.9, 39.3, 29.8, 22.2, 16.5, 13.8; MS (EI) m/z (rel intensity) 
319 ([M]+, 100), 221 (40); HRMS (EI) m/z calcd for C22H25NO 319.1936, found 319.1921. 
 
NBn
O
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(E)-2-Benzyl-3-(2-phenylprop-1-enyl)isoindolin-1-one (2-57).  According to general 
protocol B, phenylacetylene (68.0 μL, 0.619 mmol), AlMe3 (89.0 mg, 1.24 mmol), Cp2ZrCl2 (9.00 
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mg, 0.0309 mmol), CH2Cl2 (1.5 mL), H2O (11.1 mg, 0.619 mmol) and 2-48 (100 mg, 0.309 mmol) 
afforded 81.0 mg (77%) of 2-57 as a colorless oil and a 95:5 mixture of regioisomers after 
purification on SiO2 (EtOAc:Hex, 1:3): Major isomer: IR (neat) 3030, 2918, 1693, 1602, 1432, 
1400, 1250, 749 cm-1; 1H NMR δ 7.93 (dd, 1 H, J = 6.3, 2.1 Hz), 7.54-7.46 (m, 2 H), 7.35-7.26 (m, 
11 H), 5.41 (dd, 1 H, J = 9.6, 0.9 Hz), 5.35 (d, 1 H, J = 15.0 Hz), 5.27 (d, 1 H, J = 9.9 Hz), 4.21 (d, 1 
H, J = 15.0 Hz), 2.12 (d, 3 H, J = 0.9 Hz); 13C NMR δ 168.1, 145.0, 142.0, 141.3, 137.4, 132.0, 
131.6, 128.6, 128.3, 127.8, 127.5, 125.8, 123.8, 123.7, 122.9, 58.2, 44.3, 16.3; MS (EI) m/z (rel 
intensity) 339 ([M]+, 41), 248 (47), 234 (77), 91 (100); HRMS (EI) m/z calcd for C24H21NO 
339.1623, found 339.1631. Minor isomer (characteristic peaks): 1H NMR δ 1.44 (d, 3 H, J = 6.9 
Hz); 13C NMR δ 128.0, 121.9, 18.0. 
 
Ph O
 
(E)-(3-(Pent-4-ynyloxy)prop-1-enyl)benzene (2-59).  To a solution of 4-pentyn-1-ol (4.03 
mL, 43.3 mmol) in hexanes (75 mL) was added 50% NaOH (75 mL), TBAI (801 mg, 2.17 mmol) 
and cinnamyl bromide (8.97 g, 45.5 mmol).  The reaction mixture was rapidly stirred for 10 h, the 
organic layer was separated, dried (MgSO4) and concentrated.  The residue was purified by 
chromatography on SiO2 (EtOAc:Hex, 1:9) to yield 9.00 g (69%) of 2-59 as a colorless oil: IR (neat) 
3298, 3027, 2951, 2854, 2117, 1478, 1365, 1111, 967 cm-1; 1H NMR δ 7.44-7.37 (m, 2 H), 7.37-7.27 
(m, 2 H), 7.27-7.21 (m, 1 H), 6.62 (d, 1 H, J = 15.9 Hz), 6.30 (dt, 1 H, J = 15.9, 6.0), 4.15 (dd, 2 H, J 
= 6.0, 0.9 Hz), 3.60 (t, 2 H, J = 6.3 Hz), 2.34 (dt, 2 H, J = 7.2, 2.7 Hz), 1.96 (t, 1 H, J = 2.7 Hz), 1.85 
(app p, 2 H, J = 6.6 Hz); 13C NMR δ 136.5, 131.8, 128.3, 127.4, 126.2, 126.0, 83.7, 71.2, 68.5, 68.3, 
28.5, 15.1; MS (EI) m/z (rel intensity) 199 ([M]+, 100), 186 (35), 173 (35), 131 (100); HRMS (EI) 
m/z calcd for C14H16O 199.1123, found 199.1126. 
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2-Allyl-3-oxoisoindolin-1-yl pivalate (2-61).  To a solution of 2-allylisoindoline-1,3-dione 
(3.64 g, 19.4 mmol) in MeOH (100 mL) was added sodium borohydride (734 mg, 19.4 mmol) at 0 
°C.  The resulting reaction mixture was stirred at 0 °C for 2 h and carefully quenched with H2O.  The 
aqueous layer was extracted with EtOAc (2x) and the organic layer was separated, dried (MgSO4) 
and concentrated.  The residue was dried to yield a white solid which was carried on to the next step 
without further purification.  To a solution of the crude reduced phthalamide (3.60 g, 19.0 mmol) in 
THF (100 mL) was added Et3N (7.90 mL, 57.0 mmol) and pivaloyl chloride (2.81 mL, 22.8 mmol) 
at 0 °C and the reaction mixture was allowed to warm to rt and stirred at this temperature for 4 h.  
The mixture was quenched with sat. aq. NaHCO3, extracted with EtOAc (2x), dried (MgSO4) and 
concentrated. The residue was purified by chromatography on SiO2 (EtOAc:Hex, 2.5:7.5) to yield 
4.40 g (83% over 2 steps) of 2-61 as a colorless oil: IR (neat) 2976, 1716, 1405, 1135, 753; 1H NMR 
δ 7.88-7.80 (m, 1 H), 7.62-7.46 (m, 3 H), 6.99 (s, 1 H), 5.94-5.77 (m, 1 H), 5.29-5.15 (m, 2 H), 4.44 
(dd, 1 H, J = 15.9, 5.1 Hz), 3.88 (dd, 1 H, J = 15.3, 6.6 Hz), 1.23 (s, 9 H) cm-1; 13C NMR δ 178.3, 
167.5, 141.2, 132.4, 132.4, 131.8, 130.0, 123.6, 123.5, 118.0, 80.9, 42.8, 39.0, 26.9; MS (EI) m/z (rel 
intensity) 273 ([M]+, 60), 172 (100; HRMS (EI) m/z calcd for C16H19NO3 273.1365, found 273.1358. 
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2-Allyl-3-((E)-5-(cinnamyloxy)pent-1-enyl)isoindolin-1-one (2-62).  According to general 
protocol A, alkyne 2-59 (733 mg, 3.66 mmol), CH2Cl2 (10 mL), zirconocene hydrochloride (944 mg, 
3.66 mmol), Me3Al (1.0 M in CH2Cl2, 3.66 mL, 3.66 mmol) and 2-61 (500 mg, 1.83 mmol) (reaction 
time increased to 12 h) afforded 376 mg (55%) of 2-62 as a colorless oil after purification on SiO2 
(Acetone:CH2Cl2, 0.7:9.3): IR (neat) 2924, 2853, 1694, 1468, 1289, 1098, 968, 746 cm-1; 1H NMR δ 
7.85 (d, 1 H, J = 6.6 Hz), 7.57-7.20 (m, 8 H), 6.61 (d, 1 H, J = 15.9 Hz), 6.29 (dt, 1 H, J = 15.9, 6.0 
Hz), 6.02 (dt, 1 H, J = 13.8, 6.9 Hz), 5.90-5.73 (m, 1 H), 5.25-5.07 (m, 3 H), 4.87 (d, 1 H, J = 9.0 
Hz), 4.60 (ddd, 1 H, J = 15.6, 4.5, 2.7 Hz), 4.15 (dd, 2 H, J = 6.0, 1.2 Hz), 3.70 (dd, 1 H, J = 15.3, 
7.2 Hz), 3.53 (t, 2 H, J = 6.3 Hz), 2.25 (app q, 2 H, J = 6.9 Hz), 1.77 (app p, 2 H, J = 7.8 Hz); 13C 
NMR δ 167.7, 144.9, 137.2, 136.6, 133.2, 132.3, 131.8, 131.4, 128.5, 128.3, 127.6, 126.7, 126.4, 
126.1, 123.5, 122.9, 117.5, 71.5, 69.4, 62.9, 42.5, 29.2, 28.9; MS (ESI) m/z (rel intensity) 396 
([M+Na]+, 100), 307 (20), 297 (20); HRMS (ESI) m/z calcd for C25H27NO2Na 396.1939, found 
396.1928 
 
O
N
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3H-Pyrrolo[2,1-a]isoindol-5(9bH)-one (2-63).  To a solution of 2-62 (41.7 mg, 0.112 
mmol) in CH2Cl2 (6 mL) was added Grubbs 2nd generation catalyst (4.75 mg, 5.60 mmol) and the 
red solution was heated at 50 °C for 1 h, cooled to rt and concentrated.  The residue was purified by 
chromatography on SiO2 (Acetone:CH2Cl2, 0.4:9.6) to yield 11.7 mg (61%) of 2-63 as a colorless 
oil: IR (neat) 2872, 1614, 1468, 1395, 1366, 1080, 746 cm-1; 1H NMR δ 7.74-7.66 (m, 2 H), 7.66-
7.58 (m, 1 H), 7.54-7.45 (m, 1 H), 6.28-6.20 (m, 1 H), 6.08-5.99 (m, 1 H), 5.53 (app d, 1 H, J = 1.8 
Hz), 4.57-4.43 (m, 1 H), 3.98-3.83 (m, 1 H); 13C NMR δ 175.4, 148.4, 133.6, 133.1, 131.9, 129.4, 
129.2, 124.6, 124.0, 71.1, 52.0; MS (EI) m/z (rel intensity) 171 ([M]+, 60), 160 (70), 130 (55), 105 
(60), 83 (100); HRMS (EI) m/z calcd for C11H9NO 171.0684, found 171.0676. 
 
N
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(E)-2-Allyl-3-(hex-1-enyl)isoindolin-1-one (2-64).  According to general protocol A, 
hexyne (420 μL, 3.66 mmol), CH2Cl2 (10 mL), zirconocene hydrochloride (944 mg, 3.66 mmol), 
Me3Al (1.0 M in CH2Cl2, 3.66 mL, 3.66 mmol) and 2-61 (500 mg, 1.83 mmol) afforded  341 mg 
(73%) of 2-64 as a colorless oil after purification on SiO2 (EtOAc:Hex, 3:7): IR (neat) 2957, 2926, 
1697, 1468, 1396, 971, 748 cm-1; 1H NMR δ 7.83 (d, 1 H, J = 7.2 Hz), 7.57-7.38 (m, 2 H), 7.33 (d, 1 
H, J = 7.5 Hz), 5.97 (dt, 1 H, J = 15.0, 6.9 Hz), 5.88-5.71 (m, 1 H), 5.22-4.97 (m, 3 H), 4.85 (d, 1 H, 
J = 9.3 Hz), 4.59 (dd, 1 H, J = 15.6, 4.5 Hz), 3.69 (dd, 1 H, J = 15.3, 7.2 Hz), 2.12 (app q, 2 H, J = 
6.6 Hz), 1.48-1.28 (m, 4 H), 0.91 (t, 3 H, J = 6.9 Hz); 13C NMR δ 167.7, 145.0, 138.2, 133.1, 131.7, 
131.4, 128.2, 126.0, 123.4, 122.9, 117.4, 62.9, 42.5, 31.8, 31.1, 27.0, 22.0, 13.8; MS (EI) m/z (rel 
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intensity) 255 ([M]+, 30), 198 (100), 172 (55); HRMS (EI) m/z calcd for C17H21NO 255.1623, found 
255.1627. 
 
N
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2-(Pent-4-enyl)isoindoline-1,3-dione (2-66).  A solution of 4-penten-1-ol (2-65, 3.51 mL, 
34.0 mmol), phthalimide (5.00 mg, 34.0 mmol), and PPh3 (8.92 g, 34.0 mmol) in THF (220 mL) was 
cooled to 0 °C and treated with DIAD (6.69 mL, 34.0 mmol) over 5 min.  The reaction mixture was 
warmed to rt and stirred for 6 h.  The solvent was evaporated, the residue was dissolved in 
EtOAc/hex (1:1, 100 mL) and the solids were filtered off.  The filtrate was concentrated and 
chromatographed on SiO2 (EtOAc:hex, 1:5) to yield 6.44 g (88%) of imide 2-66 as a colorless oil:  
IR (neat) 3466, 3077, 2939, 1773, 1641, 1397, 995, 720 cm-1; 1H NMR δ 7.88-7.81 (m, 2 H), 7.76-
7.67 (m, 2 H), 5.90-5.73 (m, 1 H), 5.12-4.94 (m, 2 H), 3.70 (dt, 2 H, J = 7.5, 4.5 Hz), 2.20-2.07 (m, 2 
H), 1.87-1.73 (m, 2 H); 13C NMR δ 168.1, 137.1, 133.7, 131.9, 122.9, 115.1, 37.3, 30.8, 27.4; MS 
(EI) m/ +, 45), 173 (70), 160 (100), 148 (80), 130 (80), 104 (90); HRMS (EI) 
m/z calcd for C13H13NO2 215.0946, found 215.0946. 
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3-Oxo-2-(pent-4-enyl)isoindolin-1-yl pivalate (2-67).  To a solution of imide 2-66 (4.42 g, 
20.5 mmol) in MeOH (100 mL) was added sodium borohydride (776 mg, 20.5 mmol) at 0 °C.  The 
resulting reaction mixture was stirred at 0 °C for 2 h and carefully quenched with H2O.  The aqueous 
layer was extracted with EtOAc (2x) and the organic layer was separated, dried (MgSO4) and 
concentrated.  The residue was dried to yield a white solid which was carried on to the next step 
without further purification.  To a solution of the crude reduced phthalamide (4.23 g, 19.5 mmol) in 
THF (100 mL) was added Et3N (8.15 mL, 58.5 mmol), pivaloyl chloride (3.61 mL, 29.3 mmol) and 
DMAP (119 mg, 0.975 mmol) at 0 °C and the reaction mixture was allowed to warm to rt and stirred 
at this temperature for 8 h.  The mixture was quenched with sat. aq. NaHCO3, extracted with EtOAc 
(2x), dried (MgSO4) and concentrated. The residue was purified by chromatography on SiO2 
(EtOAc:Hex, 1:5) to yield 4.70 g (76% over 2 steps) of 2-67 as a colorless oil: IR (neat) 3077, 2974, 
2873, 1739, 1641, 1618, 1369, 1208, 1141, 959, 751 cm-1; 1H NMR δ  7.67 (d, 1 H, J = 6.0 Hz), 
7.49-7.32 (m, 3 H), 6.89 (s, 1 H), 5.79-5.58 (m, 1 H), 4.91 (d, 1 H, J = 17.1 Hz), 4.84 (d, 1 H, J = 
10.5 Hz), 3.73-3.55 (m, 1 H), 3.27-3.09 (m, 1 H), 2.07-1.93 (m, 2 H), 1.77-1.50 (m, 2 H), 1.11 (s, 9 
H); 13C NMR δ 178.2, 167.4, 140.9, 137.1, 132.0, 131.8, 129.8, 123.2, 123.1, 114.9, 80.8, 39.5, 38.7, 
30.7, 27.1, 26.6; MS (EI) m/z (rel intensity) 301 ([M]+, 15), 246 (45), 216 (65), 200 (85), 146 (85), 
133 (65); HRMS (EI) m/z calcd for C18H23NO3 301.1678, found 301.1681. 
 
N
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(E)-3-(Hex-1-enyl)-2-(pent-4-enyl)isoindolin-1-one (2-68).  According to general protocol 
A, hexyne (420 μL, 3.66 mmol), CH2Cl2 (10 mL), zirconocene hydrochloride (944 mg, 3.66 mmol), 
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Me3Al (1.0 M in CH2Cl2, 3.66 mL, 3.66 mmol) and 2-67 (552 mg, 1.83 mmol) afforded 368 mg 
(72%) of 2-68 as a colorless oil after purification on SiO2 (EtOAc:Hex, 3:7): IR (neat) 3076, 2967, 
2928, 2860, 1693, 1468, 1404, 972, 749 cm-1; 1H NMR δ 7.72 (d, 1 H, J = 7.5 Hz), 7.44-7.28 (m, 2 
H), 7.23 (d, 1 H, J = 7.2 Hz), 5.94 (dt, 1 H, J = 14.4, 6.6 Hz), 5.80-5.63 (m, 1 H), 5.03-4.82 (m, 3 H), 
4.75 (d, 1 H, J = 9.0 Hz), 3.83-3.65 (m, 1 H), 3.23-3.07 (m, 1 H), 2.13-1.93 (m, 4 H), 1.75-1.51 (m, 2 
H), 1.42-1.19 (m, 4 H), 0.83 (t, 3 H, J = 6.9 Hz); 13C NMR δ 167.6, 144.6, 137.5, 137.3, 131.7, 
131.0, 127.9, 126.2, 122.9, 122.6, 114.7, 39.4, 31.5, 30.8, 30.7, 27.3, 26.9, 21.8, 13.5; MS (EI) m/z 
(rel intensity) 283 ([M]+, 20), 228 (70), 160 (100), 146 (50), 76 (50); HRMS (EI) m/z calcd for 
C19H25NO 283.1936, found 283.1934. 
 
O
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(Z)-7,8,9,11a-Tetrahydro-5H-azepino[2,1-a]isoindol-5-one (2-69).  To a solution of 37 
(150 mg, 0.529 mmol) in toluene (100 mL) was added Ti(OiPr)4 (157 μL, 0.529 mmol) and Grubbs 
2nd generation catalyst (22.5 mg, 0.0265 mmol) and the red solution was stirred at rt for 12 h and 
concentrated.  The residue was purified by chromatography on SiO2 (Acetone:CH2Cl2, 0.4:9.6) to 
yield 70.7 mg (67%) of 2-69 as a colorless oil: IR (neat) 3024, 2926, 1680, 1469, 1419, 1298, 938, 
709 cm-1; 1H NMR δ 7.76 (dd, 1 H, J = 6.9, 1.2 Hz), 7.58-7.51 (m, 1 H), 7.46 (app t, 2 H, 7.2 Hz), 
6.13-6.02 (m, 1 H), 6.02-5.91 (m, 1 H), 4.49 (dd, 1 H, J = 11.4, 2.1 Hz), 4.26 (ddd, 1 H, J = 13.5, 
6.6, 3.0 Hz), 3.22 (ddd, 1 H, J = 12.6, 9.6, 2.7 Hz), 2.81 (app ddd, 1 H, J = 15.9, 7.8, 2.4 Hz), 2.53-
2.26 (m, 2 H), 2.25-2.09 (m, 1 H); 13C NMR δ 167.5, 145.9, 133.0, 132.7, 131.6, 128.8, 128.5, 
90 (35); HRMS (EI) m/z calcd for C13H13NO 199.0997, found 199.0991. 
123.5, 122.4, 60.6, 41.6, 35.2, 28.2; MS (EI) m/z (rel intensity) 199 ([M]+, 45), 145 (100), 117 (40), 
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5.3 SPIROKETALS VIA OXIDATIVE REARRANGEMENT OF ENOL ETHERS 
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(1R*,6R*)-3-Methoxy-5,5-dimethyl-7-oxabicyclo[4.1.0]hept-3-en-2-one (3-20).  To a 40 
°C solution of 3-19 (0.20 g, 1.3 mmol) in THF (30 mL) was added H2O2 (10 mL, 30% v/v in H2O) 
and K2CO3 (5 mL, 0.4 M in H2O).  The reaction mixture was stirred for 6 h, diluted with EtOAc, 
washed with brine, dried (Na2SO4) and concentrated.  The residue was purified by chromatography 
on SiO2 (4:1 hexanes/EtOAc) to afford 3-20 (0.11 g, 67%) as a colorless oil:  IR (neat) 2965, 1694, 
1627, 1205, 1158, cm ;  H NMR δ 5.23 (d, J = 2.5 Hz, 1 H), 3.54 (s, -1 1 3 H), 3.50 (d, J = 3.8 Hz, 1 
H), 3.35 (dd, J = 3.8, 2.5 Hz, 1 H), 1.33 (s, 3 H), 1.20 (s, 3 H); 13C NMR δ 189.4, 146.8, 120.8, 61.2, 
55.0, 54.8, 34.6, 28.3, 25.9; MS (EI) m/z (intensity) 168 ([M-H2O]+, 57), 153 (55), 125 (100); HRMS 
(EI) m/z calculated for C9H12O3 [M-H2O] 168.0786, found 168.0784. 
 
O
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(1R*,3S*,6R*)-Methyl-2,2-dimethyl-5-oxo-4,7-dioxabicyclo[4.1.0]heptane-3-carboxylate 
(3-21).  General Protocol A.  To a solution of 3-20 (35 mg, 0.21 mmol) in dry CH2Cl2 (2.0 mL) was 
added m-CPBA (0.15 g, 0.62 mmol, ~70 wt % m-CPBA) and Na2HPO4 (89 mg, 0.62 mmol) and the 
reaction mixture was stirred for 12 h, treated with 2-methyl-2-butene (0.10 mL of a 2 M solution in 
THF), stirred for 2 h, diluted with CH2Cl2 and washed with sat. NaHCO3 (5x).  The organic layer 
 175 
was dried (Na2SO4) and concentrated to afford 3-21 a colorless solid (42 mg, 80%, contaminated 
with 10% 3-chlorobenzoic acid).  The material was purified by chromatography on SiO2 (4:1 
hexanes/EtOAc) for analysis:  IR (neat) 2966, 1752, 1465, 1250, 1209, 907 cm-1; NMR δ 4.81 (s, 1 
H), 3.82 (s, 3 H), 3.64 (d, J = 4.0 Hz, 1 H), 3.32 (d, J = 3.9 Hz, 1 H), 1.37 (s, 3 H), 1.07 (s, 3 H); 13C 
NMR δ 167.5, 165.5, 78.6, 61.1, 52.7, 49.8, 34.9, 22.7, 17.8; MS (EI) m/z (intensity) 141 ([M-
CO2Me , 7), 84 (16); HRMS (EI) m/z calculated for C7H9O3 [M-CO2Me] 141.0552, found 
141.0550. 
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(1R*,2R*,6R*)-3-Methoxy-2,5,5-trimethyl-7-oxabicyclo[4.1.0]hept-3-en-2-ol (3-22).  To a 
cooled (-78 °C) solution of 3-20 (28 mg, 0.17 mmol) in dry THF (4.0 mL) was added MeLi (0.19 
mL, 0.30 mmol, 1.6 M in Et2O).  After 30 min, the reaction mixture was quenched with H2O (1 mL) 
and extracted with Et2O (3 x 5 mL).  The combined organic layers were washed with H2O, brine, 
dried (Na2SO4), filtered, and concentrated.  The residue was purified by chromatography on SiO2 
(3:1 hexanes/EtOAc) to afford 3-22 (28 mg, 91%) as a colorless oil:  IR (neat) 3479, 2962, 1667, 
1469, 1212, 1162, 1059 cm-1; 1H NMR δ 4.15 (d, J = 2.3 Hz, 1 H), 3.51 (s, 3 H), 3.32 (d, J = 4.1 Hz, 
1 H), 3.06 (dd, J = 4.3, 2.1 Hz, 1 H), 1.42 (s, 3 H), 1.20 (s, 3 H), 1.09 (s, 3 H); 13C NMR δ 152.4, 
100.4, 69.2, 61.1, 60.2, 54.5, 33.5, 27.7, 27.1, 25.2; MS (EI) m/z (intensity) 184 ([M]+, 17), 169 (44), 
137 (13); HRMS (EI) m/z calculated for C10H16O3 184.1099, found 184.1103. 
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Methyl tetrahydro-3,3-dimethyl-6-oxo-2H-pyran-2-carboxylate (3-23). According to 
General Protocol A,  a solution of 3-17 (0.14 g, 0.97 mmol), m-CPBA (0.67 g, 2.7 mmol, ~70 wt % 
m-CPBA) and Na2HPO4 (0.39 g, 2.7 mmol)  in CH2Cl2 (10 mL) afforded, after 12 h, 3-23 as a light 
yellow solid (0.13 g, 75%, contaminated with 15% 3-chlorobenzoic acid):  IR (neat) 2965, 1751, 
1469, 1204, 1159, 1080 cm-1;  1H NMR δ 4.53 (d, J = 1.4 Hz, 1 H),  3.79 (s, 3 H), 2.67, 2.60 (AB of 
ABMX, JAB = 18.8, JAM = 7.8 Hz, JAX = 4.3 Hz, 2 H), 1.89-1.79 (m, 1 H), 1.60 (dddd, J = 13.6, 5.7, 
4.3, 1.4 Hz, 1 H), 1.20 (s, 3 H), 1.03 (s, 3 H); 13C NMR δ 169.5 (2C), 85.1, 52.3, 31.4, 31.0, 26.8, 
25.3, 24.2; MS (EI) m/z (intensity) 171 ([M-CH3]+, 3), 156 (70), 139 (88), 127(100); HRMS (EI) m/z 
calculated for C9H14O4 186.0892, found 186.0895. 
 
 
 
O
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Methyl tetrahydro-2-methyl-5-oxofuran-2-carboxylate (3-25). According to General 
Protocol A, a solution of 3-24 (0.11 g, 0.87 mmol) in CH2Cl2 (5.0 mL), m-CPBA (0.64 g, 2.6 mmol, 
~70 wt % m-CPBA) and Na2HPO4 (0.37 g, 2.6 mmol) afforded, after 12 h, 3-25 (48 mg, 35%, 
corrected for 3-chlorobenzoic acid~10%) as a colorless solid:  IR (neat) 2992, 2957, 1788, 1743, 
1457, 1201, 1140 cm-1;  1H NMR δ 3.78 (s, 3 H), 2.73-2.48 (m, 3 H), 2.19-2.08 (m, 1 H), 1.65 (s, 3 
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H); 13C NMR δ 175.8, 172.1, 83.7, 52.9, 32.9, 28.3, 23.7; MS (EI) m/z (intensity) 99 ([M-
CO2Me]+,48), 73 (100); HRMS (EI) m/z calculated for C5H7O2 [M-CO2Me] 99.0446, found 99.0447. 
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(1R*,3S*,5S*,6R*)-Methyl-5-hydroxy-2,2,5-trimethyl-4,7-dioxabicyclo[4.1.0]heptane-3-
car-boxylate (3-26).  According to General Protocol A, enol ether 3-22 (24 mg, 0.13 mmol) in 
CH2Cl2 (1.3 mL), Na2HPO4 (55 mg, 0.39 mmol) and m-CPBA (96 mg of ~70% m-CPBA) furnished, 
after 18 h and purification on SiO2 (1:1 hexanes/EtOAc), ester 3-26 (5.6 mg, 20%) as a white solid 
which was a single diastereomer as indicated by 1H NMR :  Mp 114.5-116.3 °C (hexanes/EtOAc); 
IR (KBr) 3466, 2973, 1737, 1214, 1086, 920 cm-1;  1H NMR δ 4.10 (s, 1 H), 3.75 (s, 3 H), 3.52 (s, 1 
H), 3.33 (d, 1 H, J = 3.8 Hz), 3.10 (d, 1 H, J = 4.0 Hz), 1.64 (s, 3 H), 1.22 (s, 3 H), 1.00 (s, 3 H); 13C 
MR δ 170.0, 92.4, 71.7, 63.4, 57.7, 51.8, 33.7, 26.5, 22.3, 18.5; MS (EI) m/z (intensity) 198 ([M-
H2O]+, 49), 156 (32), 139 (76), 114 (77); HRMS (EI) m/z calculated for C10H14O4 [M-H2O] 
198.0892, found 198.0891. 
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6-Methoxy-1-oxaspiro[4.5]dec-6-ene (3-42).  General Protocol B.  A solution of ketone 3-
41 (155 mg, 1.01 mmol) in THF (3 mL) was added dropwise to a solution of KHMDS (241 mg, 1.21 
mmol) in THF (7 mL) at -78 °C.  After 10 min, DMF (2.5 mL) was added.  After 10 min, 
dimethylsulfate (254 mg, 2.01 mmol) was added and the reaction mixture was warmed to ambient 
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temperature over 4 h.  Subsequently, sat. aq. NaHCO3 (5 mL) was added and the aqueous layer was 
extracted with Et2O (4 x 10 mL).  The combined organic layers were washed with H2O, brine, dried 
(Na2SO4), filtered, concentrated and purified on SiO2 (85:15 pentane/Et2O) to furnish enol ether 3-42 
(155 mg, 0.923 mmol, 89%) as a volatile, colorless oil:  IR (neat) 2948, 2875, 1717, 1601, 1441, 
1367, 1224, 1060, 926 cm-1; 1H NMR δ 4.72 (dd, 1 H, J = 3.9, 3.9 Hz), 3.97-3.80 (m, 2 H), 3.51 (s, 3 
H), 2.24-1.51 (m, 10 H); 13C NMR δ 156.9, 96.4, 81.2, 68.6, 54.2, 37.2, 35.1, 26.9, 23.9, 20.5; MS 
(EI) m/z (intensity) 168 ([M]+, 43), 140 (40), 137 (37), 123 (52); HRMS (EI) m/z calculated for 
C10H16O2 168.1150, found 168.1151. 
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Methyl 1,6-dioxaspiro[4.5]decane-7-carboxylate (3-43).  According to General Protocol A, 
enol ether 3-42 (100 mg, 0.595 mmol), Na2HPO4 (1.79 mmol, 246 mg) and m-CPBA (1.79 mmol, 
411 mg of ~70% m-CPBA) in CH2Cl2 (6 mL) furnished, after 18 h and purification on SiO2 (4:1 
pentane/Et2O), spiroketal ester 3-43 (62 mg, 0.31 mmol, 52%) as a colorless oil and a single 
diastereomer as indicated by 1H NMR:  IR (neat) 2951, 2882, 1760, 1738, 1456, 1439, 1201, 1011, 
857 cm-1; 1H NMR (CD2Cl2) δ 4.38 (dd, 1 H, J = 12.1, 2.4 Hz), 3.89-3.83 (m, 2 H), 3.68 (s, 3 H), 
2.08-1.96 (m, 2 H), 1.92-1.60 (m, 8 H); 13C NMR (CD2Cl2) δ 172.8, 106.9, 70.6, 67.7, 52.0, 38.1, 
33.0, 28.5, 24.1, 20.5; MS (EI) m/z (rel intensity) 200 ([M]+, 53), 184 (6), 172 (10), 141 (100), 114 
(14); HRMS (EI) m/z calculated for C10H16O4 200.1049, found 200.1053. 
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6-Methoxy-10,10-dimethyl-1-oxaspiro[4.5]dec-6-ene (3-36).  General Protocol C.  A 
M solution in pentane) at -78 °C.  After 30 min, the reaction mixture was warmed to 0 °C for 30 min, 
recooled to -78 °C and treated with 2,2-dimethyl cyclopentanone.  The reaction mixture was warmed 
to ambient temperature and quenched after 6 h with aq. NaHCO3.  The aqueous layer was extracted 
with Et2O (3 x 10 mL) and the combined organic layers washed with H2O, brine, dried (Na2SO4), 
filtered, concentrated and the crude tertiary alcohol was used directly in the next step.  A solution of 
the crude tertiary alcohol in CH2Cl2 (100 mL) was treated with Dowex-50X resin (4.71 g, 0.528 
2
(1.32 g, 81% over two steps) as a colorless oil:  IR (neat) 2965, 2872, 1717, 1462, 1056 cm-1; 1H 
NMR δ 3.88-3.79 (m, 1 H), 3.73-3.66 (m, 1 H), 2.82-2.72 (m, 1 H), 2.29-2.19 (m, 2 H), 1.93-1.66 
(m, 6 H), 1.43-1.35 (m, 1 H), 0.96 (s, 3 H), 0.83 (s, 3 H); C NMR δ 212.1, 92.8, 68.7, 40.8, 37.3, 
36.0, 26.3, 25.9, 23.1, 22.3, 21.9; MS (EI) m/z (intensity) 182 ([M] ,30), 154 (8), 111 (63); HRMS 
(EI) m/z calculated for C11H18O2 182.1307, found 182.1299. 
According to General Protocol B, the -spiroether ketone (180 mg, 0.988 mmol), KHMDS 
(236 mg, 1.19 mmol), and Me2SO4 (249 mg, 1.98 mmol) furnished 3-44 (163 mg , 84%) as a 
colorless oil:  IR (neat) 2926, 1662, 1464, 1215, 1122, 1054 cm ; H NMR δ 4.56 (dd, 1 H, J = 3.8 
Hz), 3.99-3.92 (m, 1 H), 3.78-3.71 (m, 1 H), 3.47 (s, 3 H), 2.08-1.63 (m, 10 H), 1.29 (ddd, 1 H, J = 
12.9, 5.4, 5.4 Hz), 0.94 (s, 3 H), 0.86 (s, 3 H); 13C NMR δ 157.6, 93.6, 86.5, 69.8, 54.3, 37.6, 33.6, 
solution of 2,3-dihydrofuran in THF (90 mL) was treated with t-BuLi (10.7 mmol, 6.3 mL of a 1.7 
g/mmol) and stirred at ambient temperature for 24 h.  The mixture was filtered, concentrated and the 
residue purified by chromatography on SiO  (4:1 hexanes/EtOAc) to furnish the α-spiroether ketone 
13
+
α
-1 1
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30.0, 28.1, 23.1, 22.6, 20.6; MS (EI) m/z (intensity) 196 ([M]+, 14), 182 (7), 164 (27), 149 (43), 140 
(100); HRMS m/z calculated for C12H20O2 196.1463, found 196.1458. 
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(5S*,7S*)-Methyl 10,10-dimethyl-1,6-dioxaspiro[4.5]decane-7-carboxylate (3-45).  
According to General Protocol A, enol ether 3-44 (57 mg, 0.29 mmol), m-CPBA (200 mg of ~70% 
m-CPBA, 0.871 mmol) and Na2HPO4 (123 mg, 0.871 mmol) furnished, after 18 h and purification 
by chromatography on SiO2 (6:1 pentanes/Et2O), spiroketal 3-45 (32 mg, 48%) as a 2:1 mixture of 
diastereomers as indicated by NMR analysis:  Major diastereomer:  IR (neat) 2954, 2879, 1760, 
1740, 1439, 1205, 1064 cm-1; 1H NMR δ 4.40 (dd, 1 H, J = 11.1, 3.6 Hz), 3.94-3.86 (m, 2 H), 3.73 
(s, 3 H), 2.08-2.00 (m, 1 H), 1.96-1.62 (m, 6 H), 1.38-1.33 (m, 1 H), 1.07 (s, 3 H), 0.90 (s, 3 H); 13C 
NMR δ 172.9, 111.6, 69.3, 67.9, 51.9, 34.7, 34.1, 32.1, 25.4, 25.1, 23.9, 23.3; MS (EI) m/z 
(intensity) 228 ([M]+, 10), 213 (8), 198 (11), 169 (57), 142 (57); HRMS (EI) m/z calculated for 
C10H17O2 [M-CO2Me] 169.1229, found 169.1229.  Characteristic data for minor diastereomer:  1H 
NMR δ 4.17 (dd, 1 H, J = 5.1, 2.1 Hz), 3.74 (s, 3 H); 13C NMR δ 173.4, 112.1, 70.0, 68.7, 51.7, 35.1, 
32.2, 31.0, 25.0, 24.8, 23.4, 21.4. 
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 (1S*)-3-Methoxy-4',5'-dihydro-3'H-spiro[bicyclo[3.2.1]oct[3]ene-2,2'-furan] (3-46).  
According to General Protocol B, bicyclic α-spiroether ketone (430 mg, 2.39 mmol),147 KHMDS 
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(571 mg, 2.86 mmol) and Me2SO4 (451 mg, 3.58 mmol) furnished, after chromatography on SiO2 
(3:1 hexanes/EtOAc), enol ether 3-46 (308 mg, 67%) as a colorless oil:  IR (neat) 2941, 2864, 1647, 
1370, 1214, 1053 cm-1; 1H NMR δ 4.80 (d, 1 H, J = 7.1 Hz), 3.92 (ddd, 1 H, J = 7.8, 7.8, 4.8 Hz), 
3.72 (ddd, 1 H, J = 7.8, 7.8, 6.6 Hz), 3.41 (s, 3 H), 2.52-2.41 (m, 1 H), 2.22-1.34 (m, 10 H), 1.26-
1.19 (m 1 H); 13C NMR δ 155.8, 101.9, 86.7, 68.3, 54.1, 44.9, 34.5, 34.0, 32.1, 31.8, 27.4, 23.7; MS 
(EI) m/z (intensity) 194 ([M]+, 24), 162 (56), 153 (36), 135 (17); HRMS (EI) m/z calculated for 
C12H18O2 194.1307, found 194.1311. 
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(1S*,4S*)-Methyldihydro-3'H-3-oxaspiro[bicyclo[3.2.1]octane-2,2'-furan]-4-carboxylate 
(3-47).  According to General Protocol A, 3-46 (303 mg, 1.56 mmol), m-CPBA (1.08 g of ~70% m-
CPBA, 4.68 mmol), and Na2HPO4 (664 mg, 4.68 mmol) furnished, after 18 h and purification by 
chromatography on SiO2 (3:1 hexanes/EtOAc), spiroketal 3-47 (187 mg, 53%) as a single 
diastereomer as indicated by NMR analysis:  IR (neat) 2950, 2872, 1759, 1733, 1201, 1043 cm-1; 1H 
NMR δ 4.37 (s, 1 H), 3.93-3.85 (m, 2 H), 3.72 (s, 3 H), 2.41 (app t, 1 H, J = 5.1 Hz), 2.27 (app d, 1 
H, J = 11.1 Hz), 2.16-1.99 (m, 3 H), 1.88-1.77 (m, 1 H), 1.73-1.62 (m, 3 H), 1.59-1.42 (m, 3 H); 13C 
NMR δ 36.3, 33.1, 26.3, 24.1, 23.4; MS (EI) m/z 
(intensity) 226 ([M]+, 28), 138 (21), 108 (37); HRMS (EI) m/z calculated for C12H18O4 226.1205, 
found 226.1203. 
 
 171.9, 110.1, 75.6, 67.5, 51.8, 42.8, 37.8, 
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(1S,4aS,4bR,6aS,8R,10aS,10bS,12aS)-2,8-Dimethoxy-10a,12a-dimethyl-4a,4b,4',5,5'-
6,6a,7,8,9,10,10a,10b,11,12,12a-hexa-decahydro-3'H,4H-spiro-[chrysene-1,2'-furan] (3-48). 
C (hexanes/EtOAc); IR (KBr) 3399, 2930, 2865, 1716, 1452, 1052, 732 cm
Hz), 2.04-1.99 (m
 
According to General Protocol C, androsterone (1.0 g, 3.44 mmol), 2,3-dihydrofuran (507 mg, 7.23 
mmol), t-BuLi (4.5 mL of a 1.7 M solution in pentanes, 7.57 mmol), and Dowex 50X (1.82 g, 0.528 
g/mmol) furnished, after chromatography on SiO2 (6:1 hexanes/EtOAc), the α-spiroether ketone 
(754 mg, 61%) as a white solid and as a single diastereomer as determined by NMR analysis:  Mp 
196.8-198.5 ° -1; 1H NMR 
δ 3.99 (br s, 1 H), 3.72 (ddd, 1 H, J = 7.7, 7.0, 7.0 Hz), 3.57 (ddd, 1 H, J = 7.9, 6.8, 6.8 Hz), 2.86 
(ddd, 1 H, J = 13.5, 13.5, 7.2 Hz), 2.38 (ddd, 1 H, J = 6.5, 6.1, 6.1 Hz), 2.17 (dd, 1 H, J = 5.6, 2.8 
, 1 H), 1.83-1.69 (m, 5 H), 1.63-1.08 (m, 15 H), 0.94-0.83 (m, 2 H), 0.69 (s, 3 H), 
0.61 (s, 3 H) 13 δ
+
38), 361 (86), 272 (15); HRMS (ESI) m/z calculated for C H O Na [M+Na] 383.2562, found 
383.2545. 
According to General Protocol B, the α-spiroether ketone (754 mg, 2.09 mmol), KHMDS 
(918 mg, 4.60 mmol) and Me SO  (1.05 g, 8.37 mmol) furnished, after chromatography on SiO  (6:1 
hexanes/EtOAc), enol ether 3-48 (443 mg, 59%) as a white solid:  Mp 157.1-158.5 °C 
(hexanes/EtOAc); IR (KBr) 2934, 1671, 1447, 1362, 1212, 1092 cm-1; 1H NMR δ 4.60 (dd, 1 H, J = 
5.0, 1.0 Hz), 3.96 (ddd, 1 H, J = 7.7, 7.7, 2.6 Hz), 3.64-3.57 (m, 1 H), 3.46 (s, 3 H), 3.41 (br s, 1 H), 
; C NMR  211.3, 92.7, 68.5, 66.3, 53.3, 44.2, 43.3, 38.6, 37.0, 36.2, 36.0, 32.0, 31.3, 
31.2 (2 C), 29.1, 28.7, 26.3, 25.7, 23.1, 20.1, 14.7, 11.0; MS (ESI) m/z (intensity) 383 ([M+Na] , 
23 36 3
2 4 2
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3.27 (s, 3 H), 2.31-2.18 (m, 1 H), 2.13-1.93 (m, 2 H), 1.93-1.70 (m, 4 H), 1.66-1.32 (m, 10 H), 1.26-
1.03 (m, 5 H), 0.97-0.81 (m, 2 H), 0.77 (s, 3 H), 0.74 (s, 3 H); 13C NMR δ 156.4, 94.1, 87.5, 75.4, 
69.5, 55.5, 54.1, 52.6, 41.3, 40.8, 38.7, 36.8, 35.8, 32.6, 32.2, 30.7, 30.6, 28.6, 28.3, 27.2, 25.5, 25.0, 
20.0, 15.1, 11.2; MS (EI) m/z (intensity) 389 ([M+H]+, 12), 388 (50), 374 (11), 357 (10), 154 (66), 
141 (100); HRMS (EI) m/z calculated for C24H37O2 [M-OCH3] 357.2794, found 357.2797. 
 
O
O
CO2Me
MeO
H
H H
Me
Me H
 
(1'R,3'S,4a'S,4b'R,6a'S,8'R,10a'S,10b'S,12a'S)-Methyl 8'-methoxy-10a',12a'-dimethyl 
octa-deca-hydro-3H-spiro-[furan-2,1'-naphtho-[2,1-f]-isochromene]-3'-carboxylate (3-49).  
According to General Protocol A, enol ether 3-48 (443 mg, 1.24 mmol), m-CPBA (855 mg of ~70% 
m-CPBA, 3.72 mmol), Na2HPO4 (528 mg, 3.72 mmol) furnished, after 18 h and chromatography on 
SiO2 (3:1 hexanes/EtOAc), spiroketal 3-49 (396 mg, 76%) as a colorless oil and as a single 
diastereomer by NMR:  IR (neat) 2929, 1755, 1446, 1090, 732 cm-1; 1H NMR δ 4.38 (dd, 1 H, J = 
12.4, 3.2 Hz), 3.92-3.75 (m, 2 H), 3.70 (s, 3 H), 3.41-3.40 (m, 1 H), 3.27 (s, 3 H), 2.04-1.98 (m, 1 
H), 1.88-1.74 (m, 7 H), 1.68-1.09 (m, 14 H), 0.98 (s, 3 H), 0.91-0.81 (m, 2 H), 0.74 (s, 3 H); 13C 
NMR δ 172.9, 111.7, 75.4, 70.0, 67.7, 55.6, 53.1, 51.8, 42.9, 38.9, 38.8, 35.9, 35.0, 32.6, 32.4, 32.2, 
31.5, 30.5, 28.5, 27.4, 25.1, 23.8, 19.7, 15.8, 11.3; MS (EI) m/z (intensity) 421 ([M+H]+, 27), 361 
(51), 334 (80), 248 (100), 216 (95), 190 (87); HRMS (EI) m/z calculated for C25H41O5 [M+H] 
421.2954, found 421.2962. 
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5.4 ENANTIOSELECTIVE TOTAL SYNTHESIS OF DIAZONAMIDE A 
Br
N
Br
SiMe3Me3Si
 
 
2,6-Dibromo-N,N-bis(trimethylsilyl)benzenamine (4-53).  A solution of 2,6-
dibromoaniline 4-52 (15.7 g, 62.6 mmol) in THF  (400 mL) was treated with LDA (34.4 mL of a 2M 
solution, 68.8 mmol) at -78 °C.  After 5 min, TMSCl (9.53 mL, 75.1 mmol) was added.  After 15 
min, LDA (34.4 mL of a 2M solution, 68.8 mmol) was added and the reaction mixture was held at -
78 °C for 20 min.  TMSCl (9.53 mL, 75.1 mmol) was added and the reaction mixture was warmed to 
room temperature and quenched with aq. NaHCO3 (~100 mL).  The aqueous layer was washed with 
Et2O (3 x 100 mL) and the combined organic layers were washed with H2O, brine, dried (MgSO4), 
filtered, concentrated and purified by chromatography on SiO2 (hexanes) to furnish aniline 4-53 
(24.6 g, 100%) as a colorless oil:  IR (neat) 2953, 2898, 1422, 1251, 911 cm-1; 1H NMR δ 7.52 (d, 2 
H, J = 8.0 Hz), 6.75 (t, 1 H, J = 8.0 Hz), 0.18 (s, 18 H); 13C NMR δ 132.2 (2C), 127.8, 125.6, 2.6 
(6C); MS (EI) m/z (rel intensity) 380 ([M-CH3]+, 100, 301 (15); HRMS (EI) m/z calcd for 
C11H18BrNSi2 [M-CH3] 377.9345, found 377.9334. 
 
Br
NH2
I
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2-Bromo-6-iodobenzenamine (4-51).  A solution of aniline 4-53 (24.6 g, 62.6 mmol) in 
THF (400 mL) was treated with s-BuLi (93.9 mL of a 1.4 M solution, 131.4 mmol) at -78 °C.  After 
15 min, the reaction mixture was warmed to 0 °C, treated with 3M HCl (aq, ~200 mL) and 
vigorously stirred for 1 h.  The aqueous layer was extracted with Et2O (3 x 100 mL) and the 
combined organic layers were washed with H2O, brine, dried (Na2SO4), filtered and concentrated to 
yield crude aniline 4-55 which was immediately carried on to the next step.  A solution of 4-55 (15.3 
g, 62.6 mmol, based on 100% in previous reaction) in CH2Cl2 (340 mL) was cooled to -78 °C and 
treated with ICl (68.9 mL of a 1M solution, 68.9 mmol) over 30 minutes.  The reaction mixture was 
warmed to 0 °C and quenched with Na2S2O3 (aq, ~150 mL).  The organic layer was washed with 
H2O, brine, dried (Na2SO3), filtered, concentrated, and recrystallized from hexanes (3x) to furnish 
aniline 4-51 (16.8 g, 90% over two steps) as light brown needles:  IR (neat) 3416, 3317, 1607, 1448, 
1293, 1037, 754 cm-1; 1 H NMR δ 7.59 (dd, 1 H, J = 8.1, 1.5 Hz), 7.40 (dd, 1 H, J = 7.8, 1.2 Hz), 
6.33 (t, 1 H, J = 7.8 Hz), 4.59 (br s, 1 H); 13C NMR δ 144.1, 138.2, 132.8, 120.4, 107.3, 83.0; MS 
(ESI) m/z (rel intensity) 299 ([M+H]+, 15), 279 (31); HRMS (ESI) m/z calcd for C6H6BrIN [M+H] 
297.8728, found 297.8715. 
 
Bu3Sn
O
OEt
 
 
(E)-Ethyl 2-(tributylstannyl)but-2-enoate (4-57).  A solution of ethyl propiolate 4-56 
(4.44g, 39.6 mmol) in THF (200 mL, degassed) and Pd(PPh3)4 (915 mg, 0.792 mmol) at room 
temperature was treated with a solution  of Bu3SnH (11.7 mL, 43.55 mmol) in THF (40 mL, 
degassed) over 1 h.  After 1.5 h, TLC analysis indicated consumption of the starting material, and the 
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solvent was evaporated and the residue dissolved in hexanes (~200 mL).  After 1 h, the precipitates 
were filtered off and the filtrate concentrated.  A small portion of this material could be purified by 
chromatography on SiO2 (hexanes→9:1 hexanes/EtOAc) to provide stannane 4-57 (5:1 ratio of α:β 
regioisomers by 1H NMR) as a colorless oil, which was carried on to the next step without further 
purification:  IR 2957, 2926, 1708, 1461, 1180, 1036 cm-1; 1H NMR δ 6.16 (q, 1 H, J = 6.6 Hz), 4.14 
(q, 2 H, J = 7.2 Hz), 2.00 (d, 3 H, J = 6.6 Hz), 1.53-1.42 (m, 6 H), 1.35-1.21 (m, 12 H), 0.98-0.82 
(m, 12 H); 13C NMR δ 171.1, 147.9, 128.1, 59.9, 28.9, 27.2, 18.1, 14.3, 13.6, 10.2; HRMS (ESI) m/z 
calcd for C18H36O2SnNa [M+Na] 427.1635, found 427.1637.  Characteristic data for β isomer:  1H 
NMR δ 5.95 (q, 1 H, J = 1.8 Hz), 2.38 (d, 1 H, J = 1.8 Hz); 13C NMR δ 136.9, 59.4, 9.4. 
 
O
OEt
I
 
 
(E)-Ethyl 2-iodobut-2-enoate (4-58).  The crude stannane residue was dissolved in THF 
(~250 mL) and treated with a solution of I2 (13.7 g, 51.5 mmol) in THF (250 mL).  After 30 min, 
TLC analysis indicated consumption of the stannane and the solvent was removed.  The residue was 
dissolved in Et2O (200 mL) and stirred with semisaturated KF for 1 h.  Following, the solids were 
filtered off, and the aqueous layer extracted with Et2O (3 x 100 mL).  The combined organic layers 
were washed with H2O, brine, dried (MgSO4), filtered, concentrated, and the residue purified by 
chromatography on SiO2 (95:5 hexanes/Et2O) to provide iodide 4-58 (6.46 g, 68%) as a light yellow 
oil:  IR 2981, 1713, 1368, 1220, 1027 cm-1; 1H NMR δ 6.98 (q, 1 H, J = 9.0 Hz), 4.25 (q, 2 H, J = 
9.0 Hz), 1.99 (d, 3 H, J = 8.1 Hz), 1.32 (t, 3 H, J = 6.6 Hz); 13C NMR δ 163.8, 150.8, 85.5, 62.1, 
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19.3, 14.1; MS (EI) m/z (rel intensity) 240 ([M+H]+, 100), 212 (82), 195 (42); HRMS (EI) m/z calcd 
for C6H9O2I 239.9647, found 239.9638.  
 
OH
O
N
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(S)-tert-Butyl 4-(4-hydroxybenzyl)-2,2-dimethyloxazolidine-3-carboxylate (4-61).148  A 
suspension of salt 4-59 (10.0 g, 43.2 mmol) and NaHCO3 (7.25 g, 86.0 mmol) in THF/MeOH (200 
mL/60 mL) was treated with Boc2O (9.40 g, 43.2 mmol) at room temperature.  After 24 h, the 
reaction mixture was concentrated and the residue dissolved in CH2Cl2 (~150 mL) and washed with 
H2O, dried (MgSO4), filtered, and concentrated to give crude 4-60 which was used without further 
purification. This crude material was dissolved in THF (200 mL) and treated with LiBH4 (86.5 mL 
of a 2 M solution, 173 mmol) at 0 °C while vigorously stirring.  After 6 h, 3M HCl was added 
dropwise and the aqueous layer was extracted with EtOAc (3 x 100 mL).  The combined organic 
layers were washed with H2O, brine, dried (MgSO4), filtered and concentrated to furnish the crude 
alcohol which was used without further purification.  The crude alcohol was dissolved in 
dimethoxypropane/acetone (1:1, 160 mL) and treated with p-TsOH (821 mg, 4.32 mmol) at room 
temperature.  After 4 h, the reaction mixture was poured into H2O, and the aqueous layer was 
extracted with EtOAc (3 x 50 mL).  The combined organic layers were washed with brine, dried 
(MgSO4), filtered, concentrated and the solid recrystallized from hexanes (2x) to furnish phenol 4-61 
(9.37 g, 70% over three steps) as a white powder:  mp 104-106 °C (hexanes), lit. 107 °C; 1H NMR 
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(CD3CN, 333 K) δ 7.05 (d, 2 H, J = 8.4 Hz), 6.74 (d, 2 H, J = 8.4 Hz), 6.51 (s, 1 H), 4.02-3.92 (m, 1 
H), 3.81 (dd, 1 H, J = 9.0, 6.0 Hz), 3.71 (dd, 1 H, J = 8.7, 1.5 Hz), 2.99 (dd, 1 H, J = 13.2, 3.6 Hz), 
2.62 (dd, 1 H, J = 13.2, 9.6 Hz), 1.49 (s, 12 H), 1.44 (s, 3 H); [α]D23: -30.1 (c 1.0, EtOH), lit. -32.6 (c 
0.98, EtOH). 
 
MOMO
O
N
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(S)-tert-Butyl 4-(4-(methoxymethoxy)benzyl)-2,2-dimethyloxazolidine-3-carboxylate (4-
62).  A suspension of NaH (568 mg of 60% NaH, 14.2 mmol) was degreased with hexanes and 
suspended in THF (~30 mL).  A solution of phenol 4-61 (3.96 g, 12.9 mmol) in THF (~30 mL + 10 
mL rinse) was added via cannula to the NaH at room temperature.  After 30 min, the white solution 
was treated with TBAI (476 mg, 1.29 mmol) and MOMCl (2.55 mL, 33.5 mmol) was then added 
dropwise at 0 °C.  After 12 h, H2O was added to the reaction mixture and the aqueous layer was 
extracted with Et2O (3 x 25 mL).  The combined organic layers were washed with H2O, brine, dried 
(Na2SO4), filtered, concentrated and purified by chromatography on SiO2 (5:1 hexanes/EtOAc) to 
furnish MOM-ether 4-62 (4.12 g, 91%) as a colorless oil:  IR 2978, 2934, 1698, 1388, 1078, 857 cm-
1; 1H NMR (CD3CN, 353 K) δ 7.15 (d, 2 H, J = 8.7 Hz), 6.97 (d, 2 H, J = 8.4 Hz), 5.14 (s, 2 H), 
4.06-3.98 (m, 1 H), 3.83 (dd, 1 H, J = 9.0, 5.7 Hz), 3.73 (dd, 1 H, J = 9.0, 1.8 Hz), 3.43 (s, 3 H), 3.03 
(dd, 1 H, J = 13.2, 3.6 Hz), 2.68 (dd, 1 H, J = 13.2, 9.6 Hz), 1.50 (s, 12 H), 1.45 (s, 3 H); 13C NMR 
(CD3CN, 353 K) δ 157.4, 153.2, 133.6, 131.7 (2 C), 117.9 (2 C), 96.0, 94.9, 80.7, 67.4, 60.3, 56.5, 
 189 
39.7, 29.1 (3 C), 27.7, 24.6; MS (ESI) m/z (rel intensity) 375 ([M+Na]+, 6), 322 (47), 224 (42); 
HRMS (ESI) m/z calcd for C19H29NO5Na [M+Na] 374.1943, found 374.1956; [α]D23 -19.2 (c 1.0, 
CH2Cl2). 
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(S)-tert-Butyl 4-(3-((Z)-1-(ethoxycarbonyl)prop-1-enyl)-4-(methoxymethoxy)benzyl)-2,2-
dimethyloxazolidine-3-carboxylate (4-63).  A solution of MOM-ether 4-62 (1.30 g, 3.71 mmol) 
and distilled TMEDA (600 μL, 3.98 mmol) in THF (12 mL) were treated with n-BuLi (3.06 mL of a 
1.3 M solution, 3.98 mmol) at -78 °C.  The yellow reaction mixture was warmed to room 
temperature for 45 min and recooled to 0 °C, and a solution of freshly fused ZnCl2 (560 mg, 4.11 
mmol) in THF (~3 mL) was added via cannula.  After 15 min at 0 °C, a solution of vinyl iodide 4-58 
(636 mg, 2.65 mmol) and Pd(PPh3)4 (153 mg, 0.132 mmol) in THF (9 mL) was added via cannula 
and the reaction mixture was heated at 60 °C for 14 h.  The cooled reaction mixture was treated with 
aq. NaHCO3 and the aqueous layer extracted with Et2O (4 x 5 mL).  The combined organic layers 
were washed with brine, dried (MgSO4), filtered, concentrated and the residue purified by 
chromatography on SiO2 (3:1 hexanes/EtOAc) to furnish ester 4-63 (836 mg, 76% as a yellow oil:  
IR 2979, 2936, 1720, 1698, 1389, 1210, 1055 cm-1; 1H NMR (CD3CN, 333 K) δ 7.12 (dd, 1 H, J = 
9.0, 2.1 Hz), 7.07 (d, 1 H, J = 2.1 Hz), 7.00 (d, 1 H, J = 8.3 Hz), 6.24 (q, 1 H, J = 7.2 Hz), 5.07 (s, 2 
H), 4.20 (q, 2 H, J = 6.9 Hz), 4.07-3.98 (m, 1 H), 3.87 (dd, 1 H, J = 9.0, 6.0 Hz), 3.76 (dd, 1 H, J = 
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9.0, 1.8 Hz), 3.40 (s, 3 H), 3.01 (dd, 1 H, J = 13.2, 3.3 Hz), 2.73 (dd, 1 H, J = 13.2, 9.3 Hz), 2.05 (d, 
3 H, J = 7.2 Hz), 1.50 (s, 9 H), 1.45 (s, 6 H), 1.23 (t, 3 H, J = 7.2 Hz); 13C NMR (CD3CN, 333 K) δ 
169.1, 155.0, 153.7, 138.6, 134.9, 134.0, 133.0, 131.8, 131.6, 116.5, 96.9, 95.4, 81.2, 67.9, 61.8, 
60.6, 57.3, 29.6, 28.1 (3 C), 16.6, 15.4; MS (EI) m/z (rel intensity) 463 ([M]+, 8), 265 (13), 200 (46); 
HRMS (ESI) m/z calcd for C25H37NO7Na [M + Na] 486.2468, found 486.2454; [α]D23 -19.2 (c 1.0, 
CH2Cl2). 
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(S,Z)-tert-Butyl-4-(3-(1-(2-bromo-6-iodophenylamino)-1-oxobut-2-en-2-yl)-4-hydroxy 
benzyl)-2,2-dimethyloxazolidine-3-carboxylate (4-64).  A solution of AlMe3 (297mg, 0.998 
mmol) in CH2Cl2 (1 mL) was treated with a solution of aniline 4-51 (297 mg, 0.998 mmol) in 
CH2Cl2 (1 mL) at 0° C.  After 15 min, a white precipitate had formed.  The reaction mixture was 
treated with a solution of ester 4-63 (154 mg, 0.333 mmol) in CH2Cl2 (2 mL) and warmed to ambient 
temperature.  After 2 h, aq. Rochelle’s salt was added and the aqueous layer extracted with CH2Cl2 
(3 x 10 mL).  The combined organic layers were washed with brine, dried (Na2SO4), filtered, 
concentrated and the residue purified by chromatography on SiO2 (5:1 hex/EtOAc→3:1 hex/EtOAc) 
to provide anilide 4-64 (83 mg, 35%) as a colorless film which demonstrated hindered rotation by 1H 
NMR, even at elevated temperatures:  IR 3289, 2977, 1687, 1483, 1390, 1255 cm-1; 1H NMR 
(CD3CN, 353 K, reported as seen) δ 7.88 (dd, 1 H, J = 8.7, 1.8 Hz), 7.66 (dd, 1 H, J = 8.4, 1.5 Hz), 
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7.60-7.30 (br s, 1 H), 7.17-7.04 (m, 3 H), 6.94-6.86 (m, 2 H), 4.19-4.04 (br s, 1 H), 3.91-3.75 (m, 2 
H), 3.01 (dd, 1 H, J = 12.6, 4.8 Hz), 2.77 (dd, 1 H, J = 15.0, 10.2 Hz), 1.72 (d, 3 H, J = 6.6 Hz), 
1.50-1.38 (m, 15 H); 13C NMR (CD3CN, 353 K, reported as seen) δ 167.5, 154.7, 153.2, 140.3, 
139.9, 134.4, 133.6, 132.2, 131.7, 131.6, 124.5, 123.0, 117.7, 102.0, 94.9, 80.7, 67.8, 60.2, 39.7, 29.1 
(3 C), 28.0, 24.8, 15.7; MS (ESI) m/z (rel intensity) 693 ([M+Na]+, 100), 592 (44); HRMS (ESI) m/z 
calcd for C27H32BrIN2O5Na [M+Na] 693.0437, found 693.0423; [α]D23 -8.7 (c 1.0, CH2Cl2). 
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(S)-tert-Butyl 4-(4-hydroxy-3-iodobenzyl)-2,2-dimethyloxazolidine-3-carboxylate (4-67).  
A solution of iodotyrosine (4-65, 49.2 mmol) in MeOH (350 mL) was treated with SOCl2 (35.9 mL, 
492 mmol) over 30 min at 0 °C and then heated at 70 °C for 2 h.  The volume of the reaction was 
reduced to about one-third in vacuo and the remaining solution poured into anhydrous Et2O (500 
mL).  The resulting white precipitate was filtered off, dried in vacuo, and used directly in the next 
step.  A suspension of this white precipitate in THF/MeOH (300/120 mL) was treated with NaHCO3 
(8.26 g, 98.3 mmol) and Boc2O (10.7 g, 49.2 mmol) at ambient temperature.  After 24 h, the reaction 
mixture was concentrated to about one-third of its volume and partitioned between CH2Cl2 and H2O 
(200 mL/200 mL).  The aqueous layer was extracted with CH2Cl2 (3 x 100 mL) and the combined 
organic layers washed with brine, dried (Na2SO4), filtered, and concentrated to provide ester 4-66 as 
a colorless oil that was used directly in the next step.  A solution of 4-66 in THF (550 mL) was 
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treated dropwise with LiBH4 (96.5 mL of a 2 M solution, 193 mmol) at 0 °C.  The mixture was 
vigorously stirred and warmed to ambient temperature.  After 4 h, aq. HCl was added until all 
additional LiBH4 had been quenched.  The aqueous layer was extracted with EtOAc (3 x 100 mL) 
and the combined organic layers washed with brine, dried (Na2SO4), filtered, and concentrated to 
provide the intermediate reduced ester as a colorless oil which was used directly without further 
purification.  A solution of alcohol in acetone/2,2-dimethoxypropane (100 mL/100 mL) was treated 
with TsOH (918 mg, 4.82 mmol) at ambient temperature.  After 1 h, aq. NaHCO3 was added and the 
aqueous layer was extracted with EtOAc (4 x 100 mL).  The combined organic layers were washed 
with brine, dried (Na2SO4), filtered, concentrated, and the residue purified by chromatography on 
SiO2 (3:1 hexanes/EtOAc) to provide phenol 4-67 (19.6 g, 93% over four steps) as a colorless oil:  
IR 3307, 2979, 2935, 1663, 1409, 1253, 1097 cm-1; 1H NMR (CD3CN, 353 K) δ 7.57 (d, 1 H, J = 2.1 
Hz), 7.08 (dd, 1 H, J = 8.1, 2.1 Hz), 7.03 (br s, 1 H), 6.84 (d, 1 H, J = 8.1 Hz), 4.03-3.94 (m, 1 H), 
3.85 (dd, 1 H, J = 8.4, 6.0 Hz), 3.72 (dd, 1 H, J = 9.0, 1.5 Hz), 2.92 (dd, 1 H, J = 13.5, 3.6 Hz), 2.67 
(dd, 1 H, J = 13.2, 9.0 Hz), 1.49 (s, 9 H), 1.47 (s, 3 H), 1.44 (s, 3 H); 13C NMR (CD3CN, 353 K) δ 
155.9, 153.2, 141.1, 133.9, 132.1, 116.3, 94.9, 84.8, 80.7, 67.4, 60.0, 38.8, 29.0 (3 C), 27.6, 24.4; 
MS (EI) m/z (rel intensity) 433 ([M]+, 19), 360 (17), 233 (53); HRMS (EI) m/z calcd for C17H24INO4 
433.0750, found 433.0746; [α]D23 -21.4 (c 1.0, CH2Cl2). 
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(S)-tert-Butyl-(3-((Z)-1-(ethoxycarbonyl)prop-1-enyl)-4-(benzyloxy)benzyl)-2,2-dimethyl 
oxazolidine-3-carboxylate (4-69).  A solution of phenol 4-67 (7.69 g, 17.7 mmol) in THF (200 mL) 
was treated with NaH (1.06 g of 60% NaH in oil, 26.6 mmol) at 0 °C and the resulting slurry stirred 
for 30 min.  TBAI (655 mg, 1.77 mmol) and BnBr (5.28 mL, 44.4 mmol) were added and the 
reaction mixture was warmed to ambient temperature.  After 14 h, aq. NH4Cl was added and the 
aqueous layer was extracted with Et2O (3 x 50 mL).  The combined organic layers were washed with 
H2O, brine, dried (Na2SO4), filtered, concentrated and purified by chromatography on SiO2 (6:1 
hexanes/EtOAc) to proved benzyl ether 4-68 (8.04 g, 87%) as a yellow oil that was used directly in 
the next step.  A solution of benzyl ether 4-68 (624 mg, 1.19 mmol), stannane 4-57 (438 mg, 1.08 
mmol) and LiCl (138 mg, 3.24 mmol) were dissolved/suspended in DMF (3 mL).  Pd(PPh3)4 (37.9 
mg, 0.054 mmol) was added and the mixture was degassed by F-P-T (3 x).  The reaction mixture 
was heated to 85 °C for 18 h.  Following, the cooled reaction mixture was partitioned between H2O 
and Et2O (10 mL/10 mL).  The aqueous layer was extracted with Et2O (3 x 10 mL) and the 
combined organic layers were washed with H2O, brine, dried (Na2SO4), filtered, concentrated and 
the residue purified by chromatography on SiO2 (5:1 hexanes/EtOAc) to provide ester 4-69 as a 
colorless oil and approximately 2:1 mixture of regioisomers (α:β) by 1H NMR:  IR 2979, 2395, 
1697, 1389, 1259, 1095, 1026 cm-1; 1H NMR (CD3CN, 353 K, reported as seen) δ 7.56-7.30 (m, 4 
H), 7.22-6.97 (m, 3 H), 6.96 (m, 1 H), 6.27 (q, 1 H, J = 7.2 Hz), 5.13-5.08 (m, 0.5 H), 5.07-5.03 (m, 
1.5 H), 4.10 (q, 2 H, J = 7.2 Hz), 4.11-4.03 (m, 1 H), 3.93-3.84 (m, 1 H), 3.83-3.75 (m, 1 H), 3.12-
2.98 (m, 1 H), 2.84-2.69 (m, 1 H), 2.48 (d, 1 H, J = 1.2 Hz), 2.08 (d, 2 H, J = 7.2 Hz), 1.58-1.48 (m, 
15 H), 1.31 (t, 1 H, J = 7.2 Hz), 1.18 (t, 2 H, J = 7.2 Hz); 13C NMR (CD3CN, 353 K) δ 168.6, 156.3, 
153.4, 138.9, 138.2, 134.7, 132.8, 131.2, 129.9, 129.7 (2 C), 129.1, 128.9, 128.8 (2 C), 114.2, 95.1, 
80.8, 72.0, 67.7, 61.3, 60.3, 39.6, 29.3 (3 C), 27.8, 25.0, 16.2, 14.9 ; MS (ESI) m/z (rel intensity) 532 
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([M+Na]+, 4), 432 (100), 365 (14); HRMS (ESI) m/z calcd for C30H39NO6Na [M+Na] 532.2675, 
found 532.2674; [α]D23 -14.7 (c 1.0, CH2Cl2). 
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(S)-tert-Butyl-4-(3-((E)-1-(methoxycarbonyl)prop-1-enyl)-4-(benzyloxy)benzyl)-2,2-
dimethyloxazolidine-3-carboxylate (4-72).  A solution of benzyl ether 4-68 (539 mg, 1.03 mmol), 
pinacolato diboron (288 mg, 1.13 mmol), PdCl2dppf-CH2Cl2 (168 mg, 0.206 mmol), and KOAc (303 
mg, 3.09 mmol) in DMSO (5 mL) was stirred for 12 h.  Following, H2O was added and the solution 
was extracted with EtOAc (3 x 10 mL) and the combined organic layers were washed with brine, 
dried (Na2SO4), filtered, concentrated and the residue purified by chromatography in SiO2 (1:1 
hexanes/EtOAc) to proved boronate ester 4-70 (378 mg, 70%) as a colorless oil which was used 
directly in the next step.  A solution of vinyl iodide 4-71149 (147 mg, 0.65 mmol), boronate 4-70 
(374 mg, 0.715 mmol), K2CO3 (155 mg, 1.12 mmol), and PdCl2dppf-CH2Cl2 (45.9 mg, 0.056 mmol) 
in DME (6 mL) was heated at 50 °C for 8 h.  The cooled reaction mixture was diluted with H2O and 
extracted with EtOAc (3 x 10 mL).  The combined organic layers were washed with H2O, brine, 
dried (Na2SO4), filtered, concentrated and the residue purified by chromatography on SiO2 (3:1 
hexanes/EtOAc) to provide ester 4-72 (165 mg, 51%) as a colorless oil which demonstrated evidence 
of hindered rotation by 1H NMR, even at elevated temperatures:  IR 2978, 2873, 1699, 1389, 1259, 
736 cm-1; 1H NMR (CD3CN, 353 K) δ 7.40-7.33 (m, 3 H), 7.27-7.24 (m, 1 H), 7.19-7.13 (m, 2 H), 
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7.10-6.99 (m, 2 H), 6.98-6.94 (m, 1 H), 5.05-5.01 (m, 2 H), 4.08-3.92 (m, 1 H), 3.89-3.81 (m, 1 H), 
3.79-3.71 (m, 1 H), 3.68 (s, 0.5 H), 3.63 (s, 2.5 H), 3.03 (dd, 1 H, J = 13.2, 3.0 Hz), 2.73 (dd, 1 H, J 
= 13.2, 9.6 Hz), 1.69 (d, 3 H, J = 6.9 Hz), 1.52-1.48 (m, 8 H), 1.48-1.43 (m, 7 H); 13C NMR 
(CD3CN, 353 K) δ 168.6, 156.6, 153.2, 140.7, 138.9, 133.7, 132.2, 131.3, 129.7 (2 C), 129.6, 129.1, 
128.7 (2 C), 126.4, 114.2, 94.9, 80.7, 71.6, 67.3, 60.2, 52.4, 39.5, 29.1 (3 C), 27.7, 24.7, 15.9; MS 
(ESI) m/z (rel intensity) 518 ([M+Na]+, 100), 418 (100); HRMS (ESI) m/z calcd forC29H37NO6Na 
[M+Na] 518.2519, found 518.2534; [α]D23 -16.3 (c 1.0, CH2Cl2). 
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(S)-tert-Butyl-4-(3-iodo-4-(methoxymethoxy)benzyl)-2,2-dimethyloxazolidine-3-carboxyl 
ate (4-74).  A solution of phenol 4-67 (24.3 g, 56.1 mmol) in THF (500 mL) was treated with NaH 
(3.36 g of 60% NaH in grease, 84.0 mmol) portionwise at 0 °C.  After 45 min, solid TBAI (2.07 g, 
5.61 mmol) was added, followed by MOMCl (12.8 mL, 169 mmol) dropwise.  After 6 h at room 
temperature, the reaction was quenched by the addition of H2O and the aqueous layer was extracted 
with Et2O (3 x 100 mL).  The combined organic layers were washed with H2O, brine, dried 
(MgSO4), filtered, and concentrated.  The bulk of the crude MOM ether was carried on crude, but an 
analytical sample was purified by chromatography on SiO2 (6:1 hexanes/EtOAc) to provide 4-74 as 
a colorless oil:  IR (neat) 2976, 2930, 1697, 1388, 1241, 1085, 992 cm-1; 1H NMR (DMSO-d6, 353 
K) δ 7.60 (d, 1 H, J = 2.1 Hz), 7.15 (dd, 1 H, J = 8.4, 2.1 Hz), 7.02 (d, 1 H, J = 8.1 Hz), 5.19 (s, 2 H), 
4.02-3.93 (m, 1 H), 3.84 (dd, 1 H, J = 9.0, 6.0 Hz), 3.69 (dd, 1 H, J = 9.0, 1.8 Hz), 3.43 (s, 3 H), 2.88 
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(dd, 1 H, J = 13.2, 3.6 Hz), 2.67 (dd, 1 H, J = 13.2, 8.7 Hz), 1.44 (s, 9 H), 1.42 (s, 3 H), 1.41 (s, 3 H); 
13C NMR (DMSO-d6, 353 K) δ 154.0, 150.8, 139.2, 133.5, 129.9, 114.9, 94.7, 92.8, 86.9, 78.7, 65.6, 
57.7, 55.5, 37.0, 27.7 (3 C), 26.2, 23.4; MS (EI) m/z (rel intensity); HRMS (EI) m/z calcd for 
C19H28NO5Na [M+ Na] 500.0910, found 500.0886; [α]D23: -24.1 (c = 1.0, CH2Cl2). 
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(S)-tert-Butyl 4-(4-(methoxymethoxy)-3-(prop-1-ynyl)benzyl)-2,2-dimethyloxazolidine-
3-carboxylate (4-75).  A solution of MOM-ether 4-74 (26.8 g, 56.1 mmol based on 100% from 
previous reaction), PdCl2(PPh3)2 (787 mg, 1.12 mmol), and CuI (1.60 g, 8.4 mmol) was dissolved in 
CH3CN/Et2NH (400 mL/100 mL) and cooled to -20 °C.  A cold-finger containing dry ice/acetone 
was attached to the flask and a 25 g (625 mmol) container of propyne was condensed into the 
reaction mixture.  Following, the reaction mixture was warmed to room temperature, stirred for 12 h, 
and the volatile components evaporated. The residue was dissolved in boiling hexanes and then 
cooled to room temperature.  The precipitates were filtered off (celite) and the orange filtrate was 
concentrated and carried to the next step without further purification.  An analytical sample was 
purified by chromatography on SiO2 (6:1 hexanes/EtOAc) to provide 4-75 as a colorless oil:  IR 
(neat) 2978, 2234, 1740, 1701, 1078, 998 cm-1; 1H NMR (DMSO-d6, 353 K) δ 7.15 (d, 1 H, J = 2.1 
Hz), 7.08 (dd, 1 H, J = 8.7, 2.1 Hz), 7.02 (d, 1 H, J = 8.4 Hz), 5.17 (s, 2 H), 4.10-3.93 (m, 1 H), 3.83 
(dd, 1 H, J = 9.0, 6.0 Hz), 3.68 (dd, 1 H, J = 9.0, 1.8 Hz), 3.42 (s, 3 H), 2.90 (dd, 1 H, J = 13.2, 3.6 
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Hz), 2.64 (dd, 1 H, J = 13.2, 9 Hz), 2.04 (s, 3 H), 1.45 (s, 9 H), 1.43 (s, 3 H), 1.41 (s, 3 H); 13C NMR 
(DMSO-d6, 353 K) δ 155.6, 150.8, 133.3, 131.4, 129.3, 115.6, 114.0, 94.7, 92.7, 89.3, 78.7, 75.6, 
65.6, 57.7, 55.2, 37.3, 27.7 (3 C), 26.3, 23.4, 3.5; MS (EI) m/z (rel intensity) 390 ([M+H]+, 8), 389 
([M]+, 30), 200 (68); HRMS (EI) m/z calcd for C22H31NO5 389.2202, found 389.2196; [α]D23 -44.4 (c 
1.0, CH2Cl2). 
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(S)-tert-Butyl 4-(3-((E)-1-iodoprop-1-enyl)-4-(methoxymethoxy)benzyl)-2,2-dimethyl 
oxazolidine-3-carboxylate (4-76).  A solution of alkyne 4-75 (21.9 g, 56.1 mmol based on 100% 
from previous reaction) and PdCl2(PPh3)2 (1.18 g, 1.68 mmol) in THF (220 mL, degassed) at room 
temperature was treated with a solution of Bu3SnH (18.1 mL, 67.4 mmol) in THF (40 mL, degassed) 
dropwise.  Once the addition was finished, the reaction mixture was evaporated and the residue 
dissolved in hexanes (~400 mL), filtered through celite, and the filtrate evaporated.  The residue was 
dissolved in THF (300 mL) and treated with a solution of I2 (18.5 g, 72.9 mmol) in THF (100 mmL) 
over 30 min.  Following, the reaction mixture was treated with aq. Na2S2O3 and the aqueous layer 
was extracted with Et2O (3 x 100 mL).  The combined organic layers were washed with brine, dried 
(MgSO4), filtered, concentrated and purified by chromatography on SiO2 (6:1→3:1 hexanes/EtOAc, 
3x) to provide vinyl iodide 4-76 (20.6 g, 71% over 8 steps) as a yellow oil:  IR (neat) 2976, 1696, 
1390, 1309, 1168, 1000, 923 cm-1; 1H NMR (DMSO-d6, 353 K) δ 7.10 (dd, 1 H, J = 8.4, 2.1 Hz), 
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7.02 (d, 1 H, J = 8.4 Hz), 6.95 (d, 1 H, J = 2.1 Hz) 6.51 (q, 1 H, J = 6.9 Hz), 5.18 (s, 2 H), 4.01-3.93 
(m, 1 H), 3.85 (dd, 1 H, J = 8.7, 6.0 Hz), 3.70 (dd, 1 H, J = 9.0, 1.8 Hz), 3.43 (s, 3 H), 2.91 (dd, 1 H, 
J = 13.2, 3.3 Hz), 2.70 (dd, 1 H, J = 13.5, 9.0 Hz), 1.47 (s, 9 H), 1.45 (d, 3 H, J = 6.6 Hz), 1.41 (s, 3 
H), 1.39 (s, 3 H); 13C NMR (DMSO-d6, 353 K) δ 151.3, 150.8, 138.1, 130.9, 130.3, 130.2, 129.9, 
114.9, 94.0, 92.8, 89.7, 78.7, 65.4, 57.7, 55.4, 37.2, 27.7 (3 C), 26.2, 23.4, 16.9; MS (ESI) m/z (rel 
intensity) 540 ([M+Na]+, 13), 500 (100), 430 (53); HRMS (ESI) m/z calcd for C22H32INO5Na 
540.1223 [M+Na], found 540.1224; [α]D23 -43.9 (c 1.0, CH2Cl2). 
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(S)-tert-Butyl 4-(3-((E)-1-(methoxycarbonyl)prop-1-enyl)-4-(methoxymethoxy)benzyl)-
2,2-dimethyloxazolidine-3-carboxylate (4-77).  A solution of alkenyl iodide 4-76 (10.2 g, 19.7 
mmol), DIPEA (13.7 mL, 78.9 mmol), PdCl2(PPh3)2 (692 mg, 0.986 mmol), and MeOH (23.9 mL, 
591 mmol) was purged with CO for 30 min and then heated at 60 °C under a balloon of CO for 8 h.  
The cooled reaction mixture was poured into brine (500 mL) and the mixture extracted with Et2O (5 
x 150 mL).  The combined organic layers were washed with brine, dried (MgSO4), filtered, 
concentrated, and the residue purified by chromatography on SiO2 (5:1→3:1 hexanes/EtOAc) to 
furnish ester 4-77 (4.87 g, 55%) as a yellow oil:  IR (neat) 2978, 1718, 1697, 1389, 1258, 1077 cm-1; 
1H NMR (DMSO-d6, 353 K) δ 7.12 (dd, 1 H, J = 8.4, 2.1 Hz), 7.05 (d, 1 H, J = 8.4 Hz), 7.01 (q, 1 H, 
J = 6.9 Hz), 6.88 (d, 1 H, J = 2.1 Hz), 5.05 (s, 2 H), 4.02-3.93 (m, 1 H), 3.85 (dd, 1 H, J = 9.0, 6.0 
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Hz), 3.72 (dd, 1 H, J = 9.0, 1.8 Hz), 3.62 (s, 3 H), 3.32 (s, 3 H), 2.95 (dd, 1 H, J = 13.2, 3.3 Hz), 2.69 
(dd, 1 H, J = 13.2, 9.3 Hz), 1.65 (d, 3 H, J = 7.2 Hz), 1.46 (s, 9 H), 1.41 (s, 6 H); 13C NMR (DMSO-
d6, 353 K) δ 166.2, 152.8, 150.8, 138.8, 131.4, 131.1, 130.7, 129.2, 124.7, 114.6, 94.2, 92.8, 78.7, 
65.4, 57.9, 55.0, 50.9, 37.3, 27.7 (3 C), 26.2, 23.4, 14.5; MS (ESI) m/z (rel intensity) 472 ([M+Na]+, 
100), 416 (46); HRMS (ESI) m/z calcd for C24H35NO7Na  472.2311 [M+Na], found 472.2291; [α]D23 
-23.6 (c 1.0, CH2Cl2). 
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(S,E)-tert-Butyl-4-(3-(1-(2-bromo-6-iodophenylamino)-1-oxobut-2-en-2-yl)-4-hydroxy 
benzyl)-2,2-dimethyloxazolidine-3-carboxylate (4-78).  A solution of aniline 4-51 (9.55 g, 32.1 
mmol) in CH2Cl2 (60 mL) was added to a solution AlMe3 (2.31 g, 32.1 mmol, neat) in CH2Cl2 (40 
mL) at 0 °C.  After 1 h at room temperature, a white precipitate had formed.  A solution of ester 4-77 
(4.80 g, 10.7 mmol) in CH2Cl2 (60 mL) was added and the reaction mixture was immediately heated 
to reflux and held for 45 min.  The cooled reaction mixture was treated slowly with aq. Rochelle’s 
salt and stirred for 3 h.  The aqueous layer was extracted with CH2Cl2 (3 x 100 mL) and the 
combined organic layers were dried (MgSO4), filtered, concentrated and purified by chromatography 
on SiO2 (3:1→2:1 hexanes/EtOAc) to provide the anilide 4-78 (3.82 g, 53%) as a white foam:   mp 
94.5-102.6 °C (CH2Cl2); IR (neat) 3284, 2978, 1686, 1482, 1390, 1256 cm-1; 1H NMR (DMSO-d6, 
353 K) δ 8.98 (br s, 1 H), 8.74 (s, 1 H), 7.87 (dd, 1 H, J = 8.1, 1.5 Hz), 7.66 (dd, 1 H, J = 9.0, 1.2 
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Hz), 7.01-6.84 (m, 5 H), 4.03-4.00 (m, 1 H), 3.83 (dd, 1 H, J = 9.0, 6.0 Hz), 3.76 (dd, 1 H, J = 8.7, 
1.8 Hz), 2.96 (dd, 1 H, J = 13.2, 9.0 Hz), 2.65 (dd, 1 H, J = 13.2, 9.0 Hz), 1.66 (d, 3 H, J = 6.9 Hz), 
1.45 (s, 12 H), 1.41 (s, 3 H); 13C NMR (DMSO-d6, 353 K) δ 165.3, 153.1, 150.8, 138.6, 137.7, 134.2 
(2 C), 132.2, 131.4, 129.5, 129.3, 128.0, 122.5, 121.6, 115.6, 100.8, 92.6, 78.5, 65.5, 58.0, 37.5, 27.7 
(3 C), 26.3, 23.5, 14.2; MS (ESI) m/z (rel intensity) 695 ([M+Na]+, 20), 693 ([M+Na]+, 20), 572 
(95), 571 (100); HRMS (ESI) m/z calcd for C27H32BrIN2O5 Na 693.0437 [M+Na], found 693.0425; 
[α]D23 -27.3 (c 1.0, CH2Cl2).   
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(S)-tert-Butyl 4-(3-((E)-1-(N-benzyl-N-(2-bromo-6-iodophenyl)carbamoyl)prop-1-enyl)-
4-(benzyloxy)benzyl)-2,2-dimethyloxazolidine-3-carboxylate (4-79).  A solution of anilide 4-78 
(6.80 g, 10.1 mmol) in THF (100 mL) was treated with NaH (1.22 g of 60% NaH, 30.4 mmol) at 0 
°C.  After 30 min, the reaction mixture was treated with TBAI (374 mg, 1.01 mmol) and BnBr (6.01 
mL, 50.6 mmol) and heated to 65 °C for 30 min.  The cooled reaction mixture was quenched by the 
addition of H2O and the aqueous layer was extracted with Et2O (4 x 30 mL) and the combined 
organic layers were washed with brine, dried (MgSO4), filtered, concentrated and purified by 
chromatography on SiO2 (3:1 hexanes/EtOAc) to provide anilide 4-79 (7.24 g, 84%) as a white foam 
and several atropdiastereomers as indicated by 1H NMR analysis:  mp 73.6-78.0 °C (CH2Cl2); IR 
(neat) 2977, 2934, 1696, 1653, 1434, 1388, 1254, 734 cm-1; 1H NMR (DMSO-d6, 353 K, reported as 
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seen) δ 7.58 (dd, 1 H, J = 9.0, 3.9 Hz), 7.47-7.44 (m, 5 H), 7.43-7.25 (m, 3.5 H), 7.23-7.12 (m, 6 H), 
7.08-7.01 (m, 1 H), 7.01-6.93 (m, 1 H), 6.93-6.84 (m, 1 H), 6.76-6.64 (m, 1.5 H), 6.58 (app q, 1 H, J 
= 5.4 Hz), 6.35-6.23 (m, 1 H), 5.18 (s, 0.5 H), 5.00-4.92 (m, 2 H), 4.90-4.68 (m, 3 H), 4.05-3.97 (m, 
1 H), 3.90-3.70 (m, 3 H), 3.66-3.58 (m, 1 H), 3.12-2.98 (m, 1 H), 2.89-2.68 (m, 1 H), 2.46-2.33 (m, 1 
H), 1.69 (d, 1 H, J = 7.5 Hz), 1.47 (s, 9 H), 1.47-1.45 (m, 2.5 H), 1.44 (s, 2 H), 1.41 (s, 1.5 H); 13C 
NMR (DMSO-d6, 353 K, reported as seen) δ 168.6, 153.9, 150.7, 141.5, 138.9, 136.8, 136.0, 134.8, 
134.7, 133.0, 130.0, 129.8, 129.7, 129.0, 128.9, 128.8, 127.7, 127.5, 127.1, 127.0, 126.7, 126.5, 
124.1, 122.7, 112.0, 102.2, 92.7, 78.6, 68.8, 65.3, 57.8, 57.8, 51.5, 37.4, 27.8, 36.4, 23.4, 14.1; 
HRMS (ESI) m/z calcd for C41H45BrIN2O5 [M+H] 851.1557, found 851.1592; [α]D23 -11.0 (c 0.5, 
CH2Cl2). 
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(S)-tert-Butyl-4-(3-((S)-1-benzyl-7-bromo-2-oxo-3-vinylindolin-3-yl)-4-(benzyloxy)benz-
yl)-2,2-dimethyloxazolidine-3-carboxylate (4-80).  A mixture of amide 4-79 (3.00 g, 3.52 mmol), 
Pd2dba3-CHCl3 (365 mg, 0.352 mmol), (S)-BINAP (483 mg, 0.775 mmol), and PMP (2.55 mL, 14.1 
mmol) in freshly distilled NMP (35 mL) was degassed (F-P-T, 3x).  The reaction mixture was heated 
at 110 °C for 3.5 h, at which time HPLC indicated completion of the reaction.  The cooled reaction 
mixture was poured into Et2O (50 mL) and H2O (50 mL).  The aqueous layer was extracted with 
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Et2O (3 x 50 mL), and the combined organic layers were washed with H2O (5x), brine, dried 
(MgSO4), filtered, concentrated and purified by chromatography on SiO2 (3:1 hexanes/EtOAc) to 
furnish oxindole 4-80 (2.14 g, 84%) as a white foam which was 77:23 mixture of diastereomers by 
HPLC:  mp 77.5-84.2 °C (CH2Cl2); IR (neat) 2978, 2872, 1725, 1697, 1388, 1257, 1017, 738 cm-1; 
1H NMR (DMSO-d6, 353 K) δ 7.40-7.32 (m, 4 H), 7.30 (d, 1 H, J = 1.8 Hz), 7.26-7.12 (m, 4 H), 
7.08-6.80 (m, 7 H), 6.30 (dd, 1 H, J = 17.4, 10.2 Hz), 5.40 (d, 1 H, J = 10.2), 4.93 (d, 1 H, J = 17.1 
Hz), 4.85-4.71 (m, 3 H), 4.64 (d, 1 H, J = 16.8 Hz), 4.10-3.98 (m, 1 H), 3.88 (dd, 1 H, J = 9.0, 5.7 
Hz), 3.76 (dd, 1 H, J = 9.0, 1.5 Hz), 3.05-2.98 (m, 1 H, signal obscured by H2O contaminating 
DMSO), 2.78-2.68 (m, 1 H), 1.48 (s, 9 H), 1.47 (s, 3 H), 1.44 (s, 3 H); 13C NMR δ 176.7, 153.8, 
150.8, 139.8, 137.8, 137.0, 135.7, 133.8, 132.9, 129.9, 129.8, 129.3, 128.0 (2 C), 127.8 (2 C), 127.6, 
127.4, 127.3 (2 C), 126.2, 125.4 (2 C), 123.1, 123.0, 117.1, 112.2, 101.1, 92.8, 78.7, 69.6, 65.4, 58.0, 
57.0, 43.0, 37.7, 27.8 (3 C), 26.4, 23.3; HRMS (ESI) m/z calcd for C41H43BrN2O5Na [M+Na] 
745.2253, found 745.2269; [α]D23 +86.9 (c 1.0, CH2Cl2). 
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(S)-tert-Butyl 4-(3-((S)-1-benzyl-7-bromo-3-vinylindolin-3-yl)-4-(benzyloxy)benzyl)-2,2-
dimethyloxazolidine-3-carboxylate (4-82).  A solution of oxindole 4-80 (5.05 g, 6.99 mmol) in 
THF (10 mL) was treated with DIBAL (28.0 mL of a 1 M solution, 28.0 mmol) at room temperature.  
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The reaction mixture was heated at reflux for 40 min and cooled to room temperature upon 
consumption of the starting material.  The cooled reaction mixture was treated with aq. Rochelle’s 
salt and stirred for 3 h.  The aqueous layer was extracted with Et2O (3 x 30 mL) and the combined 
organic layers washed with brine, dried (MgSO4), filtered, concentrated and purified by 
chromatography on SiO2 (5:1 hexanes/EtOAc) to provide hydroindole 4-82 (3.78 g, 76%) as a white 
foam:  mp 46.2-54.1 °C (CH2Cl2); IR (neat) 2977, 2933, 2873, 1697, 1388, 1095, 735 cm-1; 1H NMR 
(DMSO-d6, 353 K) δ 7.34-7.18 (m, 9 H), 7.15-7.12 (m, 2 H), 7.08 (dd, 1 H, J = 8.4, 1.8 Hz), 7.05-
7.00 (m, 1 H), 6.92 (d, 1 H, J = 1.8 Hz), 6.82 (dd, 1 H, J = 7.2, 1.2 Hz), 6.63 (dd, 1 H, J = 7.5, 7.5 
Hz), 6.21 (dd, 1 H, J = 17.1, 10.5 Hz), 5.06 (dd, 1 H, J = 10.5, 0.9 Hz), 4.96 (d, 1 H, J = 11.7 Hz), 
4.85 (d, 1 H, J = 12.0 Hz), 4.76 (app t, 2 H, J = 15.3 Hz), 4.34 (d, 1 H, J = 15.6 Hz), 3.98-3.87 (m, 1 
H), 3.83-3.78 (m, 2 H), 3.68-3.60 (m, 2 H), 2.89 (dd, 1 H, J = 13.5, 3.6 Hz), 2.60 (dd, 1 H, J = 13.2, 
9.0 Hz), 1.43 (s, 3 H), 1.42 (s, 9 H), 1.41 (s, 3 H); 13C NMR (DMSO-d6, 353 K) δ 154.3, 150.7, 
147.5, 142.8, 138.3, 137.5, 136.4, 132.3, 131.9, 129.2, 129.0, 128.6, 127.6(4) (2 C), 127.6(0) (2 C), 
127.0, 126.9 (2 C), 126.8 (2 C), 126.2, 124.0, 119.0, 112.9, 112.3, 102.2, 92.7, 78.5, 69.4, 65.4, 64.3, 
57.8, 53.5, 52.9, 37.7, 27.7 (3 C), 26.3, 23.3; MS (ESI) m/z (rel intensity) 711 ([M+H]+, 48), 709 
([M+H]+, 48), 574 (100); HRMS (ESI) m/z calcd for C41H46BrN2O4 709.2641, found 709.2645; 
[α]D23 -2.5 (c 1.0, CH2Cl2).  Characteristic data for minor diastereomer:  1H NMR (DMSO-d6, 353 
K) δ 6.81 (dd, 1 H, J = 7.2, 1.2 Hz), 6.62 (dd, 1 H, J = 7.5, 7.5 Hz), 5.07 (dd, 1 H, J = 10.5, 0.9 Hz), 
4.33 (d, 1 H, J = 15.6 Hz); 13C NMR (DMSO-d6, 353 K) δ 137.6, 129.0, 128.5, 123.9, 27.7. 
 
 204 
N
Bn
Br
BnO
O
BocN
O
H
 
 
(S)-tert-Butyl 4-(3-((R)-1-benzyl-7-bromo-3-formylindolin-3-yl)-4-(benzyloxy)benzyl)-
2,2-dimethyloxazolidine-3-carboxylate (4-83).  A solution of hydroindole 4-82 (3.76 g, 5.31 
mmol) in THF/Acetone/pH 7 phosphate buffer (6/6/6 mL) was treated with NMO (1.06 g, 7.96 
mmol) and OsO4 (2.41 mL of a 0.33 M solution, 0.796 mmol) at room temperature.  After 8 h, aq. 
NaHSO3 was added and the mixture extracted with EtOAc (3 x 80 mL).  The combined organic 
layers were washed with brine, dried (MgSO4), filtered, and concentrated.  The crude residue was 
dissolved in THF/pH 7 phosphate buffer (25/5 mL) and treated with NaIO4 (3.41 g, 15.9 mmol).  
After 40 min, the solution was diluted with brine, extracted with EtOAc (3 x 60 mL) and the 
combined organic layers washed with brine, dried (MgSO4), filtered, concentrated, and the residue 
purified by chromatography on SiO2 (4:1 hexanes/EtOAc) to furnish the aldehyde as a white foam 
and 3.3:1 mixture of diastereomers as indicated by 1H NMR analysis:  mp 56.0-63.2 °C 
(hexanes/EtOAc); IR (neat) 2977, 2933, 1728, 1696, 1388, 1256, 1094, 735 cm-1; 1H NMR (DMSO-
d6, 353 K) δ 9.64 (s, 1 H), 7.38 (dd, 1 H, J = 8.1, 0.9 Hz), 7.35-7.21 (m, 10 H), 7.16-7.07 (m, 3 H), 
6.78 (dd, 1 H, J = 6.0, 2.1 Hz), 6.71 (dd, 1 H, J = 7.7, 7.7 Hz), 5.04 (d, 2 H, J = 2.4 Hz), 4.75 (d, 2 H, 
J = 2.4 Hz), 4.40 (d, 1 H, J = 0.8 Hz), 3.95-3.88 (m, 1 H), 3.83 (d, 1 H, J = 9.0 Hz), 3.65 (dd, 1 H, J 
= 8.7, 1.2 Hz), 3.36 (d, 1 H, J = 10.8 Hz), 2.86 (dd, 1 H, J = 13.2, 3.3 Hz), 2.63 (dd, 1 H, J = 13.5, 
9.0 Hz), 1.41 (s, 3 H), 1.40 (s, 3 H), 1.38 (s, 9 H); 13C NMR (DMSO-d6, 353 K) δ 195.1, 153.5, 
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150.7, 148.3, 137.9, 135.9, 134.0, 130.3, 129.8, 129.5, 128.9, 127.7(2) (2 C), 127.7(0) (3 C), 127.2, 
126.9 (2 C), 126.8 (2 C), 126.4, 125.4, 119.5, 112.6, 102.6, 92.7, 78.5, 69.8, 65.4, 61.5, 60.4, 57.7, 
52.7, 37.6, 27.6 (3 C), 26.2, 23.2; MS (ESI) m/z (rel intensity) 713([M+H]+, 4), 711 ([M+H]+, 4), 
657 (74), 547 (100); HRMS (ESI) m/z calcd for C40H43BrN2O5 711.2434, found 711.2488; [α]D23: -
135.5 (c = 1.0, CH2Cl2).  Characteristic data for minor diastereomer:  1H NMR (DMSO-d6, 353 K) δ 
9.66 (s, 1 H), 1.45 (s, 3 H), 1.42 (s, 3 H); 13C NMR (DMSO-d6, 353 K) δ 195.2, 130.4, 130.0, 129.9, 
129.3, 125.3, 112.7, 65.3, 61.5, 58.0, 37.8, 27.7, 26.3. 
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(S)-tert-Butyl 4-(3-(1-benzyl-7-bromo-1H-indol-3-yl)-4-(benzyloxy)benzyl)-2,2-dimethyl 
oxazolidine-3-carboxylate (4-85).  Colorless oil:  IR (neat) 2976, 2929, 1696, 1388, 1251, 1174 cm-
1; 1H NMR (DMSO-d6, 353 K) δ 7.66 (dd, 1 H, J = 6.9, 0.6 Hz), 7.61 (s, 1 H), 7.37-7.30 (m, 2 H), 
7.30-7.17 (m, 8 H), 7.16-7.11 (m, 2 H), 7.08-7.01 (m, 2 H), 6.96 (t, 1 H, J = 7.8 Hz), 5.84 (s, 2 H), 
5.07 (s, 2 H), 4.11-4.00 (m, 1 H), 3.88 (dd, 1 H, J = 8.7, 5.7 Hz), 3.78 (dd, 1 H, J = 9.0, 1.8 Hz), 
~3.02 (dd, 1 H, signal obscured by H2O contaminating DMSO), 2.73 (dd, 1 H, J = 13.2, 9.0 Hz), 
1.46 (s, 3 H), 1.43 (s, 3 H), 1.42 (s, 9 H); 13C NMR (DMSO-d6, 353 K) δ 153.9, 150.8, 138.6, 136.7, 
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131.8, 131.5, 130.8, 130.4, 130.0, 127.9 (3 C), 127.6 (2 C), 126.9, 126.7 (2 C), 126.5, 126.2, 125.6 
(2 C), 123.0, 120.3, 119.4, 113.5, 112.0, 102.7, 92.7, 78.6, 69.9, 65.6, 58.0, 50.2, 37.6, 27.6 (3 C), 
26.3, 23.4; MS (ESI) m/z (rel intensity) 705 ([M+Na]+, 100), 703 ([M+Na]+, 100), 627 (95); HRMS 
(ESI) m/z calcd for C39H41BrN2O4Na [M+Na] 703.2147, found 703.2162, [α]D23 -23.0 (c 0.5, 
CH2Cl2). 
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Methyl 5-((R)-3-(5-(((S)-3-(tert-butoxycarbonyl)-2,2-dimethyloxazolidin-4-yl)methyl)-2-
(benzyloxy)phenyl)-1-benzyl-7-bromoindolin-3-yl)-4,5-dihydrooxazole-4-carboxylate (4-94).  A 
solution of aldehyde 4-83 (2.75 g, 3.87 mmol) and methyl isocyanoacetate (1.06 mL, 11.6 mmol) in 
CH2Cl2 (40 mL) was treated with DBU (1.74 mL, 11.6 mmol) at room temperature.  After 1 h, the 
volatiles were evaporated and the residue purified by chromatography on SiO2 (1:1 hexanes/EtOAc) 
to furnish oxazoline 4-94 (3.10 g, 99%) as a white foam and a mixture of several diastereomers as 
indicated by 1H NMR analysis:  mp 73.1-82.9 °C (CH2Cl2); IR (neat) 2977, 1746, 1696, 1388, 1256, 
1098, 738 cm-1; 1H NMR (DMSO-d6, 353 K, reported as seen) δ 7.38-7.21 (m, 10 H), 7.17-7.10 (m, 
4 H), 7.09-6.98 (m, 2 H), 6.81-6.75 (m, 0.3 H), 6.65-6.51 (m, 1 H), 5.62 (d, 0.6 H, J = 7.8 Hz), 5.49 
(d, 0.4 H, J = 7.5 Hz), 5.06-4.72 (m, 3 H), 4.37 (dd, 0.3 H), 4.17-4.11 (m, 1 H), 4.30-3.89 (m, 1 H), 
3.88-3.77 (m, 1 H), 3.74-3.58 (m, 3 H), 3.53 (s, 2.3 H), 3.80 (d, 0.4 H, J = 1.8 Hz), 2.94 (dd, 1 H, J = 
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13.2, 2.7 Hz), 2.71-2.59 (m, 1 H), 1.47-1.41 (m, 15 H) ; 13C NMR (DMSO-d6, 353 K, reported as 
seen) δ 170.3, 169.9, 156.1, 155.8, 154.3, 154.2, 150.7, 148.8, 148.7, 138.1, 137.8, 135.9, 135.8, 
133.5, 133.2, 133.0, 131.7, 130.4, 129.4, 129.3, 129.2, 128.7, 127.8, 127.7(6), 127.6, 127.3, 
127.2(5), 127.2, 127.0, 126.8, 126.7(6), 126.3, 126.2(5), 125.5, 123.5, 119.1, 119.0, 113.0, 112.8, 
102.6, 101.9, 95.1, 92.7, 83.7, 82.8, 78.5, 69.8, 69.7, 68.8, 68.6, 65.4, 62.2, 57.9, 57.7, 53.7, 53.4, 
53.2, 53.1, 51.5, 51.3, 37.8, 27.6, 26.2, 23.3; MS (ESI) m/z (rel intensity) 812 ([M+H]+, 100), 810 
([M+H]+, 100), 637 (100); HRMS (ESI) m/z calcd for C44H49BrN3O7 [M+H] 810.2754, found 
810.2734; [α]D23 +14.3 (c 1.0, CH2Cl2). 
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(S)-tert-Butyl 4-(3-((R)-3-(2-((S)-2-(((9H-fluoren-9-yl)methoxy)carbonylamino)-3-methyl 
butanamido)-1-hydroxy-3-methoxy-3-oxopropyl)-1-benzyl-7-bromoindolin-3-yl)-4-(benzyloxy) 
benzyl)-2,2-dimethyloxazolidine-3-carboxylate (4-98).  A solution of oxazoline 4-94 (870 mg, 
1.08 mmol) in CH2Cl2 (5 mL) was treated with Fmoc-Val-Cl (577 mg, 1.61 mmol) at room 
temperature.  After 1 h, a solution of Et3N (300 μL, 2.15 mmol) and H2O (39 μL, 2.15 mmol) in 
THF (0.5 mL) was added and the reaction mixture was stirred for 1 h.  The volatile components were 
evaporated and the residue dissolved in MeOH (10 mL) and treated with KHCO3 (215 mg, 2.15 
mmol).  After 1 h, the mixture was filtered, evaporated and the residue purified on SiO2 (2:1 
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hexanes/EtOAc) to provide alcohol 4-98 (797 mg, 66%) as a colorless oil and a mixture of several 
diastereomers as indicated by 1H NMR analysis:  IR (neat) 3345, 2924, 2853, 1696, 1453, 1389, 
1247 cm-1; 1H NMR (DMSO-d6, 353 K, reported as seen) δ 7.85 (dd, 1.5 H, J = 7.2, 3.9 Hz), 7.73 (d, 
1.5 H, J = 7.2 Hz), 7.44-7.25 (m, 12 H), 7.18-7.08 (m, 1.5 H), 7.05 (s, 1.5 H), 6.77 (d, 0.5 H), 6.67-
6.58 (m, 0.5 H), 6.50 (t, 0.5 H, J = 6.9 Hz), 6.32 (d, 0.5 H, J = 9.0 Hz), 5.40-5.33 (m, 1 H), 5.12-4.93 
(m, 2 H), 4.81-4.61 (m, 1 H), 4.50-4.25 (m, 3 H), 4.00-3.90 (m, 1.5 H), 3.83-3.62 (m, 3 H), 3.55-3.43 
(m, 1.5 H), 3.39 (s, 0.5 H), 3.38-2.93 (m, 1 H), 2.58-2.41 (m, 1 H), 2.17-1.83 (m, 1 H), 1.51-1.42 (m, 
15 H), 0.97-0.86 (m, 1.5 H), 0.85-0.68 (m, 4.5 H); 13C NMR (DMSO-d6, 353 K, major resonances 
only, reported as seen) δ 170.9, 154.3, 150.7, 143.6, 143.4, 140.4, 140.3, 138.3, 136.3, 129.4, 129.0, 
128.0, 127.7, 127.6, 127.5, 127.4(9), 127.3, 127.2, 127.1(7), 127.1, 127.0, 126.9, 126.6, 126.4, 
126.3, 126.2, 124.6, 119.4, 118.1, 112.9, 101.8, 92.6, 78.5, 69.8, 65.5, 65.3, 59.4, 57.9, 55.7, 53.3, 
53.0, 51.0, 46.6, 37.7, 30.0, 27.7, 26.3, 18.8, 18.3, 17.3; MS (ESI) m/z (rel intensity) 1123 ([M+H]+, 
72), 1121 ([M+H]+, 54); HRMS (ESI) m/z calcd for C63H70BrN4O10 [M+H] 1121.4275, found 
1121.4340; [α]D23 -20.0 (c 0.1, CH2Cl2). 
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Table 1.  Crystal data and structure refinement for dw1030u. 
Identification code  dw1030u 
Empirical formula  C23H27NO2 
Formula weight  349.46 
Temperature  296(2) K 
Wavelength  0.71073 Å 
Crystal system  Monoclinic 
Space group  P2(1) 
Unit cell dimensions a = 8.087(2) Å α= 90°. 
 b = 6.2187(16) Å β= 95.836(5)°. 
 c = 19.865(5) Å γ = 90°. 
Volume 993.8(4) Å3 
Z 2 
Density (calculated) 1.168 Mg/m3 
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Absorption coefficient 0.074 mm-1 
F(000) 376 
Crystal size 0.23 x 0.30 x 0.40 mm3 
Theta range for data collection 2.06 to 32.55°. 
Index ranges -12<=h<=11, -9<=k<=9, -29<=l<=29 
Reflections collected 12877 
Independent reflections 6679 [R(int) = 0.0927] 
Completeness to theta = 32.55° 96.3 %  
Absorption correction Sadabs 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 6679 / 1 / 242 
Goodness-of-fit on F2 0.920 
Final R indices [I>2sigma(I)] R1 = 0.0721, wR2 = 0.1343 
R indices (all data) R1 = 0.1736, wR2 = 0.1673 
Absolute structure parameter 0.4(18) 
Largest diff. peak and hole 0.335 and -0.243 e.Å-3 
Table 2.  Atomic coordinates  ( x 104) and equivalent  isotropic displacement parameters (Å2x 103) 
for dw1030u.  U(eq) is defined as one third of  the trace of the orthogonalized Uij tensor. 
________________________________________________________________________ 
 x y z U(eq) 
________________________________________________________________________  
O(1) -1923(2) 4938(4) 2711(1) 34(1) 
O(2) 827(2) 6722(3) 2218(1) 33(1) 
N(1) 3159(3) 4795(4) 2458(1) 27(1) 
C(1) 2795(3) 4746(5) 4651(1) 32(1) 
C(2) 3664(4) 5365(5) 5246(2) 38(1) 
C(3) 3722(4) 4094(6) 5810(2) 42(1) 
C(4) 2934(4) 2110(6) 5766(1) 40(1) 
C(5) 2060(4) 1483(5) 5172(1) 33(1) 
C(6) 1945(3) 2791(4) 4601(1) 26(1) 
C(7) 958(3) 2155(4) 3956(1) 24(1) 
C(8) 879(4) -231(5) 3805(2) 37(1) 
C(9) 203(3) 3603(5) 3547(1) 25(1) 
C(10) -764(3) 3235(5) 2872(1) 27(1) 
C(11) 414(3) 2966(5) 2314(1) 24(1) 
C(12) 1508(3) 4949(5) 2326(1) 24(1) 
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C(13) 4036(4) 2820(5) 2658(2) 43(1) 
C(14) 4139(4) 6743(5) 2444(2) 48(1) 
C(15) -508(3) 2690(5) 1599(1) 27(1) 
C(16) -1715(4) 856(5) 1585(1) 34(1) 
C(17) -3324(4) 1044(7) 1430(1) 46(1) 
C(18) 733(3) 2398(5) 1077(1) 28(1) 
C(19) 1044(4) 4090(5) 652(1) 36(1) 
C(20) 2179(4) 3870(7) 184(2) 47(1) 
C(21) 2993(4) 1934(7) 122(2) 47(1) 
C(22) 2683(4) 249(6) 544(2) 41(1) 
C(23) 1565(3) 482(5) 1015(1) 32(1) 
 
 
 
 
Table 3.  Bond lengths [Å] and angles [°] for dw1030u. 
______________________________________________________________________________  
O(1)-C(10)  1.428(3) 
O(2)-C(12)  1.241(3) 
N(1)-C(12)  1.337(3) 
N(1)-C(14)  1.450(4) 
N(1)-C(13)  1.453(4) 
C(1)-C(2)  1.368(4) 
C(1)-C(6)  1.395(4) 
C(2)-C(3)  1.369(4) 
C(3)-C(4)  1.387(5) 
C(4)-C(5)  1.369(4) 
C(5)-C(6)  1.391(4) 
C(6)-C(7)  1.492(4) 
C(7)-C(9)  1.320(4) 
C(7)-C(8)  1.514(4) 
C(9)-C(10)  1.501(4) 
C(10)-C(11)  1.542(4) 
C(11)-C(12)  1.516(4) 
C(11)-C(15)  1.544(3) 
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C(15)-C(16)  1.500(4) 
C(15)-C(18)  1.526(4) 
C(16)-C(17)  1.311(4) 
C(18)-C(23)  1.380(4) 
C(18)-C(19)  1.388(4) 
C(19)-C(20)  1.378(4) 
C(20)-C(21)  1.383(5) 
C(21)-C(22)  1.380(5) 
C(22)-C(23)  1.374(4) 
 
C(12)-N(1)-C(14) 118.3(3) 
C(12)-N(1)-C(13) 124.3(3) 
C(14)-N(1)-C(13) 117.3(2) 
C(2)-C(1)-C(6) 120.9(3) 
C(1)-C(2)-C(3) 121.1(3) 
C(2)-C(3)-C(4) 119.0(3) 
C(5)-C(4)-C(3) 120.1(3) 
C(4)-C(5)-C(6) 121.5(3) 
C(5)-C(6)-C(1) 117.4(2) 
C(5)-C(6)-C(7) 122.0(3) 
C(1)-C(6)-C(7) 120.6(2) 
C(9)-C(7)-C(6) 121.4(3) 
C(9)-C(7)-C(8) 122.6(3) 
C(6)-C(7)-C(8) 116.0(2) 
C(7)-C(9)-C(10) 127.8(3) 
O(1)-C(10)-C(9) 111.0(2) 
O(1)-C(10)-C(11) 111.0(2) 
C(9)-C(10)-C(11) 110.8(2) 
C(12)-C(11)-C(10)107.6(2) 
C(12)-C(11)-C(15)109.4(2) 
C(10)-C(11)-C(15)113.4(2) 
O(2)-C(12)-N(1) 120.9(3) 
O(2)-C(12)-C(11) 118.1(2) 
N(1)-C(12)-C(11) 121.0(3) 
C(16)-C(15)-C(18)111.6(2) 
C(16)-C(15)-C(11)110.7(2) 
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C(18)-C(15)-C(11)110.4(2) 
C(17)-C(16)-C(15)124.4(3) 
C(23)-C(18)-C(19)118.7(3) 
C(23)-C(18)-C(15)121.6(3) 
C(19)-C(18)-C(15)119.7(3) 
C(20)-C(19)-C(18)120.6(3) 
C(19)-C(20)-C(21)120.1(3) 
C(22)-C(21)-C(20)119.3(3) 
C(23)-C(22)-C(21)120.4(3) 
C(22)-C(23)-C(18)120.8(3) 
 
Symmetry transformations used to generate equivalent atoms:  
  
Table 4.   Anisotropic displacement parameters  (Å2x 103) for dw1030u.  The anisotropic 
displacement factor exponent takes the form:  -2π2[ h2 a*2U11 + ...  + 2 h k a* b* U12 ] 
______________________________________________________________________________ 
 U11 U22  U33 U23 U13 U12 
______________________________________________________________________________ 
O(1)24(1)  44(1) 35(1)  0(1) 3(1)  10(1) 
O(2)30(1)  22(1) 46(1)  6(1) 1(1)  5(1) 
N(1)23(1)  23(1) 34(1)  0(1) 2(1)  0(1) 
C(1)34(2)  24(2) 36(2)  6(1) -2(1)  1(1) 
C(2)36(2)  28(2) 49(2)  0(1) -4(1)  1(1) 
C(3)39(2)  51(2) 33(2)  -5(2) -4(1)  -3(2) 
C(4)40(2)  50(2) 30(2)  9(2) 3(1)  0(2) 
C(5)36(2)  32(2) 32(2)  3(1) 6(1)  -4(1) 
C(6)23(1)  24(2) 31(1)  -1(1) 4(1)  2(1) 
C(7)25(1)  24(2) 25(1)  0(1) 8(1)  -1(1) 
C(8)48(2)  21(2) 43(2)  -1(1) 4(1)  -2(2) 
C(9)24(1)  25(2) 26(1)  -3(1) 6(1)  0(1) 
C(10) 26(1)  25(2) 30(2)  2(1) 5(1)  1(1) 
C(11) 24(1)  24(2) 24(1)  2(1) 2(1)  2(1) 
C(12) 25(1)  25(2) 21(1)  -1(1) 3(1)  1(1) 
C(13) 29(2)  30(2) 71(2)  6(2) 6(2)  9(2) 
C(14) 33(2)  33(2) 74(2)  7(2) -3(2)  -9(2) 
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C(15) 24(1)  27(2) 29(1)  2(1) -1(1)  3(1) 
C(16) 32(2)  40(2) 30(2)  -4(1) 2(1)  -6(1) 
C(17) 35(2)  62(2) 43(2)  -13(2) 6(1)  -12(2) 
C(18) 26(1)  38(2) 19(1)  1(1) -1(1)  -5(1) 
C(19) 43(2)  38(2) 27(2)  4(1) 1(1)  1(2) 
C(20) 52(2)  58(2) 32(2)  10(2) 10(2)  -10(2) 
C(21) 35(2)  75(3) 33(2)  -7(2) 11(1)  -10(2) 
C(22) 32(2)  51(2) 41(2)  -8(2) 7(1)  7(2) 
C(23) 29(2)  33(2) 36(2)  0(1) 6(1)  1(1) 
______________________________________________________________________________Ta
ble 5.   Hydrogen coordinates ( x 104) and isotropic  displacement parameters (Å2x 10 3) 
for dw1030u. 
______________________________________________________________________________ 
 x  y  z  U(eq) 
______________________________________________________________________________ 
  
H(1O) -1290(60) 5700(80) 2540(20) 78(17) 
H(1A) 2769 5640 4275 38 
H(2) 4226 6672 5267 46 
H(3) 4280 4553 6217 50 
H(4) 3000 1204 6140 48 
H(5) 1531 154 5149 39 
H(8A) 278 -462 3369 56 
H(8B) 324 -955 4145 56 
H(8C) 1987 -788 3805 56 
H(9) 281 5021 3695 30 
H(10) -1394 1897 2898 32 
H(11) 1118 1704 2419 29 
H(13A) 3681 2314 3077 65 
H(13B) 5210 3091 2715 65 
H(13C) 3795 1750 2314 65 
H(14A) 3721 7607 2064 71 
H(14B) 5278 6375 2405 71 
H(14C) 4067 7538 2855 71 
H(15) -1141 4008 1487 32 
H(16) -1294 -506 1694 41 
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H(17A) -3784 2383 1318 56 
H(17B) -4003 -162 1431 56 
H(19) 481 5384 683 44 
H(20) 2398 5025 -91 56 
H(21) 3742 1770 -200 57 
H(22) 3234 -1052 508 49 
H(23) 1367 -666 1296 39 
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APPENDIX B 
X-RAY DATA FOR COMPOUND 1-77 
Ph
O
OH
Ph
O
Br
 
Table 1.  Crystal data and structure refinement for dw1010. 
Identification code  dw1010 
Empirical formula  C28H27BrO3 
Formula weight  491.41 
Temperature  298(2) K 
Wavelength  0.71073 Å 
Crystal system  Monoclinic 
Space group  P2(1)/c 
Unit cell dimensions a = 27.5495(14) Å α= 90°. 
 b = 7.4365(4) Å β= 95.9190(10)°. 
 c = 11.4908(6) Å γ = 90°. 
Volume 2341.6(2) Å3 
Z 4 
Density (calculated) 1.394 Mg/m3 
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Absorption coefficient 1.783 mm-1 
F(000) 1016 
Crystal size 0.10 x 0.10 x 0.40 mm3 
Theta range for data collection 2.23 to 32.58°. 
Index ranges -41<=h<=40, -11<=k<=11, -16<=l<=17 
Reflections collected 29664 
Independent reflections 8292 [R(int) = 0.0781] 
Completeness to theta = 32.58° 97.0 %  
Absorption correction Sadabs 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 8292 / 0 / 289 
Goodness-of-fit on F2 0.934 
Final R indices [I>2sigma(I)] R1 = 0.0568, wR2 = 0.1237 
R indices (all data) R1 = 0.1694, wR2 = 0.1610 
Largest diff. peak and hole 0.823 and -0.283 e.Å-3 
Table 2.  Atomic coordinates  ( x 104) and equivalent  isotropic displacement parameters (Å2x 103) 
for dw1010.  U(eq) is defined as one third of  the trace of the orthogonalized Uij tensor. 
______________________________________________________________________________  
 x y z U(eq) 
______________________________________________________________________________  
Br 364(1) 3815(1) 7864(1) 86(1) 
O(1) 3060(1) -2371(3) 8029(2) 56(1) 
O(2) 2668(1) 1478(2) 6985(2) 44(1) 
O(3) 2861(1) 3752(2) 8220(2) 53(1) 
C(1) 1350(1) -2520(4) 6244(2) 53(1) 
C(2) 850(1) -2459(5) 6037(3) 65(1) 
C(3) 612(1) -3271(5) 5067(3) 68(1) 
C(4) 880(1) -4125(4) 4315(3) 67(1) 
C(5) 1381(1) -4195(4) 4508(3) 54(1) 
C(6) 1632(1) -3357(3) 5474(2) 41(1) 
C(7) 2174(1) -3421(3) 5685(2) 40(1) 
C(8) 2421(1) -2320(3) 6442(2) 43(1) 
C(9) 2959(1) -2307(3) 6781(2) 43(1) 
C(10) 3239(1) -701(3) 6347(2) 39(1) 
C(11) 3795(1) -1142(3) 6422(2) 43(1) 
C(12) 4106(1) 256(3) 5888(2) 42(1) 
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C(13) 3976(1) 956(4) 4786(3) 59(1) 
C(14) 4286(1) 2076(5) 4253(3) 69(1) 
C(15) 4727(1) 2532(4) 4817(3) 63(1) 
C(16) 4863(1) 1875(4) 5894(3) 60(1) 
C(17) 4555(1) 741(4) 6436(3) 50(1) 
C(18) 2426(1) -4792(4) 4985(3) 59(1) 
C(19) 3884(1) -2928(4) 5873(3) 58(1) 
C(20) 4064(1) -4330(4) 6449(4) 84(1) 
C(21) 3184(1) 1010(3) 7033(3) 46(1) 
C(22) 2559(1) 2844(3) 7654(2) 38(1) 
C(23) 2024(1) 3108(3) 7655(2) 37(1) 
C(24) 1855(1) 4192(3) 8503(2) 48(1) 
C(25) 1365(1) 4414(4) 8568(3) 54(1) 
C(26) 1039(1) 3548(4) 7760(3) 49(1) 
C(27) 1196(1) 2483(4) 6897(2) 50(1) 
C(28) 1692(1) 2256(4) 6853(2) 45(1) 
______________________________________________________________________________  
Table 3.   Bond lengths [Å] and angles [°] for  dw1010. 
______________________________________________________________________________  
Br-C(26)  1.887(2) 
O(1)-C(9)  1.433(3) 
O(2)-C(22)  1.326(3) 
O(2)-C(21)  1.459(3) 
O(3)-C(22)  1.208(3) 
C(1)-C(2)  1.376(4) 
C(1)-C(6)  1.384(4) 
C(2)-C(3)  1.372(4) 
C(3)-C(4)  1.352(5) 
C(4)-C(5)  1.375(4) 
C(5)-C(6)  1.392(4) 
C(6)-C(7)  1.489(3) 
C(7)-C(8)  1.330(3) 
C(7)-C(18)  1.511(4) 
C(8)-C(9)  1.495(3) 
C(9)-C(10)  1.531(3) 
C(10)-C(21)  1.513(3) 
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C(10)-C(11)  1.561(3) 
C(11)-C(19)  1.501(4) 
C(11)-C(12)  1.516(3) 
C(12)-C(17)  1.378(4) 
C(12)-C(13)  1.382(4) 
C(13)-C(14)  1.380(4) 
C(14)-C(15)  1.361(4) 
C(15)-C(16)  1.348(4) 
C(16)-C(17)  1.389(4) 
C(19)-C(20)  1.305(4) 
C(22)-C(23)  1.487(3) 
C(23)-C(24)  1.381(4) 
C(23)-C(28)  1.385(3) 
C(24)-C(25)  1.371(4) 
C(25)-C(26)  1.382(4) 
C(26)-C(27)  1.374(4) 
C(27)-C(28)  1.382(3) 
 
C(22)-O(2)-C(21) 115.96(19) 
C(2)-C(1)-C(6) 121.5(3) 
C(3)-C(2)-C(1) 120.7(3) 
C(4)-C(3)-C(2) 118.7(3) 
C(3)-C(4)-C(5) 121.3(3) 
C(4)-C(5)-C(6) 121.3(3) 
C(1)-C(6)-C(5) 116.5(3) 
C(1)-C(6)-C(7) 122.0(2) 
C(5)-C(6)-C(7) 121.5(2) 
C(8)-C(7)-C(6) 121.6(2) 
C(8)-C(7)-C(18) 122.1(2) 
C(6)-C(7)-C(18) 116.3(2) 
C(7)-C(8)-C(9) 127.0(2) 
O(1)-C(9)-C(8) 110.2(2) 
O(1)-C(9)-C(10) 107.4(2) 
C(8)-C(9)-C(10) 116.0(2) 
C(21)-C(10)-C(9) 113.9(2) 
C(21)-C(10)-C(11)107.3(2) 
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C(9)-C(10)-C(11) 110.0(2) 
C(19)-C(11)-C(12)108.2(2) 
C(19)-C(11)-C(10)111.4(2) 
C(12)-C(11)-C(10)115.2(2) 
C(17)-C(12)-C(13)117.1(2) 
C(17)-C(12)-C(11)120.8(2) 
C(13)-C(12)-C(11)121.7(2) 
C(14)-C(13)-C(12)121.4(3) 
C(15)-C(14)-C(13)120.2(3) 
C(16)-C(15)-C(14)119.8(3) 
C(15)-C(16)-C(17)120.5(3) 
C(12)-C(17)-C(16)121.0(3) 
C(20)-C(19)-C(11)124.4(3) 
O(2)-C(21)-C(10) 109.25(19) 
O(3)-C(22)-O(2) 123.8(2) 
O(3)-C(22)-C(23) 123.6(2) 
O(2)-C(22)-C(23) 112.6(2) 
C(24)-C(23)-C(28)119.2(2) 
C(24)-C(23)-C(22)118.9(2) 
C(28)-C(23)-C(22)121.8(2) 
C(25)-C(24)-C(23)121.0(3) 
C(24)-C(25)-C(26)118.8(3) 
C(27)-C(26)-C(25)121.5(2) 
C(27)-C(26)-Br 119.5(2) 
C(25)-C(26)-Br 119.0(2) 
C(26)-C(27)-C(28)118.9(2) 
C(27)-C(28)-C(23)120.5(2) 
______________________________________________________________________________  
Symmetry transformations used to generate equivalent atoms:  
  
Table 4.   Anisotropic displacement parameters  (Å2x 103) for dw1010.  The anisotropic 
displacement factor exponent takes the form:  -2π2[ h2 a*2U11 + ...  + 2 h k a* b* U12 ] 
______________________________________________________________________________  
 U11 U22  U33 U23 U13 U12 
______________________________________________________________________________  
Br37(1)  89(1) 136(1)  8(1) 23(1)  8(1) 
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O(1)56(1)  55(1) 56(1)  6(1) 2(1)  -8(1) 
O(2)31(1)  38(1) 64(1)  -9(1) 7(1)  3(1) 
O(3)39(1)  45(1) 75(1)  -13(1) -2(1)  -2(1) 
C(1)44(2)  61(2) 53(2)  -8(1) 6(1)  -11(1) 
C(2)47(2)  80(2) 71(2)  -9(2) 15(2)  -7(2) 
C(3)44(2)  73(2) 86(2)  3(2) -2(2)  -7(2) 
C(4)58(2)  69(2) 68(2)  -4(2) -19(2)  -10(2) 
C(5)63(2)  50(2) 49(2)  -2(1) 0(1)  -6(1) 
C(6)46(1)  37(1) 41(1)  2(1) 6(1)  -8(1) 
C(7)45(1)  37(1) 38(1)  3(1) 9(1)  -5(1) 
C(8)41(1)  33(1) 56(2)  -6(1) 10(1)  0(1) 
C(9)40(1)  37(1) 53(2)  -7(1) 6(1)  1(1) 
C(10) 32(1)  37(1) 48(2)  -3(1) 6(1)  3(1) 
C(11) 33(1)  45(2) 52(2)  0(1) 6(1)  7(1) 
C(12) 33(1)  41(1) 52(2)  -5(1) 7(1)  7(1) 
C(13) 41(2)  71(2) 64(2)  6(2) 5(1)  -11(1) 
C(14) 64(2)  80(2) 64(2)  12(2) 14(2)  -7(2) 
C(15) 49(2)  55(2) 90(3)  -6(2) 27(2)  -2(2) 
C(16) 33(1)  52(2) 94(3)  -15(2) 5(2)  -3(1) 
C(17) 38(1)  51(2) 62(2)  -8(1) 1(1)  8(1) 
C(18) 54(2)  66(2) 59(2)  -19(2) 13(1)  -5(2) 
C(19) 49(2)  50(2) 79(2)  -7(2) 24(2)  3(1) 
C(20) 71(2)  51(2) 134(3)  0(2) 28(2)  15(2) 
C(21) 30(1)  41(2) 68(2)  -3(1) 8(1)  1(1) 
C(22) 36(1)  33(1) 45(2)  6(1) 6(1)  0(1) 
C(23) 35(1)  32(1) 43(1)  4(1) 5(1)  1(1) 
C(24) 45(2)  41(2) 57(2)  -5(1) 6(1)  2(1) 
C(25) 49(2)  47(2) 67(2)  -4(1) 18(2)  10(1) 
C(26) 33(1)  42(2) 73(2)  10(1) 10(1)  3(1) 
C(27) 39(1)  47(2) 62(2)  0(1) -1(1)  -3(1) 
C(28) 43(1)  42(2) 50(2)  -4(1) 6(1)  1(1) 
______________________________________________________________________________Ta
ble 5.   Hydrogen coordinates ( x 104) and isotropic  displacement parameters (Å2x 10 3) 
for dw1010. 
______________________________________________________________________________  
 x  y  z  U(eq) 
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______________________________________________________________________________  
 
H(1A) 3022 -3401 8257 83 
H(1B) 1503 -1986 6917 63 
H(2A) 670 -1860 6560 78 
H(3A) 274 -3235 4930 82 
H(4A) 723 -4677 3654 80 
H(5A) 1556 -4813 3984 65 
H(8A) 2239 -1466 6799 51 
H(9A) 3094 -3400 6464 52 
H(10A) 3120 -477 5526 47 
H(11A) 3914 -1232 7253 52 
H(13A) 3673 667 4395 70 
H(14A) 4192 2519 3506 83 
H(15A) 4934 3296 4460 76 
H(16A) 5166 2183 6278 72 
H(17A) 4653 302 7181 60 
H(18A) 2772 -4731 5196 89 
H(18B) 2356 -4540 4165 89 
H(18C) 2311 -5974 5149 89 
H(19A) 3807 -3042 5070 69 
H(20A) 4146 -4261 7254 101 
H(20B) 4111 -5398 6055 101 
H(21A) 3317 838 7841 55 
H(21B) 3362 1978 6704 55 
H(24A) 2078 4779 9037 57 
H(25A) 1253 5135 9147 64 
H(27A) 973 1925 6351 60 
H(28A) 1803 1525 6279 54 
________________________________________________________________________________ 
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APPENDIX C 
X-RAY DATA FOR COMPOUND 3-21 
O
O
O
O
OMe
 
Table 1.  Crystal data and structure refinement for grenon1t. 
Identification code  compound9 
Empirical formula  C9H12O5 
Formula weight  200.19 
Temperature  295(2) K 
Wavelength  0.71073 Å 
Crystal system  Monoclinic 
Space group  C 2/c 
Unit cell dimensions a = 25.345(17) Å a= 90°. 
 b = 6.038(4) Å b= 104.129(18)°. 
 c = 12.627(10) Å g = 90°. 
Volume 1874(2) Å3 
Z 8 
Density (calculated) 1.419 Mg/m3 
Absorption coefficient 0.117 mm-1 
F(000) 848 
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Crystal size 0.28 x 0.18 x 0.12 mm3 
Theta range for data collection 1.66 to 25.00°. 
Index ranges -30<=h<=25, -6<=k<=7, -15<=l<=15 
Reflections collected 4776 
Independent reflections 1647 [R(int) = 0.2741] 
Completeness to theta = 25.00° 99.9 %  
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 0.9861 and 0.9680 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 1647 / 0 / 130 
Goodness-of-fit on F2 1.132 
Final R indices [I>2sigma(I)] R1 = 0.1225, wR2 = 0.2742 
R indices (all data) R1 = 0.1859, wR2 = 0.3053 
Largest diff. peak and hole 0.406 and -0.398 e.Å-3 
 
Table 2.  Atomic coordinates  ( x 104) and equivalent  isotropic displacement parameters (Å2x 103) 
for grenon1t.  U(eq) is defined as one third of  the trace of the orthogonalized Uij tensor. 
______________________________________________________________________________ 
 x y z U(eq) 
______________________________________________________________________________ 
O(1) 1875(2) -1574(8) 5239(4) 44(1) 
C(1) 1822(3) 0(12) 4631(5) 37(2) 
O(2) 2379(2) 2448(8) 3728(4) 39(1) 
C(2) 2157(3) 322(12) 3833(5) 34(2) 
O(3) 1431(2) 1441(8) 4633(3) 36(1) 
C(3) 1942(3) 1664(12) 2866(5) 34(2) 
C(4) 1397(2) 2796(10) 2755(5) 25(2) 
O(4) 437(2) 3109(9) 4097(6) 70(2) 
O(5) 779(2) 6390(7) 3879(4) 39(1) 
C(5) 1350(2) 3394(10) 3924(5) 27(2) 
C(6) 1405(3) 4928(12) 2108(6) 46(2) 
C(7) 958(3) 1207(12) 2174(6) 39(2) 
C(8) 798(3) 4208(11) 3980(5) 30(2) 
C(9) 281(3) 7423(14) 4022(7) 51(2) 
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 Table 3.   Bond lengths [Å] and angles [°] for  grenon1t. 
______________________________________________________________________________ 
O(1)-C(1)  1.208(8) 
C(1)-O(3)  1.320(8) 
C(1)-C(2)  1.480(10) 
O(2)-C(2)  1.421(8) 
O(2)-C(3)  1.432(8) 
C(2)-C(3)  1.456(9) 
C(2)-H(2)  0.9800 
O(3)-C(5)  1.465(8) 
C(3)-C(4)  1.515(9) 
C(3)-H(3)  0.9800 
C(4)-C(7)  1.517(9) 
C(4)-C(6)  1.527(9) 
C(4)-C(5)  1.553(8) 
O(4)-C(8)  1.169(8) 
O(5)-C(8)  1.323(8) 
O(5)-C(9)  1.456(8) 
C(5)-C(8)  1.499(9) 
C(5)-H(5)  0.9800 
C(6)-H(6A)  0.9600 
C(6)-H(6B)  0.9600 
C(6)-H(6C)  0.9600 
C(7)-H(7A)  0.9600 
C(7)-H(7B)  0.9600 
C(7)-H(7C)  0.9600 
C(9)-H(9A)  0.9600 
C(9)-H(9B)  0.9600 
C(9)-H(9C)  0.9600 
 
O(1)-C(1)-O(3) 118.9(6) 
O(1)-C(1)-C(2) 122.9(7) 
O(3)-C(1)-C(2) 118.1(6) 
C(2)-O(2)-C(3) 61.4(4) 
O(2)-C(2)-C(3) 59.7(4) 
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O(2)-C(2)-C(1) 119.2(6) 
C(3)-C(2)-C(1) 119.0(6) 
O(2)-C(2)-H(2) 115.8 
C(3)-C(2)-H(2) 115.8 
C(1)-C(2)-H(2) 115.8 
C(1)-O(3)-C(5) 121.5(5) 
O(2)-C(3)-C(2) 58.9(4) 
O(2)-C(3)-C(4) 116.0(5) 
C(2)-C(3)-C(4) 118.3(5) 
O(2)-C(3)-H(3) 116.9 
C(2)-C(3)-H(3) 116.9 
C(4)-C(3)-H(3) 116.9 
C(3)-C(4)-C(7) 107.7(5) 
C(3)-C(4)-C(6) 107.4(5) 
C(7)-C(4)-C(6) 112.2(5) 
C(3)-C(4)-C(5) 107.3(5) 
C(7)-C(4)-C(5) 112.9(5) 
C(6)-C(4)-C(5) 109.1(5) 
C(8)-O(5)-C(9) 115.3(5) 
O(3)-C(5)-C(8) 103.2(5) 
O(3)-C(5)-C(4) 111.2(5) 
C(8)-C(5)-C(4) 114.3(5) 
O(3)-C(5)-H(5) 109.3 
C(8)-C(5)-H(5) 109.3 
C(4)-C(5)-H(5) 109.3 
C(4)-C(6)-H(6A) 109.5 
C(4)-C(6)-H(6B) 109.5 
H(6A)-C(6)-H(6B)109.5 
C(4)-C(6)-H(6C) 109.5 
H(6A)-C(6)-H(6C)109.5 
H(6B)-C(6)-H(6C)109.5 
C(4)-C(7)-H(7A) 109.5 
C(4)-C(7)-H(7B) 109.5 
H(7A)-C(7)-H(7B)109.5 
C(4)-C(7)-H(7C) 109.5 
H(7A)-C(7)-H(7C)109.5 
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H(7B)-C(7)-H(7C)109.5 
O(4)-C(8)-O(5) 124.4(6) 
O(4)-C(8)-C(5) 126.0(6) 
O(5)-C(8)-C(5) 109.6(5) 
O(5)-C(9)-H(9A) 109.5 
O(5)-C(9)-H(9B) 109.5 
H(9A)-C(9)-H(9B)109.5 
O(5)-C(9)-H(9C) 109.5 
H(9A)-C(9)-H(9C)109.5 
H(9B)-C(9)-H(9C)109.5 
______________________________________________________________________________ 
Symmetry transformations used to generate equivalent atoms:  
  
Table 4.   Anisotropic displacement parameters  (Å2x 103) for grenon1t.  The anisotropic 
displacement factor exponent takes the form:  -2p2[ h2 a*2U11 + ...  + 2 h k a* b* U12 ] 
______________________________________________________________________________ 
 U11 U22  U33 U23 U13 U12 
______________________________________________________________________________ 
O(1)42(3)  41(3) 47(3)  16(2) 9(2)  9(2) 
C(1)38(4)  43(4) 27(4)  -3(3) 3(3)  4(4) 
O(2)22(2)  53(3) 43(3)  4(2) 10(2)  -6(2) 
C(2)31(3)  41(4) 31(4)  2(3) 7(3)  7(3) 
O(3)39(3)  38(3) 33(3)  5(2) 12(2)  1(2) 
C(3)25(3)  57(5) 23(3)  3(3) 10(3)  5(3) 
C(4)24(3)  30(4) 22(3)  -3(3) 8(3)  -4(3) 
O(4)37(3)  50(4) 138(6)  -9(3) 46(4)  -10(3) 
O(5)27(3)  32(3) 65(3)  1(2) 22(2)  3(2) 
C(5)23(3)  26(3) 33(4)  3(3) 8(3)  0(3) 
C(6)45(4)  48(5) 52(5)  15(4) 24(4)  18(4) 
C(7)41(4)  40(4) 35(4)  -7(3) 5(3)  0(4) 
C(8)31(4)  27(4) 34(4)  -6(3) 16(3)  -5(3) 
C(9)46(5)  46(4) 69(6)  0(4) 26(4)  20(4) 
______________________________________________________________________________
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 Table 5.   Hydrogen coordinates ( x 104) and isotropic  displacement parameters (Å2x 10 3) 
for grenon1t. 
______________________________________________________________________________  
 x  y  z  U(eq) 
______________________________________________________________________________ 
  
H(2) 2382 -942 3732 41 
H(3) 2034 1202 2189 41 
H(5) 1623 4515 4236 33 
H(6A) 1687 5885 2505 70 
H(6B) 1060 5660 2001 70 
H(6C) 1473 4578 1411 70 
H(7A) 1048 651 1527 59 
H(7B) 615 1969 1975 59 
H(7C) 932 -6 2650 59 
H(9A) -17 7021 3424 77 
H(9B) 324 9003 4041 77 
H(9C) 209 6926 4695 77 
______________________________________________________________________________ 
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APPENDIX D 
X-RAY DATA FOR COMPOUND 3-26 
O
CO2Me
O
OH
 
Crystal Data 
  
        Formula                                                C10 H16 O5   
        Formula Weight                                         216.23   
        Crystal System                                         Monoclinic   
        Space group                                  P21/c       (No. 14)   
        a, b, c [Angstrom]              8.849(2)    15.512(3)  8.0902(17)   
        alpha, beta, gamma [deg]              90  101.154(19)          90   
        V [Ang**3]                                              1089.5(4)   
        Z                                                               4   
        D(calc) [g/cm**3]                                           1.318   
        Mu(MoKa) [ /mm ]                                            0.106   
        F(000)                                                        464   
        Crystal Size [mm]                             0.00 x  0.00 x 0.00   
 
 Data Collection 
  
        Temperature (K)                                               208   
        Radiation [Angstrom]                             MoKa     0.71073   
        Theta Min-Max [Deg]                                     2.3, 26.0   
        Dataset                                -10: 10 ; -19: 17 ;  -3: 9   
        Tot., Uniq. Data, R(int)                      2284,   2132, 0.024   
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        Observed data [I > 0.0 sigma(I)]                             1408  
  
Refinement 
  
        Nref, Npar                                              2132, 200   
        R, wR2, S                                     0.0567,0.1445,1.03   
        w = 1/[\s^2^(Fo^2^)+(0.0554P)^2^+0.8218P] where                       
P=(Fo^2^+2Fc^2^)/3   
        Max. and Av. Shift/Error                                0.00,0.00   
        Min. and Max. Resd. Dens. [e/Ang^3]                    -0.21,0.25 
        
Table S2 - Final Coordinates and Equivalent Isotropic Displacement 
                   Parameters of the non-Hydrogen atoms 
                   for: compound15P 21/c       R = 0.06 
  
        Atom          x            y            z      U(eq) [Ang^2] 
        ----         ---          ---          ---     ----------- 
        O1         0.2256(2)  0.79114(12)    0.1214(2)    0.0345(7) 
  
        O2         0.4175(2)  0.96400(11)    0.1784(2)    0.0283(6) 
  
        O3         0.3308(3)  1.11782(14)    0.2665(3)    0.0517(9) 
  
        O4         0.0822(2)  1.08403(14)    0.1849(3)    0.0468(8) 
  
        O5         0.4059(2)  0.88161(14)   -0.0649(3)    0.0346(7) 
  
        C1         0.2584(3)  0.97140(18)    0.1849(4)    0.0272(8) 
  
        C2         0.2162(3)  0.91172(18)    0.3232(3)    0.0283(8) 
  
        C3         0.2732(3)  0.82226(18)    0.2906(4)    0.0302(9) 
  
        C4         0.3866(3)  0.80822(18)    0.1848(4)    0.0316(9) 
  
        C5         0.4581(3)  0.88404(17)    0.1100(3)    0.0282(9) 
  
        C6         0.2323(3)  1.06554(18)    0.2173(3)    0.0305(9) 
  
        C7         0.2951(4)    0.9402(2)    0.4992(4)   0.0400(11) 
  
        C8         0.0419(4)    0.9064(2)    0.3095(5)   0.0415(11) 
  
        C9         0.6326(4)    0.8799(2)    0.1607(5)   0.0383(11) 
  
        C10        0.0405(6)    1.1718(3)    0.2188(7)   0.0604(16) 
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        U(eq) = 1/3 of the trace of the orthogonalized U Tensor 
 
Table S3 - Hydrogen Atom Positions and Isotropic Displacement 
                   Parameters 
                   for: compound15P 21/c       R = 0.06 
  
        Atom          x            y            z     U(iso) [Ang^2] 
        ----         ---          ---          ---     ----------- 
        H1          0.201(3)   0.9564(17)     0.078(4)     0.025(7) 
  
        H3          0.270(3)   0.7838(16)     0.378(3)     0.012(6) 
  
        H4          0.453(3)     0.758(2)     0.202(3)     0.034(8) 
  
        H5O         0.462(4)     0.914(2)    -0.111(4)    0.045(10) 
  
        H7A         0.273(4)     0.901(2)     0.588(4)    0.054(10) 
  
        H7B         0.411(4)     0.942(2)     0.514(4)     0.049(9) 
  
        H7C         0.257(4)     1.001(2)     0.529(4)    0.059(10) 
  
        H8A         0.017(4)     0.863(2)     0.388(4)     0.047(9) 
  
        H8B        -0.004(3)     0.959(2)     0.339(4)     0.035(8) 
  
        H8C        -0.008(4)     0.889(2)     0.193(4)     0.044(9) 
  
        H9A         0.665(3)   0.8684(17)     0.282(4)     0.026(7) 
  
        H9B         0.666(4)     0.831(2)     0.110(4)     0.042(9) 
  
        H9C         0.677(4)     0.933(2)     0.127(4)    0.053(10) 
  
        H10A        0.074(5)     1.189(3)     0.332(6)    0.080(14) 
  
        H10B       -0.061(7)     1.175(3)     0.193(6)    0.111(19) 
  
        H10C        0.074(5)     1.207(3)     0.140(6)    0.092(17) 
  
  
______________________________________________________________________________ 
  
         The Temperature Factor has the Form of Exp(-T) Where 
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        T = 8*(Pi**2)*U*(Sin(Theta)/Lambda)**2  for Isotropic Atoms 
 
Table S4 - (An)isotropic  Displacement Parameters 
               for: compound15P 21/c       R = 0.06 
  
    Atom    U(1,1) or U  U(2,2)     U(3,3)     U(2,3)     U(1,3)     U(1,2) 
    ----      ------     ------     ------     ------     ------     ------ 
    O1      0.0359(11) 0.0307(11) 0.0385(12) -0.0066(9)  0.0109(9) -0.0080(9) 
  
    O2      0.0258(10) 0.0242(10) 0.0373(11) -0.0019(8)  0.0120(8) -0.0014(8) 
  
    O3      0.0413(13) 0.0279(11) 0.0873(19)-0.0100(12) 0.0159(12)-0.0019(10) 
  
    O4      0.0355(12) 0.0370(12) 0.0656(16)-0.0050(11) 0.0044(11) 0.0127(10) 
  
    O5      0.0370(12) 0.0371(12) 0.0316(12) -0.0009(9)  0.0116(9) -0.0063(9) 
  
    C1      0.0223(14) 0.0308(15) 0.0290(15)-0.0022(12) 0.0059(11)-0.0013(11) 
  
    C2      0.0289(15) 0.0273(14) 0.0297(15)-0.0003(12) 0.0084(11)-0.0030(11) 
  
    C3      0.0354(16) 0.0264(15) 0.0292(15) 0.0023(13) 0.0072(12)-0.0060(12) 
  
    C4      0.0308(16) 0.0233(15) 0.0406(17) 0.0014(12) 0.0067(13) 0.0023(12) 
  
    C5      0.0278(15) 0.0260(14) 0.0321(16)-0.0026(12) 0.0094(12) 0.0014(11) 
  
    C6      0.0311(16) 0.0315(15) 0.0305(16) 0.0031(12) 0.0098(12) 0.0015(13) 
  
    C7        0.046(2)   0.043(2) 0.0319(17)-0.0023(15) 0.0097(14)-0.0078(15) 
  
    C8      0.0344(17)   0.042(2)   0.052(2)-0.0033(17) 0.0181(16)-0.0060(15) 
  
    C9      0.0305(17) 0.0374(18)   0.047(2)-0.0019(16) 0.0077(15) 0.0042(14) 
  
    C10       0.058(3)   0.048(2)   0.074(3)  -0.007(2)   0.010(2)   0.025(2) 
  
  
______________________________________________________________________________ 
  
         The Temperature Factor has the Form of Exp(-T) Where 
        T = 8*(Pi**2)*U*(Sin(Theta)/Lambda)**2  for Isotropic Atoms 
        T = 2*(Pi**2)*Sumij(h(i)*h(j)*U(i,j)*Astar(i)*Astar(j)), for 
      Anisotropic Atoms. Astar(i) are Reciprocal Axial Lengths and 
          h(i) are the Reflection Indices. 
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Table S5 - Bond Distances (Angstrom) 
                   for: compound15P 21/c       R = 0.06 
  
  
        O1     -C3         1.436(4)     C5     -C9         1.520(5) 
  
        O1     -C4         1.442(3)     C1     -H1          0.94(3) 
  
        O2     -C1         1.424(3)     C3     -H3          0.93(2) 
  
        O2     -C5         1.432(3)     C4     -H4          0.97(3) 
  
        O3     -C6         1.201(4)     C7     -H7A         0.99(3) 
  
        O4     -C6         1.334(3)     C7     -H7B         1.01(4) 
  
        O4     -C10        1.451(5)     C7     -H7C         1.05(3) 
  
        O5     -C5         1.402(3)     C8     -H8A         0.98(3) 
  
        O5     -H5O         0.84(3)     C8     -H8B         0.96(3) 
  
        C1     -C2         1.552(4)     C8     -H8C         1.00(3) 
  
        C1     -C6         1.509(4)     C9     -H9A         0.98(3) 
  
        C2     -C7         1.525(4)     C9     -H9B         0.94(3) 
  
        C2     -C8         1.527(5)     C9     -H9C         0.97(3) 
  
        C2     -C3         1.517(4)     C10    -H10A        0.95(5) 
  
        C3     -C4         1.456(4)     C10    -H10B        0.88(6) 
  
        C4     -C5         1.516(4)     C10    -H10C        0.93(5) 
  
Table S6 - Bond Angles    (Degrees) 
               for: compound15P 21/c       R = 0.06 
  
  
    C3     -O1     -C4        60.77(18)   O2     -C1     -H1        107.9(17) 
  
    C1     -O2     -C5         114.1(2)   C2     -C1     -H1        110.6(17) 
  
    C6     -O4     -C10        116.4(3)   C6     -C1     -H1        108.9(16) 
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    C5     -O5     -H5O          109(2)   O1     -C3     -H3        117.6(15) 
  
    O2     -C1     -C2         110.9(2)   C2     -C3     -H3        113.3(16) 
  
    O2     -C1     -C6         105.7(2)   C4     -C3     -H3        118.5(16) 
  
    C2     -C1     -C6         112.7(2)   O1     -C4     -H4        115.7(17) 
  
    C1     -C2     -C7         111.7(2)   C3     -C4     -H4        120.2(15) 
  
    C1     -C2     -C8         111.1(2)   C5     -C4     -H4        113.1(17) 
  
    C1     -C2     -C3         106.6(2)   C2     -C7     -H7A       112.4(19) 
  
    C3     -C2     -C8         107.6(2)   C2     -C7     -H7B       112.9(18) 
  
    C7     -C2     -C8         110.9(3)   C2     -C7     -H7C       111.5(18) 
  
    C3     -C2     -C7         108.7(2)   H7A    -C7     -H7B          106(3) 
  
    O1     -C3     -C4        59.84(18)   H7A    -C7     -H7C          106(3) 
  
    C2     -C3     -C4         122.0(2)   H7B    -C7     -H7C          108(3) 
  
    O1     -C3     -C2         115.3(2)   C2     -C8     -H8A          110(2) 
  
    O1     -C4     -C3        59.39(17)   C2     -C8     -H8B       113.9(17) 
  
    O1     -C4     -C5         117.4(2)   C2     -C8     -H8C          110(2) 
  
    C3     -C4     -C5         120.5(2)   H8A    -C8     -H8B          105(3) 
  
    O2     -C5     -O5         110.8(2)   H8A    -C8     -H8C          108(3) 
  
    O2     -C5     -C4         111.3(2)   H8B    -C8     -H8C          109(3) 
  
    O5     -C5     -C4         107.5(2)   C5     -C9     -H9A       111.2(16) 
  
    O5     -C5     -C9         113.0(2)   C5     -C9     -H9B          108(2) 
  
    C4     -C5     -C9         109.9(2)   C5     -C9     -H9C          109(2) 
  
    O2     -C5     -C9         104.5(2)   H9A    -C9     -H9B          104(3) 
  
    O3     -C6     -C1         125.8(3)   H9A    -C9     -H9C          112(2) 
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    O4     -C6     -C1         110.7(2)   H9B    -C9     -H9C          113(3) 
  
    O3     -C6     -O4         123.5(3)   O4     -C10    -H10A         114(3) 
  
Table S6 - Bond Angles    (Degrees)  (continued) 
               for: compound15P 21/c       R = 0.06 
  
  
    O4     -C10    -H10B         107(3)   H10A   -C10    -H10C         115(4) 
  
    O4     -C10    -H10C         107(3)   H10B   -C10    -H10C         104(4) 
  
    H10A   -C10    -H10B         109(4) 
  
 
         Table S7 - Torsion Angles (Degrees) 
                    for: compound15P 21/c       R = 0.06 
  
  
         C4     -O1     -C3     -C2         113.7(3) 
  
         C3     -O1     -C4     -C5        -110.9(3) 
  
         C5     -O2     -C1     -C2          71.6(3) 
  
         C5     -O2     -C1     -C6        -166.1(2) 
  
         C1     -O2     -C5     -O5          73.6(3) 
  
         C1     -O2     -C5     -C4         -45.9(3) 
  
         C1     -O2     -C5     -C9        -164.4(2) 
  
         C10    -O4     -C6     -O3          -2.5(4) 
  
         C10    -O4     -C6     -C1         177.1(3) 
  
         O2     -C1     -C2     -C3         -52.4(3) 
  
         O2     -C1     -C2     -C7          66.1(3) 
  
         O2     -C1     -C2     -C8        -169.4(2) 
  
         C6     -C1     -C2     -C3        -170.6(2) 
  
         C6     -C1     -C2     -C7         -52.1(3) 
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         C6     -C1     -C2     -C8          72.4(3) 
  
         O2     -C1     -C6     -O3         -15.8(4) 
  
         O2     -C1     -C6     -O4         164.7(2) 
  
         C2     -C1     -C6     -O3         105.4(3) 
  
         C2     -C1     -C6     -O4         -74.2(3) 
  
         C1     -C2     -C3     -O1         -51.3(3) 
  
         C1     -C2     -C3     -C4          17.6(4) 
  
         C7     -C2     -C3     -O1        -171.8(2) 
  
         C7     -C2     -C3     -C4        -102.9(3) 
  
         C8     -C2     -C3     -O1          68.0(3) 
  
         C8     -C2     -C3     -C4         136.9(3) 
  
         O1     -C3     -C4     -C5         105.8(3) 
  
         C2     -C3     -C4     -O1        -102.7(3) 
  
         C2     -C3     -C4     -C5           3.1(4) 
  
 
       Table S7 - Torsion Angles (Degrees)  (continued) 
                    for: compound15P 21/c       R = 0.06 
  
  
         O1     -C4     -C5     -O2          77.8(3) 
  
         O1     -C4     -C5     -O5         -43.7(3) 
  
         O1     -C4     -C5     -C9        -167.0(2) 
  
         C3     -C4     -C5     -O2           8.9(4) 
  
         C3     -C4     -C5     -O5        -112.5(3) 
  
         C3     -C4     -C5     -C9         124.1(3) 
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        Table S8 - Contact Distances(Angstrom) 
                   for: compound15P 21/c       R = 0.06 
  
  
        O1     .O2         3.160(3)     O5     .H1          2.60(3) 
  
        O1     .O5         2.778(3)     O5     .H3_c        2.83(3) 
  
        O1     .C10_b      3.308(6)     C3     .O1_h       3.297(4) 
  
        O1     .C3_c       3.297(4)     C6     .C9_d       3.593(5) 
  
        O2     .O3         2.646(3)     C7     .O3         3.386(4) 
  
        O2     .O1         3.160(3)     C8     .O4         2.979(4) 
  
        O2     .O5_d       3.095(3)     C9     .C6_d       3.593(5) 
  
        O3     .O5_d       3.092(3)     C10    .O1_b       3.308(6) 
  
        O3     .C7         3.386(4)     C1     .H9C_d       3.07(3) 
  
        O3     .O2         2.646(3)     C3     .H10B_a      2.98(5) 
  
        O4     .C8         2.979(4)     C4     .H3_c        2.88(2) 
  
        O5     .O1         2.778(3)     C4     .H1          2.86(3) 
  
        O5     .O3_d       3.092(3)     C6     .H9C_d       3.04(3) 
  
        O5     .O2_d       3.095(3)     C6     .H5O_d       3.01(4) 
  
        O1     .H8C         2.72(3)     C6     .H7C         2.68(3) 
  
        O1     .H1          2.59(3)     C6     .H8B         2.98(3) 
  
        O1     .H10B_a      2.91(5)     H1     .O1          2.59(3) 
  
        O1     .H10B_b      2.73(5)     H1     .O5          2.60(3) 
  
        O1     .H3_c        2.38(2)     H1     .C4          2.86(3) 
  
        O2     .H5O_d       2.29(3)     H1     .H8C         2.46(4) 
  
 238 
        O2     .H7B         2.75(3)     H3     .H7A         2.49(4) 
  
        O3     .H4_e        2.88(3)     H3     .H8A         2.57(4) 
  
        O3     .H10A        2.67(5)     H3     .H10B_a      2.49(6) 
  
        O3     .H10C        2.69(5)     H3     .O1_h        2.38(2) 
  
        O3     .H7B_f       2.77(3)     H3     .O5_h        2.83(3) 
  
        O3     .H5O_d       2.47(3)     H3     .C4_h        2.88(2) 
  
        O4     .H8B         2.50(3)     H4     .H9A         2.53(4) 
  
        O5     .H7A_g       2.84(3)     H4     .H9B         2.44(4) 
  
 
  
        Table S8 - Contact Distances(Angstrom) (continued) 
                   for: compound15P 21/c       R = 0.06 
  
  
        H4     .O3_i        2.88(3)     H8B    .C6          2.98(3) 
  
        H5O    .H9C         2.45(5)     H8B    .H7C         2.60(5) 
  
        H5O    .O2_d        2.29(3)     H8C    .O1          2.72(3) 
  
        H5O    .O3_d        2.47(3)     H8C    .H1          2.46(4) 
  
        H5O    .C6_d        3.01(4)     H9A    .H4          2.53(4) 
  
        H7A    .O5_j        2.84(3)     H9A    .H7C_f       2.55(4) 
  
        H7A    .H3          2.49(4)     H9B    .H4          2.44(4) 
  
        H7A    .H8A         2.58(5)     H9C    .H5O         2.45(5) 
  
        H7B    .O2          2.75(3)     H9C    .C1_d        3.07(3) 
  
        H7B    .O3_f        2.77(3)     H9C    .C6_d        3.04(3) 
  
        H7B    .H7B_f       2.43(5)     H10A   .O3          2.67(5) 
  
        H7C    .C6          2.68(3)     H10B   .O1_k        2.91(5) 
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        H7C    .H8B         2.60(5)     H10B   .C3_k        2.98(5) 
  
        H7C    .H9A_f       2.55(4)     H10B   .H3_k        2.49(6) 
  
        H8A    .H3          2.57(4)     H10B   .O1_b        2.73(5) 
  
        H8A    .H7A         2.58(5)     H10C   .O3          2.69(5) 
  
        H8A    .H10C_a      2.55(6)     H10C   .H8A_k       2.55(6) 
  
        H8B    .O4          2.50(3) 
  
  
        Table S9 - Hydrogen Bonds (Angstrom, Deg) 
                   for: compound15P 21/c       R = 0.06 
  
  
O5   -- H5O  .. O2         0.84(3)    2.29(3)   3.095(3)     160(3)   3_675 
  
O5   -- H5O  .. O3         0.84(3)    2.47(3)   3.092(3)     132(3)   3_675 
  
C3   -- H3   .. O1         0.93(2)    2.38(2)   3.297(4)     167(2)   4_565 
  
C8   -- H8B  .. O4         0.96(3)    2.50(3)   2.979(4)     111(2)     . 
  
 Translation of Symmetry Code to Equiv.Pos 
  
  
a =[  2545.00 ]  = -x,-1/2+y,1/2-z 
b =[  3575.00 ]  = -x,2-y,-z 
c =[  4564.00 ]  = x,3/2-y,-1/2+z 
d =[  3675.00 ]  = 1-x,2-y,-z 
e =[  2655.00 ]  = 1-x,1/2+y,1/2-z 
f =[  3676.00 ]  = 1-x,2-y,1-z 
g =[  1554.00 ]  = x,y,-1+z 
h =[  4565.00 ]  = x,3/2-y,1/2+z 
i =[  2645.00 ]  = 1-x,-1/2+y,1/2-z 
j =[  1556.00 ]  = x,y,1+z 
k =[  2555.00 ]  = -x,1/2+y,1/2-z 
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